hg_47727.1

Basic information about the TSS

---

TSS ID: hg_47727.1 Species: human Chr: chr4		Start: 56435730 End: 56435779 Strand: +
TSS cluster detected*

  * The number of TSS cluster called studies (maximum 16)

Gene and protein annotation

---

Transcript_name: ENST00000514888.5 ENST00000264221.6 ENST00000505164.5 NM_006452 uc062wut.1 uc003hbs.1 uc062wuu.1 AK294821 BC010273 Distance: 0 GeneID: 10606 HGNC/MGI_ID: HGNC:8587 UniProt_ID: A0A024RD93 B4DGX3 D6RF62 E9PBS1 P22234

Gene_name: phosphoribosylaminoimidazole carboxylase; phosphoribosylaminoimidazolesuccinocarboxamide synthase Gene_symbol: PAICS Gene_synonyms: ADE2H1 AIRC Gene_source: HGNC:8587

TATA-Box annotation

---

Distance to TSS:	6
Nearest PromoterID:	NM_006452
Entrez ID:	10606
Nearest Unigene:	Hs.518774
Nearest Refseq:	NM_006452
Nearest Ensembl:	ENSG00000128050
Gene Name:	phosphoribosylaminoimidazole carboxylase; phosphoribosylaminoimidazolesuccinocarboxamide synthase
Gene Alias:	ADE2
Gene Description:	phosphoribosylaminoimidazole carboxylase and phosphoribosylaminoimidazolesuccinocarboxamide synthase
Gene Type:	protein-coding
CpG%:	0.065
GC%:	0.606965
TATA-Box(TBP)/Promoter/Homer Distance From TSS(sequence,strand,conservation):

TSS expression

Sample Category  All in vivo cell sample cell line sample tissue sample human bronchial epithelial cell sample CD19-positive B cell sample CD8-positive T cell sample CD4-positive T cell sample common myeloid progenitor sample human monocyte immature derived dendritic cell sample human endothelial cell of the aorta sample human cardiac fibroblast sample human dermal fibroblast sample human fibroblast of gingiva sample human fibroblast of periodontium sample granulocyte macrophage progenitor cell sample human hepatocyte sample human mesenchymal stem cell of umbilical cord-Sciencell sample human mesenchymal stem cell of adipose sample human mesenchymal stem cell of bone marrow sample mouse sample mouse granule cell sample mouse hepatocyte sample human neutrophil sample human osteoblast-Sciencell sample human osteoblast-Cell applications sample human renal glomerular endothelial cell sample human retinal pigment epithelial cell sample human skeletal muscle cell sample human aortic smooth muscle cell sample human smooth muscle cell of umbilical artery sample human urothelial cell sample cerebellar granule cell sample human sample mast cell- heparinase treated sample human mature adipocyte sample human cardiac mesenchymal precursor cell sample human mesenchymal precursor cell- ovarian cancer-left ovary sample human mesenchymal precursor cell- ovarian cancer-metastasis sample human mesenchymal precursor cell- ovarian cancer-right ovary sample human whole blood sample control treatment sample human adipose tissue - adult sample human brain - adult sample human parietal lobe - adult sample hippocampus - adult sample human CD14-CD16-positive Monocytes sample mouse cerebellum- embryo E13 sample mouse cerebellum- embryo E15 sample mouse cerebellum- embryo E18 sample human Monocyte-derived macrophages 0h after mock infection sample human Monocyte-derived macrophages 0h after udorn influenza infection sample human Monocyte-derived macrophages 2h after udorn influenza infection sample human Monocyte-derived macrophages 7h after udorn influenza infection sample human Monocyte-derived macrophages 24h after udorn influenza infection sample human Monocyte-derived macrophages 24h after mock infection sample mouse whole body- embryo E17.5 sample adenocarcinoma cell line sample small cell lung cancer cell sample carcinoma cell line sample teratocarcinoma cell line sample sarcoma cell line sample K-562 cell sample embryonic cell line sample epithelial cell line sample THP-1 cell sample gastrointestinal cancer cell sample acute myeloid leukemia cell line sample cervical cancer cell line sample squamous cell carcinoma cell line sample mesothelioma cell line sample NCI cell sample human nasal epithelial cell sample macrophage, TB infection sample iPS differentiation to neuron, control sample iPS differentiation to neuron, down-syndrome donor sample myoblast differentiation to myotubes, control sample H1 embryonic stem cells differentiation to CD34+ HSC sample 293SLAM rinderpest infection sample COBL-a rinderpest infection sample partial hepatectomy sample sham operation sample ES-OS25 embryonic stem cells sample ES-OS25 embryonic stem cells, untreated sample ES-46C embryonic stem cells, neuronal differentiation sample ES-OS25 embryonic stem cells, KD for exosomal component EXOSC3, biol_rep1 sample ARPE-19 EMT induced with TGF-beta and TNF-alpha sample hIPS sample

		Promoter select All p1@PAICS p2@PAICS p3@PAICS p4@PAICS p5@PAICS p8@PAICS p9@PAICS p10@PAICS
Sample		p1@PAICS	p2@PAICS	p3@PAICS	p4@PAICS	p5@PAICS	p8@PAICS	p9@PAICS	p10@PAICS
293SLAM rinderpest infection, 00hr, biol_rep1	13541-145H4	103.83	12.66	7.60	1.56	8.38	0.39	0.19	1.75
293SLAM rinderpest infection, 00hr, biol_rep2	13542-145H5	85.38	12.14	9.51	1.62	7.08	2.43	0.40	1.21
293SLAM rinderpest infection, 00hr, biol_rep3	13543-145H6	97.61	13.31	10.80	2.51	10.61	2.12	0.00	0.39
293SLAM rinderpest infection, 06hr, biol_rep1	13544-145H7	83.16	12.89	9.15	0.42	4.99	1.66	0.21	0.83
293SLAM rinderpest infection, 06hr, biol_rep2	13545-145H8	82.79	19.12	9.90	0.00	6.97	0.45	0.00	0.22
293SLAM rinderpest infection, 06hr, biol_rep3	13546-145H9	87.80	14.54	8.72	0.97	6.40	1.74	0.19	1.36
293SLAM rinderpest infection, 12hr, biol_rep1	13547-145I1	106.98	30.94	11.77	0.87	7.63	1.31	0.22	1.31
293SLAM rinderpest infection, 12hr, biol_rep2	13548-145I2	116.27	23.50	10.90	1.94	8.96	0.97	0.24	1.70
293SLAM rinderpest infection, 12hr, biol_rep3	13549-145I3	83.78	17.74	7.91	2.56	5.98	1.07	0.21	0.00
293SLAM rinderpest infection, 24hr, biol_rep1	13550-145I4	63.18	24.92	4.06	0.00	6.96	1.16	0.00	1.16
293SLAM rinderpest infection, 24hr, biol_rep2	13551-145I5	59.42	28.30	6.06	0.40	7.68	0.81	0.81	0.40
293SLAM rinderpest infection, 24hr, biol_rep3	13552-145I6	48.38	22.77	4.07	0.81	3.25	0.00	0.81	1.22
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep1	13625-146H7	52.23	8.06	3.06	1.13	0.97	0.64	0.48	0.64
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep2	13626-146H8	62.40	5.71	1.95	0.75	1.05	0.90	0.30	0.90
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep3	13627-146H9	50.72	8.12	2.42	0.22	0.88	0.66	0.22	0.22
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep1	13628-146I1	50.55	5.78	2.01	0.50	1.26	1.01	0.00	0.50
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep2	13629-146I2	52.64	6.12	2.18	1.09	0.66	0.66	0.44	0.22
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep3	13630-146I3	56.52	4.64	2.11	0.42	0.00	0.84	0.42	1.27
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep1	13631-146I4	49.05	4.80	3.73	1.07	0.00	0.00	0.00	0.53
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep2	13632-146I5	53.41	4.96	2.11	0.75	0.30	0.30	0.30	0.90
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep3	13633-146I6	55.87	6.82	2.14	1.47	1.20	1.20	0.13	0.27
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep1	13634-146I7	69.39	5.70	2.76	1.38	1.04	0.17	0.69	0.86
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep2	13635-146I8	60.36	6.20	2.59	1.03	1.03	0.26	0.13	0.39
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep3	13636-146I9	52.42	6.07	1.94	0.73	0.97	1.21	0.00	0.49
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep1	13637-147A1	55.21	8.77	1.55	1.03	0.26	0.77	0.00	0.52
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep2	13638-147A2	56.34	7.28	1.58	1.27	1.27	2.85	0.95	0.32
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep3	13639-147A3	59.89	9.34	2.75	1.10	1.10	1.65	0.55	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep1	13640-147A4	67.90	9.90	1.65	0.71	0.94	0.47	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep2	13641-147A5	51.04	5.17	2.42	1.29	0.48	0.48	0.00	0.32
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep3	13642-147A6	59.36	5.97	2.90	1.09	0.90	1.09	0.36	0.18
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep1	13643-147A7	53.59	6.07	2.51	0.84	1.26	1.26	0.21	0.21
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep2	13644-147A8	50.80	5.86	2.15	0.39	1.76	1.17	0.20	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep3	13645-147A9	51.70	5.70	2.74	1.48	1.69	2.11	0.00	1.48
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep1	13646-147B1	86.59	8.74	1.32	0.66	0.49	1.32	0.00	0.66
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep2	13647-147B2	54.41	8.41	2.62	1.50	0.37	1.12	0.19	1.31
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep3	13648-147B3	49.63	6.52	2.49	0.96	0.38	0.77	0.38	0.96
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep1	13649-147B4	48.64	5.31	0.82	0.61	1.02	0.41	0.41	1.02
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep2	13650-147B5	45.94	6.45	1.41	0.20	0.60	0.60	0.00	0.60
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep3	13651-147B6	65.91	7.83	1.89	1.08	1.35	0.81	0.27	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep1	13652-147B7	52.09	5.28	1.92	1.20	0.00	0.00	0.24	0.24
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep2	13653-147B8	45.64	8.23	1.65	1.41	0.00	0.94	0.00	0.24
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep3	13654-147B9	63.54	7.03	3.22	1.17	1.46	0.44	0.44	0.15
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep1	13655-147C1	45.55	6.12	1.27	1.27	0.00	0.84	0.84	0.63
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep2	13656-147C2	44.41	6.82	1.05	0.87	0.52	0.70	0.35	0.35
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep3	13657-147C3	55.81	7.43	2.01	1.20	0.40	0.40	0.60	0.40
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep1	13658-147C4	43.04	6.05	1.63	1.16	1.16	2.09	0.23	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep2	13659-147C5	45.34	4.80	2.16	0.24	0.96	0.72	0.00	0.24
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep3	13660-147C6	47.69	7.45	2.09	0.60	0.30	0.60	0.00	0.30
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep1	13661-147C7	32.79	6.70	2.63	1.20	0.24	0.48	0.00	0.96
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep2	13662-147C8	36.80	5.66	2.43	0.20	0.00	0.40	0.40	0.40
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep3	13663-147C9	35.05	8.61	2.46	0.61	2.87	0.61	0.00	1.23
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep1	13664-147D1	37.14	4.23	0.89	0.67	1.11	1.78	0.89	0.89
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep2	13665-147D2	545.70	27.98	0.00	0.00	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep3	13666-147D3	34.07	4.26	2.13	1.06	0.00	0.35	0.35	1.06
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep1	13667-147D4	28.50	3.65	1.33	0.66	0.66	0.99	1.33	0.66
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep2	13668-147D5	180.37	16.78	0.84	3.36	0.84	2.52	0.00	2.52
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep3	13669-147D6	58.78	5.05	2.76	0.92	0.46	2.76	0.46	1.84
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep1	13670-147D7	28.52	4.86	1.62	0.00	0.65	0.97	0.00	0.97
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep2	13671-147D8	20.88	5.14	1.28	0.00	0.32	0.64	0.32	0.64
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep3	13672-147D9	50.92	8.17	1.57	0.94	0.00	0.94	0.31	0.94
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep2	13674-147E2	25.38	2.82	2.82	0.00	2.12	2.82	0.00	0.71
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep3	13675-147E3	25.80	3.93	1.68	0.56	0.56	1.12	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep1	13676-147E4	37.42	9.55	3.98	0.00	0.00	3.18	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep2	13677-147E5	28.54	3.74	2.04	0.00	0.34	0.34	0.34	1.02
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep3	13678-147E6	17.22	4.55	3.57	0.00	0.00	0.65	0.00	0.65
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep1	13679-147E7	18.81	5.68	0.71	0.35	1.06	0.71	0.35	1.06
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep2	13680-147E8	226.30	32.33	16.16	0.00	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep3	13681-147E9	276.41	15.79	7.90	0.00	0.00	7.90	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep1	13682-147F1	31.69	5.85	2.93	0.49	0.49	0.98	0.00	1.46
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep2	13683-147F2	26.78	4.46	2.48	0.99	0.50	0.99	0.00	0.50
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep3	13684-147F3	34.71	3.28	2.35	0.47	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep1	13685-147F4	43.39	3.31	2.65	0.00	1.99	1.32	0.33	0.99
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep2	13686-147F5	31.55	3.40	0.93	1.24	1.55	0.31	0.00	0.93
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep3	13687-147F6	30.27	4.28	1.22	0.00	0.31	0.31	0.00	0.31
Adipocyte - breast, donor1	11376-118A8	18.69	6.97	0.63	1.11	0.48	0.16	0.16	0.00
Adipocyte - breast, donor2	11327-117E4	24.22	5.78	0.80	0.48	0.96	0.32	0.48	0.00
Adipocyte - omental, donor1	11473-119C6	27.86	8.14	2.93	1.15	0.25	0.38	0.13	0.13
Adipocyte - omental, donor2	11474-119C7	10.46	5.23	0.00	0.75	0.00	0.00	0.00	0.00
Adipocyte - omental, donor3	11475-119C8	11.39	3.01	0.33	0.00	0.00	0.33	0.00	0.33
Adipocyte - perirenal, donor1	11476-119C9	19.14	6.38	3.19	0.64	0.00	0.00	0.00	0.64
Adipocyte - subcutaneous, donor1	11259-116F8	13.19	3.30	1.10	0.00	0.00	1.10	0.00	0.00
Adipocyte - subcutaneous, donor2	11336-117F4	71.81	4.97	4.06	1.81	0.45	0.00	0.00	0.45
Adipocyte - subcutaneous, donor3	11408-118E4	25.20	7.12	1.22	1.04	0.35	0.00	0.00	0.17
Adipocyte differentiation, day04, donor1	13019-139D4	39.90	7.24	1.17	0.78	0.78	0.00	0.39	0.20
Adipocyte differentiation, day04, donor2	13022-139D7	27.54	2.57	0.26	0.77	0.51	0.26	0.00	0.26
Adipocyte differentiation, day04, donor3	13025-139E1	25.93	7.81	0.28	1.95	1.39	0.28	0.28	0.56
Adipocyte differentiation, day04, donor4	13028-139E4	19.99	8.23	2.94	1.18	0.00	1.18	0.59	1.18
Adipocyte differentiation, day08, donor1	13020-139D5	45.61	8.45	1.53	1.37	0.56	0.00	0.32	0.48
Adipocyte differentiation, day08, donor2	13023-139D8	17.75	5.81	0.32	0.97	0.32	0.00	0.32	0.00
Adipocyte differentiation, day08, donor3	13026-139E2	18.13	6.93	0.53	0.53	1.07	0.53	0.00	0.00
Adipocyte differentiation, day08, donor4	13029-139E5	13.35	5.01	0.00	0.56	0.00	0.56	0.00	0.00
Adipocyte differentiation, day12, donor1	13021-139D6	15.80	4.57	0.42	2.08	0.00	0.00	0.42	0.00
Adipocyte differentiation, day12, donor2	13024-139D9	16.83	5.02	1.00	0.50	1.26	0.00	0.00	0.25
Adipocyte differentiation, day12, donor3	13027-139E3	15.71	6.54	0.00	2.29	0.65	0.33	0.00	0.00
Adipocyte differentiation, day12, donor4	13030-139E6	13.70	3.35	0.30	1.52	0.61	0.30	0.00	0.30
Alveolar Epithelial Cells, donor1	11510-119G7	59.89	7.51	1.99	0.88	0.88	0.22	0.22	0.22
Alveolar Epithelial Cells, donor2	11590-120G6	11.83	2.87	0.00	0.72	0.00	0.00	0.00	0.00
Alveolar Epithelial Cells, donor3	11671-122G6	9.58	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Amniotic Epithelial Cells, donor1	11533-120A3	32.02	5.76	2.88	0.90	0.54	0.36	0.18	0.36
Amniotic Epithelial Cells, donor2	11613-122A2	6.69	3.35	1.67	3.35	0.00	0.00	0.00	0.00
Amniotic Epithelial Cells, donor3	11694-123A2	14.79	5.55	1.44	0.21	0.21	0.00	0.21	0.00
Anulus Pulposus Cell, donor1	11248-116E6	71.52	5.38	2.98	1.03	0.92	0.46	0.23	0.11
Anulus Pulposus Cell, donor2	11463-119B5	38.21	6.61	1.96	0.73	0.73	0.49	0.49	0.00
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep1 (LK1)	12642-134G5	28.75	6.29	0.90	0.45	1.35	0.00	0.45	0.45
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep2 (LK2)	12740-135I4	30.39	6.51	1.74	0.43	0.87	0.43	0.43	0.43
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep3 (LK3)	12838-137B3	32.10	6.42	0.00	0.00	2.14	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep1 (LK4)	12643-134G6	26.31	5.08	1.79	0.60	0.30	0.90	0.60	0.30
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep2 (LK5)	12741-135I5	31.62	6.32	2.53	1.26	3.79	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep3 (LK6)	12839-137B4	24.42	7.26	0.66	1.32	1.32	0.66	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep1 (LK7)	12644-134G7	20.47	5.85	1.62	0.65	2.60	0.00	0.65	0.00
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep2 (LK8)	12742-135I6	31.55	9.22	1.46	0.00	1.46	0.00	0.49	0.49
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep3 (LK9)	12840-137B5	23.76	7.72	2.38	0.59	2.38	0.59	0.59	0.00
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep1 (LK10)	12645-134G8	36.53	9.42	1.88	0.38	2.26	1.13	0.38	0.38
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep2 (LK11)	12743-135I7	26.12	5.81	1.45	1.45	4.35	0.00	1.45	0.00
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep3 (LK12)	12841-137B6	23.82	6.27	1.25	0.00	1.25	1.25	0.00	0.00
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep1 (LK13)	12646-134G9	46.46	7.91	3.13	0.82	0.66	0.16	0.00	0.00
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep2 (LK14)	12744-135I8	21.84	6.82	0.00	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep3 (LK15)	12842-137B7	28.05	4.67	1.51	1.06	0.60	0.15	0.30	0.15
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep1 (LK16)	12647-134H1	30.54	4.82	1.07	0.00	1.61	0.00	0.00	0.54
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep2 (LK17)	12745-135I9	22.67	8.31	2.27	2.08	1.32	0.00	0.00	1.13
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep3 (LK18)	12843-137B8	31.01	6.95	1.07	1.34	0.80	0.27	0.00	0.00
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep1 (LK19)	12648-134H2	22.44	8.78	2.93	0.00	0.00	0.00	0.00	0.98
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep2 (LK20)	12746-136A1	31.68	6.63	1.82	1.00	2.32	0.17	0.00	0.17
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep3 (LK21)	12844-137B9	25.22	6.00	2.40	1.20	1.20	1.20	0.00	0.00
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep1 (LK22)	12649-134H3	14.16	7.08	3.54	0.00	3.54	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep2 (LK23)	12747-136A2	29.67	5.66	2.06	1.37	0.86	0.34	0.17	0.17
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep3 (LK24)	12845-137C1	16.78	0.00	4.19	0.00	4.19	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep1 (LK25)	12650-134H4	29.13	8.74	2.43	0.97	3.40	0.00	0.97	0.49
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep2 (LK26)	12748-136A3	36.81	6.07	1.52	0.00	0.76	0.76	1.14	0.00
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep3 (LK27)	12846-137C2	30.28	7.27	0.00	3.63	1.21	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep1 (LK28)	12651-134H5	30.78	8.55	1.71	1.14	1.71	0.00	0.00	0.57
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep2 (LK29)	12749-136A4	25.44	6.63	1.50	1.07	1.28	0.00	0.21	0.00
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep3 (LK30)	12847-137C3	19.61	6.97	2.32	0.26	1.03	0.00	0.00	0.26
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep1 (LK31)	12652-134H6	30.97	7.98	3.28	0.94	4.22	0.47	0.00	0.47
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep2 (LK32)	12750-136A5	23.15	6.11	0.64	0.64	2.25	0.64	0.32	0.32
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep3 (LK33)	12848-137C4	31.39	4.99	0.71	1.43	0.71	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep1 (LK34)	12653-134H7	24.57	3.51	2.34	0.58	3.51	0.00	0.58	0.58
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep2 (LK35)	12751-136A6	30.11	6.32	2.11	0.90	1.81	0.90	0.30	1.20
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep3 (LK36)	12849-137C5	32.08	4.75	1.19	0.00	2.38	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep1 (LK37)	12654-134H8	33.06	5.59	2.03	0.00	1.53	0.51	0.00	0.51
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep2 (LK38)	12752-136A7	38.71	8.66	2.04	1.27	2.55	0.76	0.00	1.02
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep3 (LK39)	12850-137C6	32.40	5.72	1.27	0.64	1.91	0.64	0.64	0.64
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep1 (LK40)	12655-134H9	27.62	5.61	0.43	0.86	0.86	0.86	0.43	0.43
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep2 (LK41)	12753-136A8	33.02	6.99	2.12	1.06	2.33	0.00	0.42	0.42
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep3 (LK42)	12851-137C7	27.55	5.51	2.32	0.58	0.87	0.29	0.00	0.00
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep1 (LK43)	12656-134I1	23.62	11.34	0.94	1.89	0.00	0.00	0.00	1.89
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep2 (LK44)	12754-136A9	30.85	7.12	1.02	1.70	2.03	0.17	0.34	0.00
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep3 (LK45)	12852-137C8	30.11	4.63	2.32	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep1 (LK46)	12657-134I2	19.01	10.56	0.00	2.11	2.11	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep2 (LK47)	12755-136B1	23.16	7.08	1.29	1.50	1.93	0.21	0.43	0.21
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep3 (LK48)	12853-137C9	30.08	4.81	0.00	0.00	0.60	0.00	1.20	0.00
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep1 (LK49)	12658-134I3	26.24	7.29	2.19	0.00	2.92	2.19	0.73	0.00
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep2 (LK50)	12756-136B2	34.02	5.06	2.76	0.46	3.22	0.00	0.00	0.23
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep3 (LK51)	12854-137D1	25.50	5.10	0.00	0.00	0.00	5.10	0.00	0.00
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep1 (LK52)	12659-134I4	28.22	5.59	2.29	0.76	0.76	0.00	0.25	0.25
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep2 (LK53)	12757-136B3	27.25	7.43	1.03	1.65	1.65	0.00	0.41	0.83
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep3 (LK54)	12855-137D2	27.54	5.81	1.22	0.92	1.84	0.00	0.00	0.61
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep1 (LK55)	12660-134I5	27.72	7.17	2.87	0.96	1.43	0.00	0.00	1.43
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep2 (LK56)	12758-136B4	25.72	5.99	1.33	0.44	2.22	0.22	0.22	0.22
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep3 (LK57)	12856-137D3	24.41	6.10	1.53	4.58	0.00	3.05	0.00	0.00
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep1 (LK58)	12661-134I6	24.92	2.77	0.55	1.11	1.66	0.55	0.00	0.00
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep2 (LK59)	12759-136B5	25.95	5.30	2.12	1.32	0.79	0.26	0.00	0.53
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep3 (LK60)	12857-137D4	18.90	4.36	1.45	0.36	0.00	0.00	0.00	0.00
Astrocyte - cerebellum, donor1	11500-119F6	59.57	7.74	1.47	0.49	0.12	0.49	0.00	0.00
Astrocyte - cerebellum, donor2	11580-120F5	23.28	4.96	1.03	0.51	0.51	0.00	0.17	0.17
Astrocyte - cerebellum, donor3	11661-122F5	13.84	3.99	0.42	0.21	0.63	0.21	0.42	0.00
Astrocyte - cerebral cortex, donor1	11235-116D2	172.90	14.99	4.18	1.05	2.79	0.70	0.35	0.35
Astrocyte - cerebral cortex, donor2	11316-117D2	155.79	16.99	5.18	3.07	1.46	2.43	0.49	0.81
Astrocyte - cerebral cortex, donor3	11392-118C6	151.25	14.02	3.28	2.24	2.54	1.19	0.60	0.45
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep1	10821-111C2	354.26	29.82	15.37	4.59	3.90	0.57	0.23	0.69
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep2	10822-111C3	358.43	31.82	18.79	4.38	3.26	1.75	0.50	1.13
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep3	10823-111C4	365.29	30.50	18.21	5.80	3.07	1.25	0.46	0.80
Basophils, donor1	12241-129G9	2.88	6.02	0.00	0.52	0.00	0.00	0.00	0.00
Basophils, donor2	12242-129H1	3.97	9.74	0.00	1.08	0.36	0.00	0.72	0.00
Basophils, donor3	12243-129H2	5.59	7.20	0.15	0.44	0.15	0.00	0.15	0.15
Bronchial Epithelial Cell, donor1	11511-119G8	14.88	2.59	0.00	0.65	0.00	0.00	0.00	0.22
Bronchial Epithelial Cell, donor2	11591-120G7	3.66	0.46	0.00	0.46	0.00	0.00	0.00	0.00
Bronchial Epithelial Cell, donor3	11672-122G7	28.69	14.35	0.00	0.00	0.00	0.00	0.00	0.00
Bronchial Epithelial Cell, donor4	11453-119A4	43.31	9.41	0.63	0.00	0.00	0.00	0.63	0.00
Bronchial Epithelial Cell, donor5	11457-119A8	21.00	5.20	0.83	0.62	0.42	0.00	0.21	0.00
Bronchial Epithelial Cell, donor6	11461-119B3	33.16	10.13	0.00	1.84	0.00	0.00	0.00	0.00
Bronchial Epithelial Cell, donor7	11769-123I5	69.64	4.32	0.90	0.90	0.54	0.54	0.18	0.36
Burkitt's lymphoma cell line:DAUDI	10422-106C8	369.87	43.80	12.78	4.95	3.92	0.21	0.82	1.03
Burkitt's lymphoma cell line:RAJI	10476-106I8	535.91	28.41	14.67	3.03	6.99	1.16	0.23	2.33
CD133+ stem cells - adult bone marrow derived, pool1	12224-129F1	187.07	13.43	3.52	2.88	1.28	0.64	0.64	0.00
CD133+ stem cells - cord blood derived, pool1	12223-129E9	134.45	20.68	0.00	0.00	0.00	0.00	0.00	0.00
CD14+ Monocytes, donor1	11224-116B9	4.51	13.53	0.00	0.00	0.56	0.00	0.56	0.00
CD14+ Monocytes, donor2	11305-117B9	2.78	9.47	0.00	0.19	0.19	0.00	0.19	0.19
CD14+ Monocytes, donor3	11381-118B4	3.95	8.56	0.22	0.44	0.22	0.00	0.22	0.00
CD14+ monocyte derived endothelial progenitor cells, donor1	11229-116C5	9.06	4.53	0.57	0.85	0.28	0.00	0.00	0.00
CD14+ monocyte derived endothelial progenitor cells, donor2	11310-117C5	10.61	4.93	0.38	0.00	0.00	0.00	0.00	0.38
CD14+ monocyte derived endothelial progenitor cells, donor3	11386-118B9	5.92	2.96	0.33	0.33	0.00	0.00	0.00	0.00
CD14+ monocytes - mock treated, donor1	11863-125A9	1.73	3.76	0.00	0.00	0.14	0.00	0.43	0.14
CD14+ monocytes - mock treated, donor2	11873-125C1	1.21	3.62	0.00	0.60	0.00	0.00	0.00	0.00
CD14+ monocytes - mock treated, donor3	11883-125D2	0.24	4.50	0.00	0.71	0.00	0.00	0.24	0.00
CD14+ monocytes - treated with B-glucan, donor1	11869-125B6	0.17	2.85	0.00	0.00	0.33	0.00	0.00	0.00
CD14+ monocytes - treated with B-glucan, donor2	11879-125C7	1.66	3.31	0.00	0.55	0.28	0.00	0.00	0.00
CD14+ monocytes - treated with B-glucan, donor3	11889-125D8	1.74	3.22	0.00	0.74	0.00	0.00	0.50	0.00
CD14+ monocytes - treated with BCG, donor1	11860-125A6	0.20	4.11	0.00	0.39	0.00	0.00	0.39	0.00
CD14+ monocytes - treated with BCG, donor2	11870-125B7	2.14	3.38	0.18	0.00	0.00	0.00	0.18	0.00
CD14+ monocytes - treated with BCG, donor3	11880-125C8	1.96	5.01	0.00	0.44	0.00	0.00	0.00	0.00
CD14+ monocytes - treated with Candida, donor1	11868-125B5	1.64	3.51	0.00	0.00	0.00	0.00	0.23	0.23
CD14+ monocytes - treated with Candida, donor2	11878-125C6	3.70	7.39	0.00	0.00	0.00	0.00	0.00	0.00
CD14+ monocytes - treated with Candida, donor3	11888-125D7	2.22	8.87	0.00	1.11	0.00	0.00	0.00	0.00
CD14+ monocytes - treated with Cryptococcus, donor1	11867-125B4	0.74	2.97	0.15	0.15	0.30	0.00	0.00	0.00
CD14+ monocytes - treated with Cryptococcus, donor2	11877-125C5	1.00	2.39	0.20	0.40	0.00	0.00	0.40	0.00
CD14+ monocytes - treated with Cryptococcus, donor3	11887-125D6	1.04	3.75	0.00	0.21	0.00	0.00	0.42	0.00
CD14+ monocytes - treated with Group A streptococci, donor1	11864-125B1	0.23	4.35	0.23	0.00	0.00	0.00	0.23	0.00
CD14+ monocytes - treated with Group A streptococci, donor2	11874-125C2	1.58	2.26	0.23	0.00	0.00	0.00	0.00	0.23
CD14+ monocytes - treated with Group A streptococci, donor3	11884-125D3	1.75	3.49	0.00	0.00	0.44	0.00	0.00	0.00
CD14+ monocytes - treated with IFN + N-hexane, donor1	11861-125A7	0.27	4.30	0.00	0.54	0.27	0.00	0.27	0.00
CD14+ monocytes - treated with IFN + N-hexane, donor2	11871-125B8	2.09	4.54	0.00	0.35	0.17	0.00	0.17	0.00
CD14+ monocytes - treated with IFN + N-hexane, donor3	11881-125C9	0.84	4.21	0.00	0.42	0.00	0.00	0.00	0.00
CD14+ monocytes - treated with Salmonella, donor1	11866-125B3	1.29	3.12	0.00	0.00	0.00	0.18	0.00	0.00
CD14+ monocytes - treated with Salmonella, donor2	11876-125C4	1.41	3.17	0.00	1.41	0.00	0.00	0.70	0.00
CD14+ monocytes - treated with Salmonella, donor3	11886-125D5	0.44	2.63	0.00	0.44	0.00	0.00	0.00	0.00
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor1	11862-125A8	1.05	4.01	0.00	0.00	0.00	0.00	0.00	0.00
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor2	11872-125B9	1.86	4.83	0.00	0.74	0.00	0.00	0.00	0.00
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor3	11882-125D1	2.59	7.11	0.00	0.00	0.00	0.00	0.22	0.00
CD14+ monocytes - treated with lipopolysaccharide, donor1	11865-125B2	4.50	3.28	0.41	0.41	0.00	0.00	0.00	0.00
CD14+ monocytes - treated with lipopolysaccharide, donor2	11875-125C3	1.16	2.78	0.23	0.46	0.00	0.00	0.46	0.00
CD14+ monocytes - treated with lipopolysaccharide, donor3	11885-125D4	1.39	5.10	0.00	0.70	0.23	0.00	0.23	0.00
CD14+CD16+ Monocytes, donor1	11789-124B7	6.10	10.46	0.22	1.31	0.22	0.00	0.00	0.00
CD14+CD16+ Monocytes, donor2	11801-124D1	7.39	15.94	0.46	1.15	0.00	0.23	0.92	0.23
CD14+CD16+ Monocytes, donor3	11912-125G4	9.53	9.53	0.00	0.65	0.43	0.00	0.00	0.00
CD14+CD16- Monocytes, donor1	11788-124B6	6.70	12.15	0.16	0.78	0.16	0.00	0.16	0.00
CD14+CD16- Monocytes, donor2	11799-124C8	6.29	9.78	0.17	0.52	0.17	0.00	0.52	0.00
CD14+CD16- Monocytes, donor3	11910-125G2	5.57	13.82	0.45	0.89	0.22	0.00	0.22	0.22
CD14-CD16+ Monocytes, donor1	11790-124B8	2.55	14.80	1.02	0.77	0.00	0.00	0.77	0.00
CD14-CD16+ Monocytes, donor2	11800-124C9	3.73	14.93	1.32	0.88	0.22	0.00	0.00	0.22
CD14-CD16+ Monocytes, donor3	11911-125G3	3.79	13.69	0.21	1.68	0.21	0.00	0.42	0.00
CD19+ B Cells (pluriselect), donor090309, donation1	12189-129B2	34.55	8.13	0.00	0.00	0.00	0.00	0.00	0.00
CD19+ B Cells (pluriselect), donor090309, donation2	12194-129B7	37.29	10.17	1.36	2.03	0.00	0.68	0.00	0.00
CD19+ B Cells (pluriselect), donor090309, donation3	12199-129C3	25.89	8.28	0.00	5.18	2.07	0.00	0.00	0.00
CD19+ B Cells (pluriselect), donor090325, donation1	12151-128F9	37.31	13.33	2.67	0.00	1.60	0.00	0.00	0.53
CD19+ B Cells (pluriselect), donor090325, donation2	12174-128I5	43.42	13.40	1.61	1.61	0.00	0.00	0.54	0.00
CD19+ B Cells (pluriselect), donor090612, donation1	12204-129C8	23.87	10.53	2.11	1.40	0.70	0.00	0.00	0.00
CD19+ B Cells (pluriselect), donor090612, donation2	12209-129D4	29.02	15.69	0.00	2.35	0.78	0.00	0.00	0.00
CD19+ B Cells (pluriselect), donor090612, donation3	12214-129D9	42.19	17.14	0.00	2.64	2.64	0.00	0.00	0.00
CD19+ B Cells, donor1	11544-120B5	14.79	9.86	0.82	3.29	1.64	0.00	0.00	0.00
CD19+ B Cells, donor2	11624-122B4	11.61	9.43	0.73	0.00	1.45	0.00	0.00	0.00
CD19+ B Cells, donor3	11705-123B4	11.61	11.11	0.00	1.51	0.00	0.00	0.00	0.00
CD34 cells differentiated to erythrocyte lineage, biol_ rep1	11931-125I5	160.81	52.53	6.46	23.44	1.21	0.81	0.00	0.40
CD34 cells differentiated to erythrocyte lineage, biol_ rep2	11932-125I6	106.26	47.94	4.79	10.39	5.19	0.40	0.00	0.80
CD34+ Progenitors, donor1	11545-120B6	49.20	7.03	0.00	0.00	0.00	0.00	0.00	0.00
CD34+ Progenitors, donor2	11625-122B5	45.51	9.55	0.56	0.00	0.00	0.00	0.00	0.00
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep1	12225-129F2	205.54	11.65	3.76	4.51	0.75	1.88	0.38	0.00
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep2	12225-129F2	249.38	15.11	4.96	2.71	1.80	0.45	0.23	0.68
CD4+ T Cells, donor1	11225-116C1	31.42	10.35	0.36	2.50	0.00	0.00	0.00	0.00
CD4+ T Cells, donor2	11306-117C1	18.37	6.12	0.61	1.22	0.00	0.00	0.00	0.00
CD4+ T Cells, donor3	11382-118B5	14.33	6.40	0.30	1.22	0.30	0.00	0.00	0.00
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor1	11793-124C2	67.38	5.87	0.77	1.02	0.26	0.51	0.00	0.26
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor2	11915-125G7	67.15	7.86	1.12	1.35	0.90	0.00	0.00	0.22
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor3	11919-125H2	47.14	4.02	0.86	1.44	1.44	0.57	0.29	0.00
CD4+CD25+CD45RA+ naive regulatory T cells, donor1	11780-124A7	38.88	10.43	0.47	3.79	0.47	0.00	0.00	0.00
CD4+CD25+CD45RA+ naive regulatory T cells, donor2	11796-124C5	51.27	14.75	1.40	4.21	0.00	0.00	0.00	0.70
CD4+CD25+CD45RA+ naive regulatory T cells, donor3	11907-125F8	26.37	9.89	0.00	0.00	0.00	3.30	0.00	0.00
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor1	11794-124C3	41.48	5.64	0.43	0.29	0.14	0.14	0.00	0.14
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor2	11916-125G8	40.16	3.90	1.19	0.51	0.34	0.17	0.17	0.00
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor3	11920-125H3	31.27	6.29	1.13	1.13	0.81	0.32	0.00	0.16
CD4+CD25+CD45RA- memory regulatory T cells, donor1	11782-124A9	22.86	9.86	1.79	1.34	0.00	0.00	0.00	0.00
CD4+CD25+CD45RA- memory regulatory T cells, donor2	11797-124C6	25.16	5.94	0.35	0.70	0.00	0.00	0.35	0.00
CD4+CD25+CD45RA- memory regulatory T cells, donor3	11908-125F9	30.80	8.36	1.32	0.88	0.88	0.00	0.00	0.00
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor1	11791-124B9	66.62	6.75	3.79	1.69	0.00	0.00	0.00	0.42
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor2	11913-125G5	41.14	4.99	0.42	0.62	1.66	0.21	0.00	0.21
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor3	11917-125G9	34.08	8.35	0.33	0.67	1.67	0.00	0.33	0.33
CD4+CD25-CD45RA+ naive conventional T cells, donor1	11784-124B2	51.94	11.69	1.63	1.09	0.00	0.27	0.00	0.00
CD4+CD25-CD45RA+ naive conventional T cells, donor2	11795-124C4	74.50	14.47	2.68	1.07	1.07	0.00	0.00	0.00
CD4+CD25-CD45RA+ naive conventional T cells, donor3	11906-125F7	50.21	12.55	0.00	3.59	1.79	0.00	0.00	0.00
CD4+CD25-CD45RA- memory conventional T cells expanded, donor1	11792-124C1	95.31	7.97	5.38	1.30	0.56	0.74	0.37	0.00
CD4+CD25-CD45RA- memory conventional T cells expanded, donor2	11914-125G6	60.00	6.93	1.30	0.65	1.08	0.00	0.00	0.43
CD4+CD25-CD45RA- memory conventional T cells expanded, donor3	11918-125H1	42.45	5.67	1.89	0.84	0.42	0.42	0.00	0.00
CD4+CD25-CD45RA- memory conventional T cells, donor1	11786-124B4	36.91	7.58	0.00	1.52	0.00	0.00	0.00	0.00
CD4+CD25-CD45RA- memory conventional T cells, donor2	11798-124C7	26.86	6.93	0.43	0.87	0.43	0.00	0.00	0.00
CD4+CD25-CD45RA- memory conventional T cells, donor3	11909-125G1	35.74	14.82	0.87	1.74	0.00	0.44	0.44	0.00
CD8+ T Cells (pluriselect), donor090309, donation1	12186-129A8	34.64	13.86	0.99	2.47	0.49	0.00	0.00	0.00
CD8+ T Cells (pluriselect), donor090309, donation2	12191-129B4	27.70	7.39	1.85	0.92	0.00	0.00	0.00	0.00
CD8+ T Cells (pluriselect), donor090309, donation3	12196-129B9	23.73	16.75	1.40	0.00	2.79	0.00	0.00	0.00
CD8+ T Cells (pluriselect), donor090325, donation1	12148-128F6	45.69	14.12	1.38	2.49	0.00	0.00	0.55	0.00
CD8+ T Cells (pluriselect), donor090325, donation2	12171-128I2	44.42	11.78	0.98	2.70	0.25	0.00	0.25	0.25
CD8+ T Cells (pluriselect), donor090612, donation1	12201-129C5	30.80	10.78	0.00	3.08	0.00	0.00	0.00	0.00
CD8+ T Cells (pluriselect), donor090612, donation2	12206-129D1	31.87	10.03	0.00	1.43	0.00	0.00	0.00	0.00
CD8+ T Cells (pluriselect), donor090612, donation3	12211-129D6	26.31	11.08	1.38	4.15	0.00	0.00	0.00	0.00
CD8+ T Cells, donor1	11226-116C2	13.10	7.20	0.33	0.00	0.00	0.00	0.00	0.00
CD8+ T Cells, donor2	11307-117C2	5.26	5.63	0.00	0.38	0.00	0.00	0.00	0.00
CD8+ T Cells, donor3	11383-118B6	13.13	9.09	0.50	1.01	0.00	0.00	0.25	0.00
COBL-a rinderpest infection, 00hr, biol_rep1	13553-145I7	110.34	7.11	3.21	1.15	2.75	1.38	0.23	0.69
COBL-a rinderpest infection, 00hr, biol_rep2	13554-145I8	105.68	5.27	2.16	1.20	3.12	0.96	0.00	0.00
COBL-a rinderpest infection, 00hr, biol_rep3	13555-145I9	115.73	7.11	3.28	0.82	3.56	1.37	0.00	1.09
COBL-a rinderpest infection, 06hr, biol_rep1	13556-146A1	150.71	8.71	3.00	2.70	6.00	0.30	0.30	0.90
COBL-a rinderpest infection, 06hr, biol_rep2	13557-146A2	91.43	7.92	2.40	0.72	2.88	1.20	0.00	0.72
COBL-a rinderpest infection, 06hr, biol_rep3	13558-146A3	91.18	6.37	4.78	1.14	2.50	0.45	0.45	0.68
COBL-a rinderpest infection, 12hr, biol_rep1	13559-146A4	139.93	5.65	3.48	1.30	4.56	1.30	0.00	0.43
COBL-a rinderpest infection, 12hr, biol_rep2	13560-146A5	141.60	5.53	6.32	0.79	5.26	0.26	0.00	1.05
COBL-a rinderpest infection, 12hr, biol_rep3	13561-146A6	123.59	6.10	3.99	2.81	3.28	1.64	0.00	0.47
COBL-a rinderpest infection, 24hr, biol_rep1	13562-146A7	141.88	4.23	3.32	1.51	9.96	3.02	0.00	1.51
COBL-a rinderpest infection, 24hr, biol_rep2	13563-146A8	124.63	4.36	4.94	2.03	5.52	2.03	0.29	1.74
COBL-a rinderpest infection, 24hr, biol_rep3	13564-146A9	152.93	7.19	5.06	1.33	4.80	1.33	0.27	1.60
COBL-a rinderpest infection, 48hr, biol_rep1	13565-146B1	44.21	5.69	1.75	0.88	2.63	0.00	0.00	0.44
COBL-a rinderpest infection, 48hr, biol_rep2	13566-146B2	55.11	3.19	2.73	0.46	2.28	0.00	0.00	0.91
COBL-a rinderpest infection, 48hr, biol_rep3	13567-146B3	33.56	2.98	0.75	0.00	2.98	2.98	0.00	0.00
COBL-a rinderpest(-C) infection, 06hr, biol_rep1	13568-146B4	87.88	7.56	2.16	1.44	3.96	0.36	1.08	0.72
COBL-a rinderpest(-C) infection, 06hr, biol_rep2	13569-146B5	88.91	6.62	3.74	1.15	5.18	0.29	0.29	1.15
COBL-a rinderpest(-C) infection, 06hr, biol_rep3	13570-146B6	79.67	5.19	2.83	0.47	1.41	0.47	0.00	0.94
COBL-a rinderpest(-C) infection, 12hr, biol_rep1	13571-146B7	173.03	6.02	3.80	1.27	6.02	0.95	0.32	1.27
COBL-a rinderpest(-C) infection, 12hr, biol_rep2	13572-146B8	132.25	5.23	4.61	2.46	11.07	0.31	0.31	0.31
COBL-a rinderpest(-C) infection, 12hr, biol_rep3	13573-146B9	134.97	7.69	2.56	0.96	2.89	1.92	0.00	0.32
COBL-a rinderpest(-C) infection, 24hr, biol_rep1	13574-146C1	117.42	6.50	4.59	1.91	7.65	0.76	0.76	1.15
COBL-a rinderpest(-C) infection, 24hr, biol_rep2	13575-146C2	107.98	4.34	3.15	0.79	5.52	0.00	0.00	0.79
COBL-a rinderpest(-C) infection, 24hr, biol_rep3	13576-146C3	109.68	6.81	3.03	1.51	4.54	3.03	0.00	2.27
COBL-a rinderpest(-C) infection, 48hr, biol_rep1	13577-146C4	29.71	11.24	0.00	0.00	4.82	0.80	0.00	0.00
COBL-a rinderpest(-C) infection, 48hr, biol_rep2	13578-146C5	38.47	11.19	0.00	0.00	2.10	0.00	0.00	0.70
COBL-a rinderpest(-C) infection, 48hr, biol_rep3	13579-146C6	48.08	10.02	1.00	1.00	1.00	0.00	0.00	1.00
Cardiac Myocyte, donor1	11525-119I4	38.38	5.48	0.00	0.00	0.00	0.00	0.00	0.00
Cardiac Myocyte, donor2	11605-120I3	42.99	3.46	1.98	0.00	0.99	0.99	0.00	0.00
Cardiac Myocyte, donor3	11686-122I3	99.13	7.68	0.74	2.00	0.74	0.21	0.11	0.32
Chondrocyte - de diff, donor1	11261-116G1	70.37	6.93	4.16	2.77	1.04	0.69	0.69	0.00
Chondrocyte - de diff, donor2	11338-117F6	31.27	8.17	1.78	1.78	0.36	0.00	0.00	0.00
Chondrocyte - de diff, donor3	11410-118E6	36.64	12.06	1.37	1.02	0.46	0.91	0.11	0.11
Chondrocyte - re diff, donor2	11339-117F7	105.64	13.43	3.58	4.48	0.00	0.00	0.90	0.00
Chondrocyte - re diff, donor3	11411-118E7	20.62	6.47	0.40	1.62	0.00	0.40	0.40	0.00
Ciliary Epithelial Cells, donor1	11242-116D9	163.76	14.12	3.79	2.64	2.18	0.57	0.57	0.57
Ciliary Epithelial Cells, donor2	11323-117D9	93.42	6.41	2.78	0.64	1.07	0.86	0.21	1.71
Ciliary Epithelial Cells, donor3	11399-118D4	97.97	9.65	1.86	1.33	1.24	0.88	0.09	0.44
Clontech Human Universal Reference Total RNA, pool1	10000-101A1	20.36	21.27	2.57	1.74	0.28	0.18	2.11	0.18
Corneal Epithelial Cells, donor1	11526-119I5	21.52	4.61	0.44	0.44	0.44	0.00	0.00	0.00
Corneal Epithelial Cells, donor2	11606-120I4	21.61	5.69	2.28	0.00	1.14	0.00	0.00	1.14
Corneal Epithelial Cells, donor3	11687-122I4	37.83	9.20	0.77	0.77	0.00	0.00	0.26	0.26
Dendritic Cells - monocyte immature derived, donor1, rep2	11227-116C3	4.79	4.79	0.17	0.33	0.00	0.00	0.00	0.00
Dendritic Cells - monocyte immature derived, donor1, tech_rep1	11227-116C3	5.05	5.05	0.00	0.95	0.32	0.00	0.00	0.00
Dendritic Cells - monocyte immature derived, donor2	11308-117C3	6.90	6.90	0.00	0.00	0.00	0.00	0.00	0.00
Dendritic Cells - monocyte immature derived, donor3	11384-118B7	6.70	4.97	0.32	0.76	0.22	0.22	0.00	0.00
Dendritic Cells - plasmacytoid, donor1	11228-116C4	35.53	9.57	1.37	2.39	0.68	0.00	0.00	0.00
Dendritic Cells - plasmacytoid, donor2	11309-117C4	30.03	5.22	0.00	0.65	0.65	0.00	0.00	0.00
Dendritic Cells - plasmacytoid, donor3	11385-118B8	33.39	4.84	0.48	0.00	0.00	0.00	0.00	0.00
Endothelial Cells - Aortic, donor0	11207-116A1	55.53	5.17	2.50	0.33	0.50	0.00	0.00	0.33
Endothelial Cells - Aortic, donor1	11263-116G3	31.69	6.45	0.59	0.00	0.00	0.00	0.00	0.00
Endothelial Cells - Aortic, donor2	11340-117F8	46.66	4.24	2.26	0.57	0.85	0.00	0.00	0.28
Endothelial Cells - Aortic, donor3	11412-118E8	29.88	3.93	1.97	0.00	0.00	0.39	0.00	0.00
Endothelial Cells - Artery, donor1	11264-116G4	34.61	0.87	0.87	0.58	0.58	0.87	0.58	0.00
Endothelial Cells - Artery, donor2	11341-117F9	69.88	2.82	2.12	0.71	0.94	0.47	0.71	0.24
Endothelial Cells - Artery, donor3	11413-118E9	54.70	3.68	2.80	0.88	0.18	0.18	0.00	0.18
Endothelial Cells - Lymphatic, donor1	11236-116D3	42.78	4.88	2.44	0.44	0.00	0.00	0.00	0.00
Endothelial Cells - Lymphatic, donor2	11317-117D3	34.08	3.04	1.52	1.22	0.00	0.91	0.30	0.00
Endothelial Cells - Lymphatic, donor3	11393-118C7	34.96	2.26	1.41	0.56	0.00	0.56	0.00	0.00
Endothelial Cells - Microvascular, donor1	11265-116G5	29.42	3.57	2.67	0.00	0.30	0.30	0.00	0.30
Endothelial Cells - Microvascular, donor2	11342-117G1	45.30	2.60	1.04	0.52	0.00	1.04	0.00	0.52
Endothelial Cells - Microvascular, donor3	11414-118F1	12.76	2.55	1.42	0.57	0.28	0.00	0.00	0.28
Endothelial Cells - Thoracic, donor1	11266-116G6	114.83	6.80	4.00	1.20	1.20	0.00	0.40	0.00
Endothelial Cells - Thoracic, donor2	11343-117G2	22.01	1.05	0.00	0.00	0.52	0.00	0.00	0.52
Endothelial Cells - Umbilical vein, donor1	11243-116E1	204.51	10.44	3.98	2.24	2.11	0.87	0.25	0.25
Endothelial Cells - Umbilical vein, donor2	11324-117E1	61.49	3.91	0.22	1.09	1.52	0.43	0.22	0.43
Endothelial Cells - Umbilical vein, donor3	11400-118D5	84.76	7.57	1.34	0.61	2.93	0.73	0.00	0.73
Endothelial Cells - Vein, donor1	11267-116G7	38.68	4.55	1.14	1.14	0.00	0.00	0.00	0.00
Endothelial Cells - Vein, donor2	11344-117G3	46.10	2.10	2.10	1.40	0.00	0.00	0.00	0.70
Endothelial Cells - Vein, donor3	11416-118F3	51.18	4.40	1.26	0.79	0.47	0.47	0.00	0.16
Eosinophils, donor1	12244-129H3	15.25	0.00	0.00	15.25	0.00	0.00	0.00	0.00
Eosinophils, donor2	12245-129H4	3.30	3.30	0.00	1.65	0.00	0.00	0.00	0.00
Eosinophils, donor3	12246-129H5	3.57	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Esophageal Epithelial Cells, donor1	11507-119G4	20.03	3.66	0.24	0.49	0.24	0.00	0.00	0.00
Esophageal Epithelial Cells, donor2	11587-120G3	2.08	14.56	0.00	0.00	0.00	0.00	0.00	0.00
Esophageal Epithelial Cells, donor3	11668-122G3	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Ewing's sarcoma cell line:Hs 863.T	10705-109H3	18.47	8.62	1.64	1.64	0.41	0.00	0.41	0.82
Fibroblast - Aortic Adventitial donor2 (cytoplasmic fraction)	14331-155F2	16.42	4.05	0.66	0.00	0.88	0.66	0.11	0.66
Fibroblast - Aortic Adventitial donor3 (cytoplasmic fraction)	14310-155C8	37.48	4.88	1.41	0.54	1.63	1.30	0.33	0.76
Fibroblast - Aortic Adventitial, donor1	11245-116E3	85.99	8.25	2.18	2.18	0.97	1.09	0.24	0.24
Fibroblast - Aortic Adventitial, donor2 (nuclear fraction)	14332-155F3	68.10	19.38	2.18	2.18	0.27	0.27	0.27	0.27
Fibroblast - Aortic Adventitial, donor2	11326-117E3	37.02	7.91	1.27	1.58	0.63	0.21	0.11	0.11
Fibroblast - Aortic Adventitial, donor3 (nuclear fraction)	14311-155C9	55.33	6.85	1.05	0.53	0.26	0.26	0.79	0.00
Fibroblast - Aortic Adventitial, donor3	11401-118D6	73.42	10.30	1.99	1.66	0.33	0.33	0.66	0.33
Fibroblast - Cardiac, donor1	11268-116G8	50.35	7.26	1.81	2.27	0.00	0.00	0.00	0.45
Fibroblast - Cardiac, donor2	11345-117G4	37.14	9.10	1.52	1.52	2.27	0.76	0.00	0.00
Fibroblast - Cardiac, donor3	11417-118F4	23.82	3.79	2.21	0.63	0.47	0.16	0.00	0.32
Fibroblast - Cardiac, donor4	11452-119A3	84.57	3.33	2.42	0.91	0.30	0.30	0.30	0.30
Fibroblast - Cardiac, donor5	11456-119A7	62.82	7.11	1.90	0.89	0.38	0.76	0.00	0.25
Fibroblast - Cardiac, donor6	11460-119B2	88.99	7.12	2.27	0.91	0.61	1.21	0.15	0.15
Fibroblast - Choroid Plexus, donor1	11492-119E7	33.36	4.96	2.01	0.80	0.00	0.13	0.00	0.00
Fibroblast - Choroid Plexus, donor2	11572-120E6	36.67	5.61	0.86	0.00	1.29	0.00	0.00	0.00
Fibroblast - Choroid Plexus, donor3	11653-122E6	158.20	13.18	4.39	0.00	2.93	1.46	1.46	0.00
Fibroblast - Conjunctival, donor1	11531-120A1	42.21	11.30	0.92	2.31	0.69	0.23	0.23	0.00
Fibroblast - Conjunctival, donor3	11692-122I9	73.61	5.60	2.54	0.17	0.51	0.17	0.00	0.00
Fibroblast - Dermal, donor1	11269-116G9	91.33	13.62	2.82	2.11	0.94	1.41	0.23	0.47
Fibroblast - Dermal, donor2	11346-117G5	102.83	9.43	2.36	2.36	1.42	0.47	0.00	0.00
Fibroblast - Dermal, donor3	11418-118F5	82.57	11.73	3.99	1.81	0.97	0.60	0.36	0.48
Fibroblast - Dermal, donor4	11450-119A1	179.40	13.90	2.37	2.37	1.47	0.57	0.11	0.79
Fibroblast - Dermal, donor5	11454-119A5	183.00	16.92	3.31	1.22	2.09	1.05	0.00	0.00
Fibroblast - Dermal, donor6	11458-119A9	231.62	14.46	3.74	2.60	2.60	0.49	0.49	0.81
Fibroblast - Gingival, donor1	11237-116D4	112.65	11.24	2.08	2.92	0.21	0.21	0.00	0.21
Fibroblast - Gingival, donor10 (periodontitis)	11928-125I2	40.09	8.38	0.79	1.31	0.52	0.79	0.79	0.79
Fibroblast - Gingival, donor2	11318-117D4	144.30	10.15	2.64	1.45	2.24	0.92	0.26	1.19
Fibroblast - Gingival, donor3	11394-118C8	53.76	8.41	1.55	1.16	0.19	0.10	0.10	0.00
Fibroblast - Gingival, donor4 (GFH2)	11222-116B7	36.36	7.27	3.12	2.08	0.00	0.00	0.00	0.00
Fibroblast - Gingival, donor5 (GFH3)	11303-117B7	18.85	6.52	0.88	0.70	0.70	0.18	0.18	0.00
Fibroblast - Gingival, donor6 (aggressive periodontitis)	11921-125H4	97.28	14.97	2.34	2.49	0.94	1.09	0.62	0.62
Fibroblast - Gingival, donor6 (control)	11922-125H5	89.66	12.58	4.33	1.62	1.76	0.81	0.27	0.54
Fibroblast - Gingival, donor7 (aggressive periodontitis)	11923-125H6	14.12	5.29	1.06	0.00	0.00	0.35	0.35	0.00
Fibroblast - Gingival, donor7 (control)	11924-125H7	54.55	11.55	3.66	2.05	1.32	0.58	0.44	0.29
Fibroblast - Gingival, donor8 (chronic periodontitis)	11925-125H8	81.54	11.73	3.14	1.09	0.82	0.41	0.14	0.41
Fibroblast - Gingival, donor8 (control)	11926-125H9	103.77	13.38	3.62	1.86	0.22	0.55	0.88	0.44
Fibroblast - Gingival, donor9 (control)	11927-125I1	18.20	6.31	1.03	0.88	0.00	0.59	0.15	0.00
Fibroblast - Lung, donor1	11270-116H1	33.98	1.36	0.00	0.00	0.00	0.00	0.00	0.00
Fibroblast - Lung, donor2	11347-117G6	152.20	10.45	5.97	1.49	0.00	1.49	0.00	0.00
Fibroblast - Lung, donor3	11419-118F6	79.35	8.23	3.80	0.84	0.63	0.21	0.42	0.21
Fibroblast - Lymphatic, donor1	11506-119G3	32.49	7.50	3.33	2.50	0.00	0.00	0.00	0.00
Fibroblast - Lymphatic, donor2	11586-120G2	12.59	2.80	0.00	0.00	0.00	1.40	1.40	0.00
Fibroblast - Lymphatic, donor3	11667-122G2	4.20	1.96	0.28	0.00	0.00	0.00	0.00	0.00
Fibroblast - Mammary, donor1	11540-120B1	70.64	12.59	5.28	4.47	0.00	0.00	0.81	0.00
Fibroblast - Mammary, donor2	11620-122A9	0.00	0.00	3.99	0.00	0.00	0.00	0.00	0.00
Fibroblast - Mammary, donor3	11701-123A9	23.83	17.87	0.00	0.00	0.00	0.00	0.00	0.00
Fibroblast - Periodontal Ligament, donor1	11238-116D5	228.69	16.49	4.85	2.13	2.52	1.16	0.39	0.19
Fibroblast - Periodontal Ligament, donor2	11319-117D5	170.04	11.07	3.49	2.43	0.76	0.46	0.91	0.30
Fibroblast - Periodontal Ligament, donor3	11395-118C9	148.40	15.61	5.20	4.28	0.00	0.31	0.00	0.00
Fibroblast - Periodontal Ligament, donor4 (PL29)	11223-116B8	38.54	6.49	3.82	0.76	0.76	0.00	0.38	0.38
Fibroblast - Periodontal Ligament, donor5 (PL30)	11304-117B8	38.34	13.77	1.35	1.35	1.35	0.54	0.00	0.00
Fibroblast - Periodontal Ligament, donor6 (PLH3)	11380-118B3	17.40	7.19	0.70	0.81	0.00	0.00	0.23	0.00
Fibroblast - Pulmonary Artery, donor1	11250-116E8	150.32	12.16	5.53	1.99	2.54	0.33	0.11	1.33
Fibroblast - Villous Mesenchymal, donor1	11535-120A5	36.17	7.72	3.66	0.61	0.20	0.00	0.00	0.20
Fibroblast - Villous Mesenchymal, donor2	11615-122A4	33.41	6.01	3.34	0.00	0.00	0.00	0.00	0.00
Fibroblast - Villous Mesenchymal, donor3	11696-123A4	69.98	5.54	3.56	2.37	0.40	0.00	0.00	0.00
Fibroblast - skin dystrophia myotonica, donor1 (nuclear fraction)	14329-155E9	101.41	14.88	1.98	2.58	0.40	1.19	1.39	0.00
Fibroblast - skin dystrophia myotonica, donor1	11556-120C8	40.50	7.10	2.49	1.42	0.71	0.18	0.18	0.18
Fibroblast - skin dystrophia myotonica, donor2	11557-120C9	81.99	11.43	2.76	1.77	1.18	0.39	0.00	0.20
Fibroblast - skin dystrophia myotonica, donor3 (nuclear fraction)	14308-155C6	86.35	15.95	4.21	2.71	0.30	0.60	0.60	0.00
Fibroblast - skin dystrophia myotonica, donor3	11560-120D3	81.83	11.98	3.35	1.73	0.54	0.54	0.11	0.11
Fibroblast - skin normal, donor1 (nuclear fraction)	14323-155E3	43.78	15.44	0.51	0.76	0.25	0.51	0.25	0.00
Fibroblast - skin normal, donor1	11553-120C5	39.05	9.02	3.94	0.82	0.66	0.16	0.16	0.16
Fibroblast - skin normal, donor2 (nuclear fraction)	14302-155B9	99.25	13.83	4.41	2.21	0.40	0.00	0.20	0.20
Fibroblast - skin normal, donor2	11561-120D4	86.10	12.16	3.72	2.11	0.50	0.10	0.10	0.30
Fibroblast - skin spinal muscular atrophy, donor1 (nuclear fraction)	14326-155E6	96.41	12.39	3.32	3.02	0.91	0.00	0.91	0.60
Fibroblast - skin spinal muscular atrophy, donor1	11555-120C7	50.29	11.10	2.98	1.57	0.41	0.17	0.33	0.25
Fibroblast - skin spinal muscular atrophy, donor2	11558-120D1	64.45	6.50	1.88	1.54	0.00	0.34	0.17	0.00
Fibroblast - skin spinal muscular atrophy, donor3 (nuclear fraction)	14305-155C3	59.77	12.81	2.63	1.31	0.00	0.00	0.33	0.00
Fibroblast - skin spinal muscular atrophy, donor3	11559-120D2	81.06	13.10	4.15	2.02	0.21	0.43	0.43	0.21
Fibroblast - skin walker warburg, donor1	11554-120C6	113.18	12.82	5.06	3.20	0.84	0.34	0.67	0.51
Fibroblast - skin, normal donor1 (cytoplasmic fraction)	14322-155E2	41.87	6.74	1.73	1.10	0.94	0.63	0.63	0.31
Fibroblast - skin, normal donor2 (cytoplasmic fraction)	14301-155B8	1041.51	110.80	66.48	22.16	0.00	0.00	0.00	0.00
Fingernail (including nail plate, eponychium and hyponychium), donor2	10301-104H4	34.86	11.33	1.74	3.49	0.87	0.00	0.00	0.00
Gingival epithelial cells, donor1 (GEA11)	11221-116B6	39.01	9.88	2.08	1.21	0.17	0.00	0.17	0.17
Gingival epithelial cells, donor2 (GEA14)	11302-117B6	80.15	8.33	2.08	1.30	0.00	0.00	0.00	0.52
Gingival epithelial cells, donor3 (GEA15)	11379-118B2	61.32	7.15	1.79	3.58	1.28	0.00	0.26	0.51
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep1	13523-145F4	223.54	19.14	9.95	1.53	8.42	2.30	1.53	3.83
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep2	13524-145F5	359.23	20.42	24.25	1.28	21.69	3.19	0.00	4.47
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep3	13525-145F6	515.76	31.38	20.82	2.28	27.96	2.57	1.43	7.70
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep1	13526-145F7	175.11	21.78	8.82	2.21	9.10	1.65	0.28	3.31
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep2	13527-145F8	133.11	19.64	9.59	1.60	7.31	0.91	1.14	2.74
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep3	13528-145F9	316.61	29.92	17.04	0.79	18.23	1.78	0.40	3.37
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep1	13529-145G1	175.52	17.97	9.78	1.32	10.84	3.97	1.32	6.61
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep2	13530-145G2	102.41	13.70	8.48	0.33	7.50	1.63	1.30	3.91
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep3	13531-145G3	415.25	29.19	23.88	2.21	20.78	3.10	0.00	7.52
H9 Embryoid body cells, melanocytic induction, day00, biol_rep1 (H9EB-1 d0)	12627-134E8	337.62	26.57	10.46	2.26	2.69	1.55	0.71	1.13
H9 Embryoid body cells, melanocytic induction, day00, biol_rep2 (H9EB-2 d0)	12725-135G7	174.00	24.01	5.17	2.22	1.35	0.74	1.11	0.62
H9 Embryoid body cells, melanocytic induction, day00, biol_rep3 (H9EB-3 d0)	12823-136I6	246.60	23.64	11.01	1.61	2.95	0.81	0.54	0.54
H9 Embryoid body cells, melanocytic induction, day01, biol_rep1 (H9EB-1 d1)	12628-134E9	169.49	20.32	6.44	1.49	0.99	0.87	0.12	1.36
H9 Embryoid body cells, melanocytic induction, day01, biol_rep2 (H9EB-2 d1)	12726-135G8	189.78	22.56	7.34	1.52	2.21	1.11	1.52	0.42
H9 Embryoid body cells, melanocytic induction, day01, biol_rep3 (H9EB-3 d1)	12824-136I7	212.04	15.86	10.17	0.61	1.83	0.41	0.41	0.41
H9 Embryoid body cells, melanocytic induction, day03, biol_rep1 (H9EB-1 d3)	12629-134F1	109.53	10.95	6.62	0.91	4.34	1.83	0.46	1.60
H9 Embryoid body cells, melanocytic induction, day03, biol_rep2 (H9EB-2 d3)	12727-135G9	128.55	14.20	6.35	0.50	1.74	0.50	0.50	0.50
H9 Embryoid body cells, melanocytic induction, day03, biol_rep3 (H9EB-3 d3)	12825-136I8	116.50	12.46	4.37	1.97	0.66	0.44	0.66	0.00
H9 Embryoid body cells, melanocytic induction, day06, biol_rep1 (H9EB-1 d6)	12630-134F2	119.67	11.52	5.61	1.18	2.66	0.59	0.30	0.89
H9 Embryoid body cells, melanocytic induction, day06, biol_rep2 (H9EB-2 d6)	12728-135H1	132.57	15.90	4.29	1.27	0.48	0.32	0.64	0.48
H9 Embryoid body cells, melanocytic induction, day06, biol_rep3 (H9EB-3 d6)	12826-136I9	107.02	10.28	6.03	0.45	0.89	0.67	0.00	0.45
H9 Embryoid body cells, melanocytic induction, day09, biol_rep1 (H9EB-1 d9)	12631-134F3	119.17	10.89	8.47	1.41	1.61	0.81	0.81	0.40
H9 Embryoid body cells, melanocytic induction, day09, biol_rep2 (H9EB-2 d9)	12729-135H2	155.22	13.57	7.12	1.19	1.19	0.85	0.34	0.51
H9 Embryoid body cells, melanocytic induction, day09, biol_rep3 (H9EB-3 d9)	12827-137A1	208.11	12.86	12.50	1.06	1.42	0.71	0.35	0.44
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	172.32	7.80	5.93	1.14	0.31	0.10	0.10	0.31
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	163.09	10.08	7.86	0.85	0.85	0.00	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day12, biol_rep2 (H9EB-2 d12)	12730-135H3	128.25	13.61	3.65	0.77	0.11	0.77	0.00	0.22
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	180.62	12.56	11.40	1.66	1.33	0.75	0.08	0.67
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	180.09	12.86	12.05	1.02	2.45	0.41	0.00	0.61
H9 Embryoid body cells, melanocytic induction, day15, biol_rep1 (H9EB-1 d15)	12633-134F5	117.39	8.66	4.75	1.86	2.68	0.62	0.00	0.41
H9 Embryoid body cells, melanocytic induction, day15, biol_rep2 (H9EB-2 d15)	12731-135H4	112.07	11.30	2.65	0.69	0.69	1.15	0.46	0.23
H9 Embryoid body cells, melanocytic induction, day15, biol_rep3 (H9EB-3 d15)	12829-137A3	102.23	11.51	5.17	1.33	0.17	0.50	0.00	0.33
H9 Embryoid body cells, melanocytic induction, day18, biol_rep1 (H9EB-1 d18)	12634-134F6	80.68	6.17	3.53	0.22	1.76	0.66	0.44	0.88
H9 Embryoid body cells, melanocytic induction, day18, biol_rep2 (H9EB-2 d18)	12732-135H5	117.83	10.95	3.32	0.86	0.61	0.61	0.25	0.25
H9 Embryoid body cells, melanocytic induction, day18, biol_rep3 (H9EB-3 d18)	12830-137A4	100.01	10.05	7.29	0.81	1.46	0.49	0.32	0.49
H9 Embryoid body cells, melanocytic induction, day21, biol_rep1 (H9EB-1 d21)	12635-134F7	78.25	9.94	2.57	0.64	1.92	0.00	0.32	0.32
H9 Embryoid body cells, melanocytic induction, day21, biol_rep2 (H9EB-2 d21)	12733-135H6	87.36	12.98	3.13	1.23	0.76	0.47	0.57	0.38
H9 Embryoid body cells, melanocytic induction, day21, biol_rep3 (H9EB-3 d21)	12831-137A5	94.43	10.76	4.59	0.79	1.11	0.16	0.32	0.00
H9 Embryoid body cells, melanocytic induction, day24, biol_rep1 (H9EB-1 d24)	12636-134F8	99.44	7.91	3.65	1.22	0.91	0.30	0.00	0.61
H9 Embryoid body cells, melanocytic induction, day24, biol_rep2 (H9EB-2 d24)	12734-135H7	92.93	12.23	5.12	1.05	0.84	0.42	0.21	0.21
H9 Embryoid body cells, melanocytic induction, day24, biol_rep3 (H9EB-3 d24)	12832-137A6	90.90	11.20	3.95	0.66	1.32	0.44	0.22	0.22
H9 Embryoid body cells, melanocytic induction, day27, biol_rep1 (H9EB-1 d27)	12637-134F9	83.32	10.38	3.65	1.40	1.68	0.84	0.56	0.28
H9 Embryoid body cells, melanocytic induction, day27, biol_rep2 (H9EB-2 d27)	12735-135H8	56.11	7.31	3.33	0.83	0.28	0.00	0.28	0.09
H9 Embryoid body cells, melanocytic induction, day27, biol_rep3 (H9EB-3 d27)	12833-137A7	94.93	5.88	5.08	0.80	1.60	0.27	0.53	0.27
H9 Embryoid body cells, melanocytic induction, day30, biol_rep1 (H9EB-1 d30)	12638-134G1	75.13	8.26	6.58	0.77	1.38	0.15	0.46	0.46
H9 Embryoid body cells, melanocytic induction, day30, biol_rep2 (H9EB-2 d30)	12736-135H9	73.06	8.94	2.59	0.52	0.39	0.52	0.52	0.26
H9 Embryoid body cells, melanocytic induction, day30, biol_rep3 (H9EB-3 d30)	12834-137A8	61.53	5.42	2.17	0.81	1.08	0.54	0.00	0.27
H9 Embryoid body cells, melanocytic induction, day34, biol_rep1 (H9EB-1 d34)	12639-134G2	57.52	7.01	2.58	0.55	1.11	0.37	0.18	0.18
H9 Embryoid body cells, melanocytic induction, day34, biol_rep2 (H9EB-2 d34)	12737-135I1	57.90	5.70	2.41	1.10	1.32	0.66	0.00	0.44
H9 Embryoid body cells, melanocytic induction, day34, biol_rep3 (H9EB-3 d34)	12835-137A9	37.69	6.94	1.98	0.99	0.00	0.00	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day41, biol_rep1 (H9EB-1 d41)	12640-134G3	48.15	7.91	1.85	0.66	0.40	0.40	0.00	0.26
H9 Embryoid body cells, melanocytic induction, day41, biol_rep2 (H9EB-2 d41)	12738-135I2	45.60	4.04	1.82	0.61	0.20	0.61	0.20	0.20
H9 Embryoid body cells, melanocytic induction, day41, biol_rep3 (H9EB-3 d41)	12836-137B1	48.29	6.86	2.03	0.76	0.00	0.25	0.00	0.00
H9 Embryonic Stem cells, biol_rep1 (H9ES-1)	12626-134E7	624.85	37.22	31.65	3.58	2.19	0.60	1.39	1.59
H9 Embryonic Stem cells, biol_rep2 (H9ES-2)	12724-135G6	318.78	28.66	13.56	2.16	2.31	1.85	0.92	0.46
H9 Embryonic Stem cells, biol_rep3 (H9ES-3)	12822-136I5	437.81	43.37	23.32	2.25	4.91	0.82	1.02	1.23
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep1 (UH-1)	13364-143F7	372.07	21.91	22.22	1.56	2.82	3.13	0.31	1.25
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep2 (UH-2)	13365-143F8	357.15	21.47	22.32	2.26	5.93	3.67	0.85	2.26
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep3 (UH-3)	13366-143F9	328.84	22.14	22.14	1.84	14.76	1.84	0.92	5.53
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep1	13328-143B7	264.80	19.80	17.32	4.95	2.47	9.90	2.47	2.47
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep2	13340-143D1	292.81	20.89	15.86	1.55	10.44	3.48	0.39	2.32
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep3	13352-143E4	224.63	14.44	27.28	0.00	9.63	8.02	0.00	4.81
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep1	13329-143B8	227.79	17.39	15.65	0.00	8.69	1.74	0.00	1.74
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep2	13341-143D2	218.40	18.55	13.67	1.30	9.44	3.91	0.98	2.93
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep3	13353-143E5	280.44	13.59	11.12	2.47	7.41	5.77	0.41	2.47
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep1	13330-143B9	176.61	10.00	13.33	0.00	6.66	3.33	0.00	16.66
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep2	13342-143D3	195.19	12.86	14.82	1.40	9.51	1.96	0.00	3.08
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep3	13354-143E6	210.81	15.03	17.32	0.33	8.50	3.27	0.33	1.63
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep1	13331-143C1	209.71	18.45	11.74	0.84	7.55	2.52	0.00	3.36
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep2	13343-143D4	222.33	13.36	14.95	2.23	6.68	2.23	0.00	2.86
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep3	13355-143E7	206.17	12.91	12.23	2.04	11.55	2.72	0.00	3.06
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep1	13332-143C2	263.11	16.71	10.44	2.09	2.09	0.00	0.00	4.18
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep2	13344-143D5	259.43	13.74	20.04	0.57	10.31	3.44	0.00	1.15
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep3	13356-143E8	145.03	10.95	11.84	1.18	11.84	3.85	0.00	2.96
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep1	13333-143C3	155.86	10.16	8.47	0.00	11.86	6.78	0.00	3.39
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep2	13345-143D6	219.12	11.60	10.77	0.41	5.80	1.24	0.41	1.24
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep3	13357-143E9	216.09	10.13	11.97	1.84	9.67	1.84	0.69	1.61
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep1	13334-143C4	168.59	0.00	15.81	0.00	10.54	5.27	0.00	10.54
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep2	13346-143D7	149.54	9.23	10.38	0.00	4.61	0.38	0.00	0.38
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep3	13358-143F1	155.49	10.11	7.50	0.65	6.19	3.59	0.00	0.98
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep1	13335-143C5	131.09	9.36	6.69	0.67	3.34	2.68	0.67	1.34
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep2	13347-143D8	184.93	9.25	8.09	1.54	5.39	3.47	0.00	0.39
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep3	13359-143F2	177.67	13.35	7.53	2.40	6.85	2.40	0.00	2.40
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep1	13336-143C6	129.21	9.94	2.48	0.00	7.45	7.45	0.00	4.97
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep2	13348-143D9	158.54	11.80	4.72	0.94	6.13	4.72	0.00	0.94
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep3	13360-143F3	134.58	9.05	5.43	1.21	5.43	3.62	0.00	0.60
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep1	13337-143C7	173.97	8.65	6.10	1.53	0.51	2.03	0.00	0.51
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep2	13349-143E1	176.69	15.55	7.98	1.20	2.39	4.79	0.00	1.99
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep3	13361-143F4	158.86	6.91	7.89	0.00	6.91	1.48	0.00	1.48
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep1	13338-143C8	160.54	8.26	5.90	1.18	10.62	3.54	0.00	2.36
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep2	13350-143E2	127.77	8.17	6.42	1.17	6.42	3.50	0.00	1.75
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep3	13362-143F5	121.57	9.22	2.63	0.00	1.76	0.00	0.00	1.32
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep1	13339-143C9	96.64	6.78	3.39	2.54	4.24	1.70	0.00	0.85
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep2	13351-143E3	101.48	9.55	6.57	0.60	4.18	3.58	0.00	0.60
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep3	13363-143F6	115.00	6.79	3.88	0.49	5.82	3.40	0.00	1.94
Hair Follicle Dermal Papilla Cells, donor1	11271-116H2	23.97	4.57	0.00	0.00	0.00	0.00	0.00	0.00
Hair Follicle Dermal Papilla Cells, donor2	11348-117G7	19.96	4.57	1.25	0.42	0.00	0.00	0.42	0.00
Hair Follicle Dermal Papilla Cells, donor3	11420-118F7	28.11	10.12	1.12	2.25	0.00	0.00	0.00	0.00
Hair Follicle Outer Root Sheath Cells, donor1	11504-119G1	30.76	10.47	1.59	1.27	0.63	0.63	0.63	0.00
Hair Follicle Outer Root Sheath Cells, donor2	11584-120F9	30.50	7.10	1.25	2.51	2.09	0.42	0.42	0.00
Hep-2 cells mock treated, biol_rep1	11898-125E8	194.83	9.05	4.06	2.20	2.67	1.16	0.00	0.35
Hep-2 cells mock treated, biol_rep2	11899-125E9	191.76	10.47	7.26	1.52	5.74	1.52	0.34	1.01
Hep-2 cells mock treated, biol_rep3	11900-125F1	189.74	9.56	5.92	1.14	2.50	0.68	0.00	1.14
Hep-2 cells treated with Streptococci strain 5448, biol_rep1	11890-125D9	180.14	10.06	5.03	1.75	4.04	1.20	0.33	0.87
Hep-2 cells treated with Streptococci strain 5448, biol_rep2	11891-125E1	202.23	8.17	5.16	3.01	4.51	0.21	0.00	0.86
Hep-2 cells treated with Streptococci strain 5448, biol_rep3	11892-125E2	172.87	7.97	3.66	1.72	4.09	0.43	0.00	0.22
Hep-2 cells treated with Streptococci strain JRS4, biol_rep1	11894-125E4	177.96	9.59	5.11	1.12	3.49	1.49	0.25	0.25
Hep-2 cells treated with Streptococci strain JRS4, biol_rep2	11895-125E5	169.83	7.89	3.95	1.03	3.77	1.54	0.17	0.00
Hep-2 cells treated with Streptococci strain JRS4, biol_rep3	11896-125E6	185.82	10.25	4.49	0.64	1.60	1.92	0.32	0.64
Hepatic Sinusoidal Endothelial Cells, donor1	11521-119H9	17.91	2.80	2.24	0.00	0.00	0.00	0.00	0.00
Hepatic Sinusoidal Endothelial Cells, donor2	11601-120H8	7.79	3.90	0.00	0.43	0.00	0.00	0.00	0.00
Hepatic Sinusoidal Endothelial Cells, donor3	11682-122H8	55.52	5.29	0.00	0.00	2.64	5.29	0.00	0.00
Hepatic Stellate Cells (lipocyte), donor1	11524-119I3	25.40	3.53	1.76	0.71	0.35	0.00	0.35	0.35
Hepatic Stellate Cells (lipocyte), donor2	11604-120I2	9.44	0.00	1.45	0.00	0.00	0.00	0.00	0.00
Hepatic Stellate Cells (lipocyte), donor3	11685-122I2	94.94	5.94	2.97	0.35	4.20	0.87	0.00	0.87
Hepatocyte, donor1	11523-119I2	54.48	50.85	3.63	2.42	2.42	4.84	0.00	3.63
Hepatocyte, donor2	11603-120I1	79.72	19.39	2.15	2.15	2.15	1.08	0.00	0.00
Hepatocyte, donor3	11684-122I1	46.63	21.47	3.07	6.75	5.52	1.23	0.00	0.61
Hodgkin's lymphoma cell line:HD-Mar2	10435-106E3	229.09	13.05	7.18	2.61	2.61	0.00	0.00	0.65
Intestinal epithelial cells (polarized), donor1	11246-116E4	109.06	13.63	2.80	2.45	0.87	0.70	0.35	0.35
Iris Pigment Epithelial Cells, donor1	11530-119I9	152.99	9.33	3.02	1.51	2.06	0.55	0.00	0.41
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep1	13079-140B1	38.21	0.00	3.18	3.18	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep2	13145-140I4	33.38	6.68	6.68	0.00	0.00	6.68	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep3	13211-141G7	108.33	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep1	13080-140B2	44.30	8.31	8.31	1.38	0.00	1.38	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep2	13146-140I5	57.56	7.51	7.51	2.50	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep3	13212-141G8	47.47	11.87	11.87	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep1	13081-140B3	48.70	10.25	5.13	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep2	13147-140I6	50.28	18.28	9.14	4.57	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep3	13213-141G9	81.22	8.12	12.99	0.00	0.00	0.00	1.62	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep1	13082-140B4	61.69	8.34	0.00	1.67	1.67	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep2	13148-140I7	54.46	0.00	3.63	3.63	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep3	13214-141H1	52.94	10.59	5.29	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep1	13083-140B5	99.78	5.54	4.43	2.22	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep2	13149-140I8	78.57	10.48	5.24	5.24	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep3	13215-141H2	113.38	13.23	6.30	2.52	0.63	0.63	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep1	13084-140B6	85.06	12.37	3.09	4.64	1.55	0.00	1.55	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep2	13150-140I9	43.90	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep3	13216-141H3	85.28	7.11	3.23	0.00	0.65	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep1	13085-140B7	38.64	4.83	4.83	3.22	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep2	13151-141A1	23.90	35.84	11.95	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep3	13217-141H4	83.12	4.07	4.89	3.26	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep1	13086-140B8	64.65	6.72	3.36	2.10	0.00	0.00	0.42	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep2	13152-141A2	28.74	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep3	13218-141H5	106.09	8.04	4.82	0.80	0.00	0.80	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep1	13087-140B9	86.79	10.16	6.46	0.92	0.00	0.92	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep2	13153-141A3	15.08	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep3	13219-141H6	86.85	12.75	4.72	2.36	0.94	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep1	13088-140C1	85.26	1.81	6.35	1.81	0.00	0.91	0.00	0.91
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep2	13154-141A4	44.23	29.48	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep3	13220-141H7	79.63	8.61	2.15	1.08	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep1	13089-140C2	72.42	8.89	5.08	3.81	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep2	13155-141A5	32.86	16.43	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep3	13221-141H8	53.57	7.01	4.46	1.28	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep1	13090-140C3	51.03	12.76	3.65	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep2	13156-141A6	63.22	0.00	15.80	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep3	13222-141H9	74.98	8.57	5.71	0.71	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep1	13091-140C4	69.68	0.00	0.00	3.32	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep2	13157-141A7	62.55	20.85	20.85	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep3	13223-141I1	88.59	11.11	5.86	1.54	0.93	0.31	0.00	0.31
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep1	13092-140C5	66.73	1.76	10.54	1.76	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep2	13158-141A8	50.29	6.29	3.14	3.14	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep3	13224-141I2	59.11	6.95	4.87	0.70	0.70	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep1	13093-140C6	39.84	8.85	4.43	2.21	0.00	2.21	0.00	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep2	13159-141A9	84.29	12.97	3.24	3.24	0.00	3.24	0.00	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep3	13225-141I3	59.29	8.72	2.62	3.49	0.00	0.00	0.87	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep1	13094-140C7	27.00	9.00	6.75	0.00	2.25	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep2	13160-141B1	27.88	17.42	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep3	13226-141I4	42.67	12.80	5.33	1.07	1.07	0.00	1.07	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep1	13095-140C8	66.50	9.70	5.54	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep2	13161-141B2	39.89	11.40	11.40	2.85	2.85	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep3	13227-141I5	41.42	8.28	5.52	1.84	1.84	0.92	0.00	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep1	13096-140C9	45.38	9.08	3.03	6.05	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep2	13162-141B3	37.25	6.21	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep3	13228-141I6	30.66	13.75	4.23	4.23	0.00	0.00	0.00	0.00
Keratinocyte - epidermal, donor1	11272-116H3	75.32	7.10	1.22	1.31	0.82	0.08	0.16	0.41
Keratinocyte - epidermal, donor2	11349-117G8	35.72	5.86	0.00	2.34	0.59	0.00	0.00	0.00
Keratinocyte - epidermal, donor3	11421-118F8	130.91	6.44	1.61	1.42	1.61	0.57	0.00	0.09
Keratinocyte - oral, donor1	11251-116E9	229.31	15.21	2.84	2.84	3.52	0.45	0.23	0.79
Keratocytes, donor1	11527-119I6	37.13	9.97	0.34	1.72	0.69	0.34	0.00	0.00
Keratocytes, donor2	11607-120I5	24.61	7.03	2.34	0.00	1.17	0.00	0.00	0.00
Keratocytes, donor3	11688-122I5	63.63	12.05	1.78	1.78	0.00	0.40	0.59	0.20
Krukenberg tumor cell line:HSKTC	10687-109F3	10.99	26.37	2.20	0.00	0.00	0.00	0.00	0.00
Lens Epithelial Cells, donor1	11529-119I8	118.66	5.39	1.08	3.24	2.16	1.08	0.00	0.00
Lens Epithelial Cells, donor2	11609-120I7	95.73	10.38	3.00	0.92	0.69	0.46	0.81	0.58
Lens Epithelial Cells, donor3	11690-122I7	57.01	5.85	1.92	0.91	0.30	0.00	0.10	0.10
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep1 (MM XIX - 1)	12260-130A1	60.83	4.27	2.73	1.19	0.47	0.47	0.12	0.24
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep2 (MM XIV - 1)	12382-131E6	37.95	4.47	0.56	0.28	0.84	0.00	0.00	0.28
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep3 (MM XXII - 1 )	12504-133A2	48.80	4.56	2.83	1.10	1.42	0.00	0.16	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep1 (MM XIX - 2)	12261-130A2	36.03	2.69	0.54	0.54	2.15	0.00	0.54	0.54
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep2 (MM XIV - 2)	12383-131E7	29.31	3.15	2.21	0.63	0.00	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep3 (MM XXII - 2)	12505-133A3	31.70	3.67	0.97	0.32	0.86	0.11	0.00	0.22
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep1 (MM XIX - 3)	12262-130A3	37.35	2.46	2.05	0.82	0.82	0.41	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep2 (MM XIV - 3)	12384-131E8	25.28	1.26	1.52	0.25	0.51	0.25	0.00	0.25
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep3 (MM XXII - 3)	12506-133A4	31.95	3.24	1.55	0.28	0.84	0.14	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep1 (MM XIX - 4)	12263-130A4	39.55	3.16	1.19	0.79	0.00	0.40	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep2 (MM XIV - 4)	12385-131E9	38.00	3.10	0.58	0.19	0.97	0.19	0.39	0.39
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep3 (MM XXII - 4)	12507-133A5	18.70	2.59	0.37	0.37	0.37	0.19	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep1 (MM XIX - 5)	12264-130A5	37.63	4.88	1.39	0.00	1.05	0.35	0.35	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep2 (MM XIV - 5)	12386-131F1	35.78	3.58	1.43	0.00	0.72	0.00	0.24	0.24
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep3 (MM XXII - 5)	12508-133A6	25.96	3.57	1.65	0.69	0.69	0.27	0.41	0.41
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep1 (MM XIX - 6)	12265-130A6	39.42	4.93	1.23	1.23	1.23	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep2 (MM XIV - 6)	12387-131F2	19.64	2.81	0.94	0.62	0.62	0.00	0.00	0.31
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep3 (MM XXII - 6)	12509-133A7	30.56	4.03	0.55	0.55	0.55	0.00	0.00	0.37
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep1 (MM XIX - 7)	12266-130A7	39.82	3.62	1.32	0.99	0.99	0.33	0.00	0.66
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep2 (MM XIV - 7)	12388-131F3	23.43	4.98	0.00	0.29	0.88	0.00	0.29	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep3 (MM XXII - 7)	12510-133A8	14.94	1.24	0.25	0.25	0.25	0.25	0.25	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep1 (MM XIX - 8)	12267-130A8	38.31	4.85	3.88	0.48	0.97	0.48	0.00	0.97
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep2 (MM XIV - 8)	12389-131F4	38.78	4.31	1.35	0.27	0.27	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep3 (MM XXII - 8)	12511-133A9	35.42	2.57	1.21	0.61	0.45	0.15	0.15	0.15
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep1 (MM XIX - 9)	12268-130A9	28.51	4.15	0.00	0.00	1.56	0.52	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep2 (MM XIV - 9)	12390-131F5	37.69	3.56	1.05	0.84	0.84	0.21	0.21	0.42
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep3 (MM XXII - 9)	12512-133B1	28.12	2.41	1.95	0.45	1.20	0.15	0.15	0.45
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep1 (MM XIX - 10)	12269-130B1	32.33	3.44	0.00	0.00	1.38	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep2 (MM XIV - 10)	12391-131F6	33.68	2.82	0.94	0.19	0.94	0.19	0.38	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep3 (MM XXII - 10)	12513-133B2	25.02	2.33	1.38	0.42	0.53	0.11	0.11	0.21
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep1 (MM XIX - 11)	12270-130B2	32.95	3.39	1.94	0.48	0.48	0.48	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep2 (MM XIV - 11)	12392-131F7	28.12	2.65	1.65	0.66	0.33	0.00	0.33	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep3 (MM XXII - 11)	12514-133B3	22.30	1.49	0.87	0.25	0.37	0.12	0.00	0.25
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep1 (MM XIX - 12)	12271-130B3	45.17	4.07	1.48	0.37	0.37	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep2 (MM XIV - 12)	12393-131F8	30.64	2.22	0.74	0.99	0.00	0.25	0.00	0.25
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep3 (MM XXII - 12)	12515-133B4	17.05	3.30	0.55	0.27	0.27	0.00	0.14	0.27
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep1 (MM XIX - 13)	12272-130B4	41.49	5.79	1.93	0.64	1.61	0.00	0.32	0.64
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep2 (MM XIV - 13)	12394-131F9	41.08	3.35	1.83	0.61	1.22	0.30	0.30	0.30
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep3 (MM XXII - 13)	12516-133B5	37.79	3.36	0.98	0.56	1.68	0.00	0.14	0.28
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep1 (MM XIX - 14)	12273-130B5	37.33	2.84	1.42	0.00	0.36	0.00	0.00	0.71
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep2 (MM XIV - 14)	12395-131G1	25.21	1.94	1.45	0.00	0.97	0.48	0.48	0.00
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep3 (MM XXII - 14)	12517-133B6	15.25	1.56	0.93	0.31	1.40	0.16	0.16	0.00
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep1 (MM XIX - 15)	12274-130B6	34.74	3.58	2.15	0.72	1.79	0.36	0.00	0.36
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep2 (MM XIV - 15)	12396-131G2	27.77	1.96	0.65	0.33	0.98	0.00	0.00	0.33
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep3 (MM XXII - 15)	12518-133B7	12.01	2.83	0.24	0.94	0.47	0.00	0.47	0.24
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep1 (MM XIX - 16)	12275-130B7	60.14	3.47	2.23	1.24	0.87	0.12	0.00	0.12
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep2 (MM XIV - 16)	12397-131G3	16.90	2.56	1.02	0.26	0.00	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep3 (MM XXII - 16)	12519-133B8	25.36	2.39	1.49	0.90	1.19	0.30	0.60	0.30
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep1	13031-139E7	22.66	9.06	2.27	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep2	13097-140D1	23.01	6.90	0.77	0.00	0.00	0.77	0.00	1.53
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep3	13163-141B4	32.66	8.91	2.23	1.48	0.00	0.74	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep1	13032-139E8	29.62	10.58	2.54	0.42	0.85	0.85	0.42	0.00
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep2	13098-140D2	30.95	7.74	2.11	2.11	0.70	0.70	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep3	13164-141B5	34.56	3.74	1.87	0.00	0.00	0.93	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep1	13033-139E9	32.46	10.82	4.12	0.52	0.00	0.00	1.55	0.00
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep2	13099-140D3	21.41	9.52	0.00	1.19	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep3	13165-141B6	31.67	9.05	1.58	1.58	0.00	0.00	0.45	0.00
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep1	13034-139F1	46.53	10.18	4.07	2.04	2.33	1.16	0.29	0.58
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep2	13100-140D4	50.87	10.80	1.80	2.70	1.35	3.15	0.45	0.90
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep3	13166-141B7	48.23	9.08	3.93	1.35	0.41	0.41	0.81	0.00
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep1	13035-139F2	38.00	7.70	3.59	3.08	1.03	0.51	0.51	0.51
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep2	13101-140D5	46.93	12.00	2.47	1.76	0.35	0.35	0.35	0.00
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep3	13167-141B8	40.64	8.66	4.66	4.00	3.33	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep1	13036-139F3	38.20	8.66	2.55	1.02	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep2	13102-140D6	58.43	13.07	1.87	0.80	1.07	0.53	1.07	0.27
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep3	13168-141B9	56.68	11.90	3.02	0.76	0.57	0.19	0.19	0.57
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep1	13037-139F4	25.16	6.75	2.45	0.61	0.00	0.00	0.00	0.61
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep2	13103-140D7	39.96	8.15	0.82	2.45	0.00	1.63	0.00	0.82
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep3	13169-141C1	50.19	12.29	3.33	1.04	1.04	0.62	1.04	0.00
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep1	13038-139F5	56.05	13.73	2.52	1.12	2.52	1.96	1.40	0.00
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep2	13104-140D8	23.70	5.15	4.12	1.03	0.00	1.03	1.03	1.03
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep3	13170-141C2	50.51	11.03	2.90	1.16	0.58	1.45	0.00	0.58
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep1	13039-139F6	45.44	10.76	1.79	0.90	2.09	0.90	0.60	0.00
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep2	13105-140D9	48.69	9.96	3.87	1.11	1.11	0.00	0.00	1.11
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep3	13171-141C3	44.19	9.54	2.83	1.77	0.00	1.06	0.35	0.00
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep1	13040-139F7	45.36	8.48	0.74	1.84	0.37	0.74	0.37	0.74
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep2	13106-140E1	29.93	12.66	2.30	0.00	0.00	0.00	0.00	1.15
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep3	13172-141C4	34.54	8.06	1.15	1.92	0.00	0.38	0.77	0.77
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep1	13041-139F8	35.67	5.10	1.70	1.13	0.57	1.13	0.57	0.00
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep2	13107-140E2	37.74	10.67	2.46	0.00	0.82	0.00	0.82	0.00
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep3	13173-141C5	27.56	8.13	1.81	0.00	0.00	1.81	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep1	13042-139F9	36.63	6.46	2.15	3.59	0.00	2.15	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep2	13108-140E3	41.08	12.70	2.99	2.24	0.75	0.75	0.75	0.00
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep3	13174-141C6	36.79	10.03	2.60	1.11	0.74	0.74	0.37	0.37
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep1	13043-139G1	47.81	7.32	2.58	2.58	1.29	0.00	0.86	0.86
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep2	13109-140E4	41.10	4.28	0.86	3.43	0.86	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep3	13175-141C7	42.31	8.00	2.00	1.67	1.00	1.67	0.33	0.00
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep1	13044-139G2	39.82	7.24	0.60	2.41	0.60	0.60	1.21	0.00
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep2	13110-140E5	20.62	7.11	0.71	1.42	0.71	0.00	0.71	0.00
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep3	13176-141C8	36.09	6.53	1.37	1.37	0.34	0.69	0.34	0.00
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep1	13045-139G3	39.18	6.98	1.61	0.54	0.54	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep2	13111-140E6	32.99	3.37	0.67	0.67	0.00	0.00	0.67	0.67
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep3	13177-141C9	39.63	8.15	2.59	1.11	0.37	0.37	0.37	0.37
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep1	13046-139G4	36.05	8.14	3.49	1.16	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep2	13112-140E7	31.73	5.29	2.12	1.06	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep3	13178-141D1	31.61	6.40	1.60	1.20	0.00	0.00	0.40	0.00
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep1	13048-139G6	23.99	7.27	2.18	0.00	0.00	0.00	0.73	0.00
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep2	13114-140E9	21.46	10.73	2.30	3.07	1.53	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep3	13180-141D3	31.57	8.88	2.47	0.99	0.49	0.49	0.00	0.49
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep1	13049-139G7	31.99	3.76	1.88	0.94	0.94	0.00	0.94	0.00
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep2	13115-140F1	33.19	9.55	1.51	1.01	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep3	13181-141D4	32.90	10.81	3.60	1.80	0.00	1.80	1.35	0.00
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep1	13050-139G8	34.42	0.00	0.00	0.00	1.72	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep2	13116-140F2	33.85	5.79	4.01	0.45	0.45	0.45	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep3	13182-141D5	34.02	7.82	2.74	0.39	0.00	0.39	0.00	0.00
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep1	13051-139G9	32.33	5.94	1.98	0.00	0.66	1.32	0.00	0.00
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep2	13117-140F3	30.62	9.34	1.56	2.08	0.00	1.04	0.00	0.00
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep3	13183-141D6	35.01	8.31	1.75	1.31	0.44	0.00	0.44	0.88
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep1	13052-139H1	38.58	12.86	3.91	2.80	0.00	0.56	1.12	0.00
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep2	13118-140F4	36.21	11.04	1.77	1.32	0.88	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep3	13184-141D7	42.81	8.87	1.54	0.00	0.00	0.39	0.39	0.00
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep1	13053-139H2	37.98	9.11	2.03	0.00	1.52	1.52	0.00	0.00
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep2	13119-140F5	35.09	10.09	0.96	0.00	0.48	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep3	13185-141D8	45.72	7.95	1.99	1.19	0.40	0.40	0.40	0.00
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep1	13054-139H3	46.18	8.51	3.04	1.82	1.22	2.43	0.61	0.61
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep2	13120-140F6	39.43	8.99	1.38	0.00	0.00	0.69	0.69	0.00
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep3	13186-141D9	40.66	6.46	0.76	1.52	0.76	0.38	0.00	0.00
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep1	13055-139H4	44.93	9.30	3.10	1.03	0.52	0.52	0.52	0.00
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep2	13121-140F7	35.07	7.86	1.21	1.21	0.60	0.00	1.21	0.00
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep3	13187-141E1	41.83	8.56	1.58	1.27	0.63	2.54	0.00	0.00
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep1	13056-139H5	29.32	5.33	1.07	0.53	0.00	0.00	1.07	0.53
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep2	13122-140F8	33.91	10.92	1.15	1.15	1.72	0.57	0.57	0.57
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep3	13188-141E2	45.25	7.71	1.54	2.06	0.00	0.51	1.03	0.51
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep1	13057-139H6	34.66	7.07	2.12	2.12	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep2	13123-140F9	37.45	7.38	1.13	0.57	1.13	0.57	0.00	0.57
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep3	13189-141E3	32.87	6.66	3.74	0.83	0.00	0.83	0.42	0.42
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep1	13058-139H7	44.63	3.92	4.70	0.78	0.00	0.00	0.78	1.57
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep2	13124-140G1	40.08	7.10	1.67	0.42	0.42	0.42	0.00	0.42
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep3	13190-141E4	27.41	8.36	1.39	0.46	0.46	1.39	0.46	0.00
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep1	13059-139H8	33.45	8.03	2.01	0.67	0.00	0.67	0.67	0.00
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep2	13125-140G2	34.22	11.76	2.67	2.14	0.53	0.00	0.53	0.00
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep3	13191-141E5	42.03	8.49	2.42	0.00	0.40	1.21	0.81	0.81
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep1	13060-139H9	31.20	8.26	1.84	0.00	0.00	0.00	0.92	0.00
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep2	13126-140G3	30.23	5.33	0.00	0.89	0.00	1.78	0.00	0.00
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep3	13192-141E6	42.17	7.41	0.57	2.28	0.57	0.00	0.57	0.00
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep1	13061-139I1	35.28	6.90	0.00	1.53	0.00	0.00	0.00	0.77
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep2	13127-140G4	55.26	7.11	2.19	1.64	1.09	0.00	0.00	1.09
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep3	13193-141E7	40.54	8.02	0.89	0.89	0.45	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep1	13062-139I2	49.39	8.84	2.08	0.78	0.00	0.26	0.26	0.00
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep2	13128-140G5	45.09	12.60	1.99	0.66	0.00	1.99	0.00	0.00
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep3	13194-141E8	31.18	12.47	0.00	0.00	0.00	0.00	0.00	0.00
Macrophage - monocyte derived, donor1	11232-116C8	12.99	7.52	1.14	0.68	0.68	0.00	0.00	0.00
Macrophage - monocyte derived, donor2	11313-117C8	19.45	8.81	0.92	0.73	0.18	0.00	0.18	0.00
Macrophage - monocyte derived, donor3	11389-118C3	18.09	8.26	0.66	0.39	0.00	0.00	0.00	0.00
Mallassez-derived cells, donor1 (MZH3)	12142-128E9	45.14	1.59	2.12	0.00	0.00	0.53	0.00	0.00
Mallassez-derived cells, donor2	11929-125I3	47.85	7.45	2.85	1.27	0.48	0.16	0.32	0.16
Mallassez-derived cells, donor3	11930-125I4	123.98	11.26	4.17	1.53	1.67	0.69	0.14	0.56
Mammary Epithelial Cell, donor1	11273-116H4	170.99	21.52	3.29	2.39	2.19	1.30	0.60	0.30
Mammary Epithelial Cell, donor2	11350-117G9	198.05	12.74	5.50	2.32	2.90	0.58	0.00	0.87
Mammary Epithelial Cell, donor3	11422-118F9	50.63	8.23	1.00	1.50	0.00	0.25	0.00	0.25
Mast cell - stimulated, donor1	11487-119E2	121.35	37.96	2.03	5.42	0.00	0.00	0.68	0.00
Mast cell, donor1	11563-120D6	26.71	15.79	1.19	1.95	0.43	0.22	0.43	0.22
Mast cell, donor2	11565-120D8	11.59	18.42	0.00	1.19	0.30	0.00	0.30	0.00
Mast cell, donor3	11566-120D9	9.23	14.86	0.00	2.25	0.68	0.00	0.00	0.00
Mast cell, donor4	11567-120E1	6.74	13.65	0.18	1.06	0.35	0.00	0.53	0.00
Mast cell, expanded and stimulated, donor5	11940-126A5	51.23	22.51	1.22	2.55	0.44	0.44	0.55	0.33
Mast cell, expanded and stimulated, donor8	11942-126A7	81.72	22.18	2.33	1.75	1.17	0.58	0.00	1.75
Mast cell, expanded, donor5	11939-126A4	28.11	13.42	1.38	1.38	0.23	0.34	0.00	0.23
Mast cell, expanded, donor8	11941-126A6	21.26	7.36	1.00	0.50	0.17	0.00	0.33	0.17
Melanocyte - dark, donor1	11502-119F8	90.94	4.88	2.59	0.70	0.10	0.50	0.10	0.10
Melanocyte - dark, donor2	11582-120F7	47.76	3.46	0.69	0.00	2.77	0.00	0.35	0.69
Melanocyte - dark, donor3	11663-122F7	148.94	13.04	4.49	2.25	1.67	0.43	0.72	0.43
Melanocyte - light, donor1	11274-116H5	22.10	3.53	0.94	0.94	0.00	0.24	0.00	0.00
Melanocyte - light, donor2	11351-117H1	14.33	2.73	0.68	1.36	0.00	0.00	0.00	0.00
Melanocyte - light, donor3	11423-118G1	18.21	6.94	2.60	0.87	0.00	0.00	0.00	1.73
Melanocyte, donor1 (MC+1)	12641-134G4	141.82	10.93	2.19	0.73	2.19	0.83	0.21	0.42
Melanocyte, donor2 (MC+2)	12739-135I3	83.37	7.26	4.57	0.27	2.42	0.54	0.27	0.81
Melanocyte, donor3 (MC+3)	12837-137B2	69.91	4.02	2.68	0.80	1.61	1.07	0.00	0.54
Meningeal Cells, donor1	11493-119E8	115.00	9.18	5.58	0.99	0.25	0.12	0.12	0.00
Meningeal Cells, donor2	11573-120E7	73.94	5.28	3.96	1.32	0.88	0.88	0.00	0.44
Meningeal Cells, donor3	11654-122E7	328.86	13.94	10.35	2.28	3.10	0.98	0.33	1.14
Mesenchymal Stem Cells - Vertebral, donor1	11219-116B4	168.81	15.97	2.57	1.43	2.85	0.57	0.29	0.29
Mesenchymal Stem Cells - Wharton's Jelly, donor1	11548-120B9	35.02	6.14	1.51	0.40	0.40	0.10	0.50	0.40
Mesenchymal Stem Cells - adipose, donor1	11537-120A7	6.57	1.31	0.00	0.00	0.00	0.00	0.00	0.00
Mesenchymal Stem Cells - adipose, donor2	11617-122A6	17.01	3.92	1.31	1.31	0.00	0.00	0.00	0.00
Mesenchymal Stem Cells - adipose, donor3	11698-123A6	104.77	8.61	2.15	1.44	3.59	1.44	0.00	0.00
Mesenchymal Stem Cells - amniotic membrane, donor1	11547-120B8	34.09	5.29	1.48	0.21	0.64	0.00	0.00	0.00
Mesenchymal Stem Cells - amniotic membrane, donor2	11627-122B7	30.16	7.54	1.01	0.00	0.50	0.50	1.01	0.00
Mesenchymal Stem Cells - bone marrow, donor1	11536-120A6	54.50	8.35	2.20	1.32	2.42	0.44	0.22	0.00
Mesenchymal Stem Cells - bone marrow, donor2	11616-122A5	52.60	8.77	1.46	0.73	0.00	0.00	0.00	1.46
Mesenchymal Stem Cells - bone marrow, donor3	11697-123A5	31.51	5.73	0.82	0.61	0.00	0.00	0.00	0.20
Mesenchymal Stem Cells - bone marrow, donor4	11464-119B6	83.94	9.28	2.49	1.39	0.83	0.42	0.28	0.28
Mesenchymal Stem Cells - hepatic, donor1	11538-120A8	13.75	2.97	0.00	0.00	0.37	0.00	0.00	0.00
Mesenchymal Stem Cells - hepatic, donor2	11618-122A7	99.86	7.37	1.71	0.66	0.92	0.39	0.26	0.00
Mesenchymal Stem Cells - umbilical, donor1	11539-120A9	16.62	2.08	0.59	0.00	0.59	0.00	0.30	0.00
Mesenchymal Stem Cells - umbilical, donor2	11619-122A8	4.67	7.01	0.00	0.00	0.00	0.00	0.00	0.00
Mesenchymal Stem Cells - umbilical, donor3	11700-123A8	35.86	4.48	2.56	0.64	0.00	0.00	0.00	0.00
Mesenchymal stem cells - adipose, donor0	11217-116B2	183.96	13.82	3.90	2.48	5.32	1.06	0.35	0.35
Mesenchymal stem cells - hepatic, donor0	11218-116B3	81.00	5.94	0.94	0.94	0.63	0.31	0.00	0.00
Mesenchymal stem cells - umbilical, donor0	11214-116A8	140.78	7.26	4.35	2.90	2.18	0.00	0.00	0.00
Mesothelial Cells, donor1	11247-116E5	31.56	6.10	2.12	1.33	0.53	0.27	0.53	0.27
Mesothelial Cells, donor2	12156-128G5	16.52	3.50	1.00	0.50	1.00	0.00	1.00	0.00
Mesothelial Cells, donor3	11402-118D7	19.01	3.25	1.95	1.37	0.29	0.07	0.14	0.22
Monocyte-derived macrophages response to LPS, 00hr00min, donor1 (t1 Subject1)	12698-135D7	0.00	4.05	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr00min, donor2 (t1 Subject2)	12796-136F6	10.84	10.10	0.25	0.25	0.49	0.00	0.49	0.25
Monocyte-derived macrophages response to LPS, 00hr00min, donor3 (t1 Subject3)	12894-137H5	8.54	7.95	1.18	0.59	0.29	0.29	0.88	0.00
Monocyte-derived macrophages response to LPS, 00hr15min, donor1 (t2 Subject1)	12699-135D8	0.00	6.91	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr15min, donor2 (t2 Subject2)	12797-136F7	8.37	6.20	0.31	0.62	0.62	0.00	1.24	0.00
Monocyte-derived macrophages response to LPS, 00hr15min, donor3 (t2 Subject3)	12895-137H6	9.33	4.56	0.62	0.83	0.00	0.21	0.41	0.00
Monocyte-derived macrophages response to LPS, 00hr30min, donor1 (t3 Subject1)	12700-135D9	0.00	2.32	0.00	0.00	2.32	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr30min, donor2 (t3 Subject2)	12798-136F8	7.01	4.50	1.50	1.00	0.75	0.00	0.25	0.25
Monocyte-derived macrophages response to LPS, 00hr30min, donor3 (t3 Subject3)	12896-137H7	4.19	2.79	1.40	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor1 (t4 Subject1)	12701-135E1	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor2 (t4 Subject2)	12799-136F9	6.71	4.47	0.20	0.61	0.00	0.00	0.20	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor3 (t4 Subject3)	12897-137H8	9.11	7.13	0.40	0.79	0.40	0.00	0.40	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor1 (t5 Subject1)	12702-135E2	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor2 (t5 Subject2)	12800-136G1	7.08	4.42	2.65	0.88	1.77	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor3 (t5 Subject3)	12898-137H9	10.64	6.84	1.14	0.76	0.00	0.76	0.00	0.38
Monocyte-derived macrophages response to LPS, 01hr20min, donor1 (t6 Subject1)	12703-135E3	1.32	5.26	0.00	1.32	0.00	0.00	0.00	1.32
Monocyte-derived macrophages response to LPS, 01hr20min, donor2 (t6 Subject2)	12801-136G2	7.22	5.73	0.64	0.21	0.21	0.00	0.21	0.21
Monocyte-derived macrophages response to LPS, 01hr20min, donor3 (t6 Subject3)	12899-137I1	4.60	3.68	0.00	0.92	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor1 (t7 Subject1)	12704-135E4	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor2 (t7 Subject2)	12802-136G3	7.75	4.77	0.89	0.89	0.89	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor3 (t7 Subject3)	12900-137I2	0.00	5.03	0.00	0.00	0.00	0.00	1.68	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor1 (t8 Subject1)	12705-135E5	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor2 (t8 Subject2)	12803-136G4	6.27	5.77	0.50	0.50	0.25	0.00	0.25	0.25
Monocyte-derived macrophages response to LPS, 02hr00min, donor3 (t8 Subject3)	12901-137I3	4.52	4.75	0.24	0.24	0.24	0.00	0.24	0.00
Monocyte-derived macrophages response to LPS, 02hr30min, donor1 (t9 Subject1)	12706-135E6	0.00	6.63	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr30min, donor2 (t9 Subject2)	12804-136G5	5.30	4.14	0.69	0.46	0.46	0.00	0.23	0.00
Monocyte-derived macrophages response to LPS, 02hr30min, donor3 (t9 Subject3)	12902-137I4	7.99	4.00	0.21	0.21	0.21	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 03hr00min, donor1 (t10 Subject1)	12707-135E7	5.91	4.08	0.41	0.41	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 03hr00min, donor2 (t10 Subject2)	12805-136G6	9.01	4.93	0.43	0.86	0.43	0.00	0.00	0.43
Monocyte-derived macrophages response to LPS, 03hr00min, donor3 (t10 Subject3)	12903-137I5	4.67	3.78	0.22	0.67	0.00	0.00	0.22	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor1 (t11 Subject1)	12708-135E8	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor2 (t11 Subject2)	12806-136G7	5.48	4.60	0.44	0.22	0.44	0.22	0.00	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor3 (t11 Subject3)	12904-137I6	3.04	4.56	0.00	0.51	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor1 (t12 Subject1)	12709-135E9	1.66	1.66	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor2 (t12 Subject2)	12807-136G8	5.71	4.62	0.00	0.54	0.54	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor3 (t12 Subject3)	12905-137I7	4.41	7.06	0.29	0.29	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor1 (t13 Subject1)	12710-135F1	1.09	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor2 (t13 Subject2)	12808-136G9	5.29	3.84	0.48	0.96	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor3 (t13 Subject3)	12906-137I8	5.60	2.40	0.00	0.40	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor1 (t14 Subject1)	12711-135F2	4.11	2.74	0.00	0.00	2.74	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor2 (t14 Subject2)	12809-136H1	8.01	6.51	0.00	0.50	0.50	0.50	0.50	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor3 (t14 Subject3)	12907-137I9	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor1 (t15 Subject1)	12712-135F3	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor2 (t15 Subject2)	12810-136H2	8.76	4.82	0.00	0.88	0.88	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor3 (t15 Subject3)	12908-138A1	0.00	1.10	0.00	0.00	0.00	0.00	1.10	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor1 (t16 Subject1)	12713-135F4	2.56	5.12	0.00	0.64	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor2 (t16 Subject2)	12811-136H3	9.92	8.68	0.50	1.49	0.50	0.25	0.25	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor3 (t16 Subject3)	12909-138A2	1.39	4.87	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor1 (t17 Subject1)	12714-135F5	4.42	2.21	0.00	2.21	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor2 (t17 Subject2)	12812-136H4	17.78	5.47	0.34	0.00	0.34	0.00	0.00	0.34
Monocyte-derived macrophages response to LPS, 10hr, donor3 (t17 Subject3)	12910-138A3	1.31	3.06	0.00	0.00	0.00	0.00	0.44	0.00
Monocyte-derived macrophages response to LPS, 12hr, donor1 (t18 Subject1)	12715-135F6	2.84	2.84	0.00	0.00	0.36	0.00	0.36	0.00
Monocyte-derived macrophages response to LPS, 12hr, donor2 (t18 Subject2)	12813-136H5	18.24	6.17	0.84	0.84	0.56	0.00	0.00	0.28
Monocyte-derived macrophages response to LPS, 12hr, donor3 (t18 Subject3)	12911-138A4	2.91	7.48	0.00	0.42	0.42	0.00	0.83	0.42
Monocyte-derived macrophages response to LPS, 14hr, donor1 (t19 Subject1)	12716-135F7	3.50	2.91	0.00	0.58	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 14hr, donor2 (t19 Subject2)	12814-136H6	10.56	4.83	0.30	0.90	0.90	0.60	0.30	0.00
Monocyte-derived macrophages response to LPS, 14hr, donor3 (t19 Subject3)	12912-138A5	4.59	3.76	0.42	0.00	0.00	0.00	0.42	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor1 (t20 Subject1)	12717-135F8	7.22	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor2 (t20 Subject2)	12815-136H7	8.31	4.62	0.00	0.92	0.00	0.00	0.00	0.92
Monocyte-derived macrophages response to LPS, 16hr, donor3 (t20 Subject3)	12913-138A6	2.28	1.71	1.14	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 18hr, donor1 (t21 Subject1)	12718-135F9	8.98	3.59	0.28	0.14	0.14	0.00	0.69	0.14
Monocyte-derived macrophages response to LPS, 18hr, donor2 (t21 Subject2)	12816-136H8	16.07	4.41	0.78	0.52	0.52	0.00	0.00	0.52
Monocyte-derived macrophages response to LPS, 18hr, donor3 (t21 Subject3)	12914-138A7	1.72	3.00	0.00	0.43	0.43	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 20hr, donor1 (t22 Subject1)	12719-135G1	3.18	4.45	0.00	0.64	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 20hr, donor2 (t22 Subject2)	12817-136H9	6.14	4.54	0.00	0.27	0.27	0.00	0.53	0.27
Monocyte-derived macrophages response to LPS, 20hr, donor3 (t22 Subject3)	12915-138A8	3.59	5.39	1.20	0.60	0.00	0.00	0.30	0.00
Monocyte-derived macrophages response to LPS, 22hr, donor1 (t23 Subject1)	12720-135G2	5.51	5.79	0.00	0.42	0.14	0.00	0.00	0.14
Monocyte-derived macrophages response to LPS, 22hr, donor2 (t23 Subject2)	12818-136I1	8.60	6.37	0.32	0.32	0.64	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 22hr, donor3 (t23 Subject3)	12916-138A9	4.20	3.32	0.88	0.44	0.00	0.00	0.88	0.00
Monocyte-derived macrophages response to LPS, 24hr, donor1 (t24 Subject1)	12721-135G3	2.28	6.07	0.00	0.38	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 24hr, donor2 (t24 Subject2)	12819-136I2	9.38	4.55	0.00	0.57	0.57	0.00	0.28	0.28
Monocyte-derived macrophages response to LPS, 24hr, donor3 (t24 Subject3)	12917-138B1	5.90	4.42	0.74	0.98	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 36hr, donor1 (t25 Subject1)	12722-135G4	0.65	2.61	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 36hr, donor2 (t25 Subject2)	12820-136I3	5.59	6.17	0.29	0.59	0.29	0.00	0.29	0.00
Monocyte-derived macrophages response to LPS, 36hr, donor3 (t25 Subject3)	12918-138B2	4.04	3.46	0.00	0.29	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 48hr, donor1 (t26 Subject1)	12723-135G5	3.71	3.30	0.41	0.00	0.00	0.00	0.41	0.00
Monocyte-derived macrophages response to LPS, 48hr, donor2 (t26 Subject2)	12821-136I4	2.68	2.38	0.30	0.00	0.60	0.00	0.00	0.30
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor1 (868_121:MI_0h)	13304-142I1	11.30	7.53	0.00	3.77	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor2 (150_120:MI_0h)	13316-143A4	10.69	7.13	0.00	0.00	0.00	0.00	1.78	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor3 (536_119:MI_0h)	13322-143B1	13.14	3.61	0.66	0.33	0.00	0.33	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor4 (227_121:MI_0h)	13310-142I7	12.62	5.26	2.10	0.00	1.05	0.00	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor1 (868_121:MI_24h)	13309-142I6	6.33	4.74	0.40	0.40	0.79	0.00	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor2 (150_120:MI_24h)	13321-143A9	3.73	6.52	0.93	1.86	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor3 (536_119:MI_24h)	13327-143B6	4.88	9.76	0.00	0.75	0.00	0.38	0.00	1.13
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor4 (227_121:MI_24h)	13315-143A3	5.33	5.33	1.07	1.07	0.00	0.00	0.27	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor1 (868_121:Ud_0h)	13305-142I2	11.08	5.99	1.02	0.57	0.45	0.34	0.34	0.11
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor2 (150_120:Ud_0h)	13317-143A5	6.63	4.42	0.74	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor3 (536_119:Ud_0h)	13323-143B2	6.60	5.13	0.73	0.37	0.37	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor4 (227_121:Ud_0h)	13311-142I8	17.11	1.56	1.56	0.00	1.56	0.00	1.56	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor1 (868_121:Ud_2h)	13306-142I3	6.95	5.34	1.07	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor2 (150_120:Ud_2h)	13318-143A6	7.73	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor3 (536_119:Ud_2h)	13324-143B3	13.13	4.04	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor4 (227_121:Ud_2h)	13312-142I9	5.48	1.26	1.69	0.42	0.00	0.42	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor1 (868_121:Ud_7h)	13307-142I4	4.09	1.36	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor2 (150_120:Ud_7h)	13319-143A7	0.64	2.54	0.64	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor3 (536_119:Ud_7h)	13325-143B4	1.62	4.05	0.81	0.81	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor4 (227_121:Ud_7h)	13313-143A1	3.02	0.00	0.00	0.00	0.00	0.00	0.00	1.51
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor1 (868_121:Ud_24h)	13308-142I5	0.00	5.71	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor2 (150_120:Ud_24h)	13320-143A8	13.05	26.10	0.00	0.00	3.26	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor3 (536_119:Ud_24h)	13326-143B5	4.75	9.50	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor4 (227_121:Ud_24h)	13314-143A2	0.00	12.55	0.00	0.00	0.00	0.00	0.00	0.00
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor1	11549-120C1	57.95	8.62	4.31	1.29	0.86	0.43	0.22	0.00
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor2	11629-122B9	24.56	9.41	1.05	0.00	1.05	0.52	0.52	0.00
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor1	13496-145C4	20.69	5.34	2.00	0.00	0.67	0.00	0.67	0.67
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor2	13505-145D4	7.93	5.84	1.25	0.00	0.83	0.00	0.00	1.25
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor3	13514-145E4	68.26	8.18	2.09	1.90	0.38	0.57	1.52	1.14
Myoblast differentiation to myotubes, day00, control donor1	13469-144I4	22.34	6.38	3.19	0.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day00, control donor2	13478-145A4	9.52	4.76	0.68	0.00	1.36	2.04	0.00	0.68
Myoblast differentiation to myotubes, day00, control donor3	13487-145B4	163.55	16.54	0.00	0.00	0.00	1.84	3.68	0.00
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor1	13497-145C5	12.56	6.28	1.26	0.00	1.67	0.84	1.26	0.42
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor2	13506-145D5	22.78	6.97	1.39	0.70	0.93	0.23	0.46	0.23
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor3	13515-145E5	11.08	3.24	0.81	0.54	0.27	0.00	1.08	0.27
Myoblast differentiation to myotubes, day01, control donor1	13470-144I5	20.18	4.84	1.68	0.42	0.84	0.21	0.42	1.05
Myoblast differentiation to myotubes, day01, control donor2	13479-145A5	200.42	11.13	11.13	0.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day01, control donor3	13488-145B5	14.89	5.46	0.99	0.00	0.50	0.50	0.50	0.00
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor1	13498-145C6	14.89	4.06	1.35	0.81	0.27	0.27	0.27	0.00
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor2	13507-145D6	14.73	2.27	1.36	0.00	0.00	0.45	0.23	0.23
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor3	13516-145E6	9.31	3.10	0.82	0.00	0.16	0.16	0.00	0.49
Myoblast differentiation to myotubes, day02, control donor1	13471-144I6	28.43	2.92	1.82	0.73	0.18	0.73	0.00	0.18
Myoblast differentiation to myotubes, day02, control donor2	13480-145A6	9.55	2.12	0.00	0.53	0.00	0.00	0.53	0.00
Myoblast differentiation to myotubes, day02, control donor3	13489-145B6	12.61	4.80	1.20	0.60	0.00	0.60	0.00	1.20
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor1	13499-145C7	33.47	7.22	1.97	0.33	0.66	0.33	0.33	0.98
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor2	13508-145D7	7.81	4.23	1.63	1.14	0.00	0.33	0.33	0.00
Myoblast differentiation to myotubes, day03, control donor1	13472-144I7	18.70	3.88	0.53	0.35	0.53	0.18	0.53	0.00
Myoblast differentiation to myotubes, day03, control donor2	13481-145A7	9.14	5.63	2.11	0.00	0.70	1.41	0.70	1.41
Myoblast differentiation to myotubes, day03, control donor3	13490-145B7	4.60	4.60	0.46	0.46	0.46	0.46	0.92	0.46
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor1	13500-145C8	7.71	1.61	0.96	0.00	0.96	0.32	0.00	0.00
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor2	13509-145D8	32.07	6.21	1.38	0.69	0.69	1.03	0.34	1.03
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor3	13518-145E8	96.08	20.23	0.00	5.06	0.00	2.53	0.00	2.53
Myoblast differentiation to myotubes, day04, control donor1	13473-144I8	14.70	4.46	1.34	0.67	0.45	0.00	0.00	0.22
Myoblast differentiation to myotubes, day04, control donor2	13482-145A8	9.31	4.23	0.85	0.00	0.00	0.85	0.00	0.85
Myoblast differentiation to myotubes, day04, control donor3	13491-145B8	9.02	2.14	0.71	0.00	0.47	0.24	0.00	1.19
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor1	13501-145C9	16.31	7.73	0.43	0.86	1.72	0.43	0.43	0.00
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor2	13510-145D9	189.58	18.06	0.00	0.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor3	13519-145E9	9.66	3.33	0.67	0.33	0.33	0.00	0.33	1.00
Myoblast differentiation to myotubes, day06, control donor1	13474-144I9	5.41	6.76	0.90	0.45	0.90	0.45	0.00	0.45
Myoblast differentiation to myotubes, day06, control donor2	13483-145A9	11.90	5.16	0.79	0.00	0.00	0.40	0.40	0.40
Myoblast differentiation to myotubes, day06, control donor3	13492-145B9	14.86	4.64	1.86	0.00	0.93	0.00	2.79	0.00
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor1	13502-145D1	9.84	4.16	0.38	0.00	0.38	1.14	0.00	0.38
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor2	13511-145E1	9.45	2.93	0.98	0.33	0.33	0.65	0.33	0.65
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor3	13520-145F1	2.18	3.05	0.44	0.00	0.00	0.44	0.00	0.87
Myoblast differentiation to myotubes, day08, control donor1	13475-145A1	13.57	4.07	0.90	0.45	0.45	0.00	0.00	0.45
Myoblast differentiation to myotubes, day08, control donor2	13484-145B1	9.70	3.53	0.00	0.88	1.76	0.00	0.88	0.88
Myoblast differentiation to myotubes, day08, control donor3	13493-145C1	5.32	3.99	0.00	0.00	0.00	0.00	1.99	0.66
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor1	13503-145D2	6.94	2.98	0.99	0.00	0.99	0.50	0.00	0.99
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor2	13512-145E2	5.36	2.30	0.77	0.38	0.77	0.77	0.00	0.00
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor3	13521-145F2	19.66	5.14	1.51	0.60	0.30	0.60	0.30	0.00
Myoblast differentiation to myotubes, day10, control donor1	13476-145A2	13.92	3.76	1.99	0.44	0.44	0.66	0.22	0.44
Myoblast differentiation to myotubes, day10, control donor2	13485-145B2	14.23	4.07	1.36	0.00	0.00	0.68	0.00	0.68
Myoblast differentiation to myotubes, day10, control donor3	13494-145C2	102.19	15.33	0.00	0.00	0.00	10.22	0.00	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor1	13504-145D3	11.58	0.61	0.00	0.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor2	13513-145E3	3.46	1.89	0.31	0.94	0.31	0.63	0.31	0.31
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor3	13522-145F3	4.84	3.33	0.00	0.00	0.61	0.00	0.30	0.00
Myoblast differentiation to myotubes, day12, control donor1	13477-145A3	7.91	4.75	0.79	0.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day12, control donor2	13486-145B3	36.28	7.94	2.27	2.27	0.00	1.13	1.13	1.13
Myoblast differentiation to myotubes, day12, control donor3	13495-145C3	96.10	20.23	5.06	0.00	0.00	0.00	0.00	0.00
Myoblast, donor1	11241-116D8	58.14	11.93	3.35	2.61	1.61	0.99	0.00	0.50
Myoblast, donor2	11322-117D8	60.03	6.33	4.60	0.96	1.34	0.58	0.00	0.19
Myoblast, donor3	11398-118D3	73.82	12.11	4.88	2.02	0.67	0.34	1.01	0.00
NK T cell leukemia cell line:KHYG-1	10777-110G3	119.96	24.52	3.36	3.65	2.19	0.58	0.15	0.15
Natural Killer Cells, donor1	11230-116C6	8.92	10.76	0.00	1.54	0.00	0.00	0.00	0.00
Natural Killer Cells, donor2	11311-117C6	7.54	7.54	0.30	0.60	0.00	0.00	0.00	0.00
Natural Killer Cells, donor3	11387-118C1	7.73	7.55	0.55	0.74	0.55	0.00	0.18	0.18
Neural stem cells, donor1	11275-116H6	179.29	22.14	7.26	3.99	0.00	0.36	0.73	1.09
Neural stem cells, donor2	11352-117H2	121.32	15.41	1.93	3.85	0.00	0.00	1.93	0.00
Neurons, donor1	11494-119E9	59.17	17.07	6.83	4.55	0.00	1.14	1.14	1.14
Neurons, donor2	11574-120E8	73.31	16.51	1.98	1.76	1.32	0.22	1.10	0.22
Neurons, donor3	11655-122E8	61.66	13.98	0.00	1.64	0.00	0.00	0.00	0.82
Neutrophils, donor1	11233-116C9	0.93	2.78	0.00	0.00	0.00	0.00	0.00	0.00
Neutrophils, donor2	11314-117C9	0.00	5.80	0.00	0.00	0.00	0.00	0.00	0.00
Neutrophils, donor3	11390-118C4	0.61	1.22	0.00	0.61	0.00	0.00	0.00	0.00
Nucleus Pulposus Cell, donor1	11252-116F1	69.10	10.57	1.54	0.71	1.19	0.24	0.12	0.36
Nucleus Pulposus Cell, donor2	11409-118E5	30.61	2.93	0.98	0.00	2.93	0.00	0.00	0.33
Nucleus Pulposus Cell, donor3	11462-119B4	57.96	9.02	1.20	0.40	1.00	0.40	0.60	0.40
Olfactory epithelial cells, donor1	11933-125I7	28.63	6.33	2.20	0.69	1.24	0.28	0.28	0.28
Olfactory epithelial cells, donor2	11934-125I8	48.63	7.09	2.32	0.58	1.16	0.14	0.14	0.72
Olfactory epithelial cells, donor3	11935-125I9	27.35	4.99	0.79	0.23	1.25	0.00	0.23	0.11
Olfactory epithelial cells, donor4	11936-126A1	34.67	6.82	2.05	1.07	0.39	0.10	0.58	0.39
Oligodendrocyte - precursors, donor1	11496-119F2	113.14	10.23	3.61	3.01	1.20	0.60	0.60	0.00
Osteoblast - differentiated, donor1	11276-116H7	20.21	4.68	1.06	0.43	0.21	0.00	0.64	0.00
Osteoblast - differentiated, donor2	11353-117H3	8.00	3.43	1.14	0.00	0.00	0.00	0.00	0.00
Osteoblast - differentiated, donor3	11425-118G3	15.52	2.48	0.62	0.00	0.62	0.00	0.00	0.00
Osteoblast, donor1	11277-116H8	50.23	2.93	2.54	1.17	0.00	0.00	0.39	0.00
Osteoblast, donor2	11354-117H4	156.62	12.64	3.51	2.11	0.70	0.70	0.00	0.00
Osteoblast, donor3	11426-118G4	61.49	12.62	1.60	3.02	0.18	0.18	0.36	0.18
Pancreatic stromal cells, donor1	11249-116E7	115.74	9.52	4.63	2.02	0.84	0.34	0.25	0.93
Pericytes, donor1	11491-119E6	11.24	2.11	0.33	0.11	0.33	0.00	0.33	0.00
Pericytes, donor2	11571-120E5	6.56	3.17	0.68	0.45	0.00	0.00	0.00	0.00
Pericytes, donor3	11652-122E5	33.37	6.92	2.03	0.20	0.20	0.20	0.20	0.20
Perineurial Cells, donor1	11499-119F5	188.07	11.98	4.07	2.03	2.83	0.23	0.11	0.57
Perineurial Cells, donor2	11579-120F4	87.59	4.69	2.30	0.28	0.83	0.00	0.37	0.46
Peripheral Blood Mononuclear Cells, donor1	11231-116C7	24.22	9.24	0.96	0.64	0.00	0.00	0.00	0.00
Peripheral Blood Mononuclear Cells, donor2	11312-117C7	9.30	7.84	0.24	0.24	0.00	0.00	0.24	0.00
Peripheral Blood Mononuclear Cells, donor3	11388-118C2	10.48	5.82	0.26	0.78	0.00	0.26	0.39	0.00
Placental Epithelial Cells, donor1	11278-116H9	28.94	7.89	1.20	1.91	0.00	0.00	0.48	0.00
Placental Epithelial Cells, donor2	11355-117H5	29.94	2.22	1.11	1.11	0.00	0.00	0.00	0.00
Placental Epithelial Cells, donor3	11427-118G5	24.93	4.32	0.79	0.39	0.00	0.39	0.00	0.20
Preadipocyte - breast donor2 (cytoplasmic fraction)	14319-155D8	9.49	2.85	0.95	0.95	0.00	0.63	0.00	0.95
Preadipocyte - breast, donor1	11467-119B9	18.20	4.69	2.25	0.94	0.19	0.00	0.00	0.00
Preadipocyte - breast, donor2 (nuclear fraction)	14320-155D9	32.11	10.31	1.96	1.31	0.00	0.13	0.26	0.00
Preadipocyte - breast, donor2	11328-117E5	17.34	5.85	0.45	1.13	0.23	0.23	0.00	0.23
Preadipocyte - omental, donor1	11468-119C1	26.43	7.89	2.24	1.49	0.64	0.00	0.32	0.11
Preadipocyte - omental, donor2	11329-117E6	15.28	8.29	0.87	0.87	0.00	0.00	0.44	0.00
Preadipocyte - omental, donor3	11403-118D8	15.33	3.72	1.15	0.57	0.57	0.43	0.14	0.14
Preadipocyte - perirenal, donor1	11469-119C2	11.81	3.94	0.00	0.98	0.00	0.00	0.00	0.00
Preadipocyte - subcutaneous, donor1	11279-116I1	30.40	3.69	1.54	0.31	0.00	0.00	0.00	0.00
Preadipocyte - subcutaneous, donor2	11356-117H6	146.80	13.46	4.25	2.30	1.24	0.71	0.00	0.71
Preadipocyte - subcutaneous, donor3	11428-118G6	84.80	8.68	3.24	1.70	0.51	0.51	0.34	0.00
Preadipocyte - visceral, donor1	11280-116I2	194.49	16.30	6.80	3.35	0.65	0.37	0.28	0.75
Preadipocyte - visceral, donor2	11357-117H7	87.89	7.82	3.22	1.84	0.92	0.46	0.46	0.46
Preadipocyte - visceral, donor3	11429-118G7	108.67	10.97	2.93	1.88	1.46	1.04	0.52	0.63
Prostate Epithelial Cells (polarized), donor1	11253-116F2	156.28	8.60	4.53	1.51	2.26	0.75	0.60	0.60
Prostate Epithelial Cells, donor2	11331-117E8	21.94	4.33	1.35	0.41	0.14	0.41	0.27	0.14
Prostate Epithelial Cells, donor3	11404-118D9	33.44	15.19	0.67	2.27	0.55	0.24	0.18	0.18
Prostate Stromal Cells, donor1	11254-116F3	133.49	14.12	2.96	3.64	1.48	0.00	0.46	0.34
Prostate Stromal Cells, donor2	11332-117E9	96.82	8.43	3.59	1.43	0.54	0.90	0.18	0.00
Prostate Stromal Cells, donor3	11405-118E1	28.47	4.17	1.15	0.52	0.31	0.00	0.21	0.00
Renal Cortical Epithelial Cells, donor1	11516-119H4	25.55	8.76	0.73	0.73	0.73	0.00	0.00	0.36
Renal Cortical Epithelial Cells, donor2	11596-120H3	139.11	17.40	5.41	2.01	1.32	0.28	0.49	0.42
Renal Epithelial Cells, donor1	11517-119H5	19.27	5.07	1.52	0.00	0.51	0.00	0.00	0.00
Renal Epithelial Cells, donor2	11597-120H4	19.92	2.85	0.71	0.71	0.71	0.71	0.00	0.00
Renal Epithelial Cells, donor3	11678-122H4	146.52	13.44	6.14	1.48	1.69	0.74	0.42	0.11
Renal Glomerular Endothelial Cells, donor1	11514-119H2	4.09	3.40	0.00	0.68	0.00	0.00	0.00	0.68
Renal Glomerular Endothelial Cells, donor2	11594-120H1	28.30	3.23	0.94	0.81	0.81	0.40	0.00	0.54
Renal Glomerular Endothelial Cells, donor3	11675-122H1	97.02	13.99	4.44	2.22	2.66	0.44	0.00	0.89
Renal Glomerular Endothelial Cells, donor4	11783-124B1	7.32	0.67	0.00	0.67	0.00	0.67	0.00	0.00
Renal Mesangial Cells, donor1	11518-119H6	31.25	6.38	1.32	1.10	0.88	0.00	0.22	0.00
Renal Mesangial Cells, donor2	11598-120H5	29.47	8.78	1.88	0.63	1.25	0.00	0.00	0.63
Renal Mesangial Cells, donor3	11679-122H5	8.32	3.61	0.00	0.00	0.00	0.00	0.00	0.00
Renal Proximal Tubular Epithelial Cell, donor1	11515-119H3	79.18	16.11	4.03	3.22	0.54	0.27	0.81	0.54
Renal Proximal Tubular Epithelial Cell, donor2	11595-120H2	28.68	8.43	1.27	0.00	0.84	0.00	0.42	0.00
Renal Proximal Tubular Epithelial Cell, donor3	11676-122H2	36.64	7.91	1.16	0.96	0.96	0.19	0.58	0.19
Retinal Pigment Epithelial Cells, donor0	11215-116A9	232.58	17.37	4.67	1.81	3.63	1.30	0.52	1.30
Retinal Pigment Epithelial Cells, donor1	11528-119I7	59.98	7.39	2.56	0.57	0.57	0.00	0.00	0.28
Retinal Pigment Epithelial Cells, donor2	11608-120I6	23.67	5.15	2.06	2.06	0.00	0.00	0.00	0.00
Retinal Pigment Epithelial Cells, donor3	11689-122I6	110.15	16.81	2.76	1.51	2.01	0.50	0.00	0.25
SABiosciences XpressRef Human Universal Total RNA, pool1	10002-101A5	58.00	13.36	2.54	2.27	1.74	0.27	0.13	0.27
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep1 (B1 T17)	12697-135D6	72.37	11.61	2.68	2.68	3.57	1.79	2.68	1.79
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep2 (B2 T17)	12795-136F5	227.85	20.91	8.81	3.85	5.50	1.10	0.00	2.20
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep3 (B3 T17)	12893-137H4	102.67	15.66	3.48	2.32	1.16	1.74	0.00	1.16
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep1 (A1 T0)	12662-134I7	257.71	23.27	12.74	2.86	1.56	1.82	0.39	0.65
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep2 (A2 T0)	12760-136B6	175.17	19.17	8.24	2.09	2.78	0.79	0.70	1.79
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep3 (A3 T0)	12858-137D5	323.80	22.64	14.28	2.90	3.79	0.89	0.22	1.12
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep1 (A1 T1)	12663-134I8	405.37	32.00	13.15	2.60	3.35	1.74	0.74	0.74
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep2 (A2 T1)	12761-136B7	205.47	20.05	8.51	3.15	3.85	1.28	0.35	1.98
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep3 (A3 T1)	12859-137D6	284.99	17.57	10.17	3.47	3.00	1.16	0.23	1.85
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep1 (A1 T2)	12664-134I9	184.28	23.00	6.43	2.33	1.23	1.10	0.14	1.10
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep2 (A2 T2)	12762-136B8	229.63	24.51	11.19	1.82	1.82	0.61	0.15	0.91
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep3 (A3 T2)	12860-137D7	220.58	19.35	10.39	3.58	1.97	0.90	0.18	1.08
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep1 (A1 T3)	12665-135A1	194.67	18.51	12.05	2.15	2.01	1.58	0.72	1.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep2 (A2 T3)	12763-136B9	196.28	21.36	9.77	2.25	3.00	1.07	0.54	0.75
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep3 (A3 T3)	12861-137D8	192.95	17.26	9.74	2.21	4.43	0.89	0.44	0.89
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep1 (A1 T4)	12666-135A2	181.43	24.09	10.51	3.06	1.15	1.34	0.38	1.15
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep2 (A2 T4)	12764-136C1	176.08	21.33	7.36	2.98	2.52	0.84	0.47	1.96
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep3 (A3 T4)	12862-137D9	340.86	25.93	16.35	4.32	1.69	1.69	0.75	0.38
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep1 (A1 T5)	12667-135A3	162.17	24.55	8.23	3.58	1.19	1.99	0.80	1.19
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep2 (A2 T5)	12765-136C2	175.70	19.37	8.47	2.73	0.97	0.49	0.49	0.97
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep3 (A3 T5)	12863-137E1	240.23	20.05	9.93	1.53	2.29	0.95	0.38	1.15
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep1 (A1 T6)	12668-135A4	178.77	20.93	9.50	1.71	0.64	2.03	0.43	0.85
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep2 (A2 T6)	12766-136C3	183.88	20.46	7.01	2.24	3.08	2.24	1.12	2.24
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep3 (A3 T6)	12864-137E2	178.93	18.29	10.25	2.05	2.22	0.34	0.51	0.34
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep1 (A1 T7)	12669-135A5	160.09	24.61	7.29	2.92	0.36	2.37	0.18	0.91
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep2 (A2 T7)	12767-136C4	165.06	21.83	7.97	2.21	1.59	1.10	0.49	0.74
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep3 (A3 T7)	12865-137E3	190.60	20.82	9.00	3.22	3.36	0.94	0.40	1.21
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep1 (A1 T8)	12670-135A6	217.24	25.00	13.92	3.30	4.95	2.83	1.42	1.65
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep2 (A2 T8)	12768-136C5	183.53	27.78	12.90	3.57	1.39	0.20	0.79	2.38
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep3 (A3 T8)	12866-137E4	214.20	21.98	12.63	2.34	2.81	1.17	1.17	0.94
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep1 (A1 T9)	12671-135A7	203.42	25.50	11.61	3.53	1.66	1.24	0.00	0.83
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep2 (A2 T9)	12769-136C6	203.29	23.01	11.72	2.65	1.99	1.11	1.11	0.88
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep3 (A3 T9)	12867-137E5	160.21	17.13	9.19	2.30	1.04	1.25	0.42	0.84
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep1 (A1 T10)	12672-135A8	179.67	20.86	9.29	3.77	1.21	1.08	0.81	1.21
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep2 (A2 T10)	12770-136C7	132.32	27.93	7.15	2.72	1.36	1.19	0.51	0.34
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep3 (A3 T10)	12868-137E6	169.85	21.79	9.06	1.74	2.31	1.74	0.58	2.70
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep1 (A1 T11)	12673-135A9	204.26	19.26	8.42	4.13	1.89	1.03	0.52	0.69
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep2 (A2 T11)	12771-136C8	101.09	20.58	7.00	2.61	0.96	1.51	0.41	0.96
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep3 (A3 T11)	12869-137E7	191.91	16.25	10.51	3.12	3.45	1.64	0.99	2.13
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep1 (A1 T12)	12674-135B1	164.47	15.17	6.82	2.05	2.05	1.19	0.51	2.39
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep2 (A2 T12)	12772-136C9	190.13	17.75	7.99	3.11	1.78	0.30	0.30	0.59
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep3 (A3 T12)	12870-137E8	117.82	18.13	6.13	2.13	1.07	0.27	0.53	1.33
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep1 (A1 T13)	12675-135B2	124.85	23.51	4.01	2.21	1.38	0.69	0.55	1.24
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep2 (A2 T13)	12773-136D1	162.15	17.14	7.62	3.57	4.05	0.24	0.71	1.19
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep3 (A3 T13)	12871-137E9	166.67	23.18	10.08	2.02	2.82	1.21	0.40	2.42
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep1 (A1 T14)	12676-135B3	141.45	16.95	9.89	1.51	1.13	1.13	0.85	0.85
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep2 (A2 T14)	12774-136D2	142.89	18.87	5.94	3.49	1.40	0.70	0.70	0.35
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep3 (A3 T14)	12872-137F1	75.55	16.92	4.23	2.42	2.42	0.60	0.91	1.51
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep1 (A1 T15)	12677-135B4	152.00	15.30	8.44	1.59	1.22	0.86	0.24	0.49
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep2 (A2 T15)	12775-136D3	182.81	28.53	9.90	2.91	0.73	0.58	0.29	0.29
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep3 (A3 T15)	12873-137F2	103.43	14.60	3.04	2.43	3.04	0.00	0.00	0.61
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep1 (A1 T16)	12678-135B5	152.81	16.28	9.34	2.11	3.01	1.81	0.30	1.51
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep2 (A2 T16)	12776-136D4	81.65	16.51	4.52	2.49	1.13	0.45	0.00	1.36
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep3 (A3 T16)	12874-137F3	88.06	18.27	2.40	0.90	0.90	0.90	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep1 (A1 T17)	12679-135B6	132.24	17.36	5.31	2.72	0.71	0.94	0.59	0.94
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep2 (A2 T17)	12777-136D5	74.92	14.51	1.92	1.92	0.21	0.00	0.43	0.21
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep3 (A3 T17)	12875-137F4	73.92	11.42	2.40	1.20	0.00	0.00	0.00	0.00
Schwann Cells, donor1	11498-119F4	25.01	4.70	0.75	0.75	0.38	0.19	0.00	0.00
Schwann Cells, donor2	11578-120F3	105.47	6.80	3.40	3.40	0.00	0.00	0.00	0.00
Schwann Cells, donor3	11659-122F3	63.53	8.76	1.10	1.10	3.51	1.10	0.22	1.10
Sebocyte, donor1	11220-116B5	81.07	7.12	0.00	1.10	0.00	0.00	0.00	0.00
Sebocyte, donor2	11301-117B5	51.47	4.14	0.00	0.46	1.38	0.00	0.00	0.00
Sebocyte, donor3	11378-118B1	28.03	4.12	0.62	1.65	0.21	0.21	0.00	0.41
Sertoli Cells, donor1	11255-116F4	91.11	11.60	4.97	1.66	0.00	3.31	1.66	0.00
Sertoli Cells, donor2	11333-117F1	48.01	8.47	0.00	2.82	0.00	0.00	0.00	0.00
Skeletal Muscle Cells, donor1	11281-116I3	87.71	14.69	4.22	2.73	0.62	0.53	0.62	0.18
Skeletal Muscle Cells, donor2	11358-117H8	5.78	1.45	0.00	0.72	0.00	0.00	0.00	0.00
Skeletal Muscle Cells, donor3	11430-118G8	45.15	4.18	0.00	0.84	0.00	0.84	0.84	1.67
Skeletal Muscle Cells, donor4	11451-119A2	176.10	13.20	2.98	1.57	3.14	0.63	0.31	1.26
Skeletal Muscle Cells, donor5	11455-119A6	155.04	11.00	1.93	2.08	1.64	0.89	0.00	0.45
Skeletal Muscle Cells, donor6	11459-119B1	211.92	12.77	3.69	3.08	2.62	0.15	0.46	1.23
Skeletal Muscle Satellite Cells, donor1	11240-116D7	199.59	11.97	4.54	1.39	3.02	0.38	0.25	0.25
Skeletal Muscle Satellite Cells, donor2	11321-117D7	99.74	12.70	1.43	1.28	2.14	0.43	0.29	0.57
Skeletal Muscle Satellite Cells, donor3	11397-118D2	166.97	15.68	2.38	1.79	2.48	0.89	0.69	1.09
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor1	11282-116I4	86.61	9.35	3.37	1.69	0.84	0.76	0.34	0.25
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor2	11359-117H9	39.08	5.07	0.72	0.00	0.00	0.00	0.00	1.45
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor3	11431-118G9	27.52	3.58	1.24	0.28	0.00	0.55	0.14	0.00
Skin - palm, donor1	10286-104F7	8.06	18.80	2.69	2.69	2.69	0.00	0.00	0.00
Small Airway Epithelial Cells donor2 (cytoplasmic fraction)	14334-155F5	27.10	4.32	0.58	0.43	0.86	0.43	0.43	0.43
Small Airway Epithelial Cells donor2 (nuclear fraction)	14335-155F6	56.43	4.91	0.82	2.45	0.00	1.64	0.82	1.64
Small Airway Epithelial Cells donor3 (cytoplasmic fraction)	14316-155D5	42.84	4.67	0.91	0.78	0.91	1.30	0.26	1.69
Small Airway Epithelial Cells, donor1	11256-116F5	71.73	14.32	0.83	2.36	1.25	0.42	0.56	0.28
Small Airway Epithelial Cells, donor2	11334-117F2	24.33	8.16	0.56	0.70	0.42	0.14	0.42	0.00
Small Airway Epithelial Cells, donor3 (nuclear fraction)	14317-155D6	119.26	14.17	1.48	3.17	0.85	0.42	0.42	0.63
Small Airway Epithelial Cells, donor3	11406-118E2	22.71	14.02	0.15	1.50	0.82	0.30	0.07	0.30
Smooth Muscle Cells - Aortic, donor0 (cytoplasmic fraction)	14313-155D2	63.57	8.33	2.16	2.47	1.85	1.85	0.00	0.00
Smooth Muscle Cells - Aortic, donor0 (nuclear fraction)	14314-155D3	70.26	16.45	2.89	2.45	0.22	0.22	0.67	0.67
Smooth Muscle Cells - Aortic, donor0	11210-116A4	53.49	11.76	2.94	1.18	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Aortic, donor1	11283-116I5	29.17	6.41	0.88	1.10	0.22	0.22	0.00	0.22
Smooth Muscle Cells - Aortic, donor2	11360-117I1	30.71	5.51	1.18	1.97	0.00	0.00	0.39	0.00
Smooth Muscle Cells - Aortic, donor3	11432-118H1	37.86	8.50	4.64	3.09	1.55	0.77	0.77	0.00
Smooth Muscle Cells - Bladder, donor1	11519-119H7	40.03	0.00	3.00	0.00	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Brachiocephalic, donor1	11284-116I6	42.45	5.59	1.86	1.46	0.40	0.00	0.13	0.13
Smooth Muscle Cells - Brachiocephalic, donor2	11361-117I2	67.38	8.87	4.21	1.55	1.99	0.66	0.22	0.44
Smooth Muscle Cells - Brachiocephalic, donor3	11433-118H2	39.95	7.17	2.69	1.54	0.13	0.13	0.13	0.26
Smooth Muscle Cells - Brain Vascular, donor1	11234-116D1	93.12	7.81	2.28	1.63	0.98	0.00	0.33	0.65
Smooth Muscle Cells - Brain Vascular, donor2	11315-117D1	74.42	6.79	0.89	0.89	0.59	0.89	0.00	0.30
Smooth Muscle Cells - Brain Vascular, donor3	11391-118C5	33.60	3.42	0.85	1.28	0.28	0.28	0.14	0.14
Smooth Muscle Cells - Bronchial, donor1	11512-119G9	18.87	3.74	0.81	0.33	0.33	0.33	0.00	0.16
Smooth Muscle Cells - Bronchial, donor2	11592-120G8	35.92	14.92	1.83	0.61	0.30	0.61	0.00	0.61
Smooth Muscle Cells - Carotid, donor1	11285-116I7	42.68	9.85	4.04	2.27	0.00	0.00	0.76	0.25
Smooth Muscle Cells - Carotid, donor2	11362-117I3	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Carotid, donor3	11434-118H3	30.04	7.15	1.43	0.95	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Colonic, donor1	11239-116D6	84.94	8.26	1.77	1.62	1.03	0.15	0.29	0.44
Smooth Muscle Cells - Colonic, donor2	11320-117D6	65.43	4.52	1.94	0.22	1.08	0.22	0.43	0.00
Smooth Muscle Cells - Colonic, donor3	11396-118D1	91.63	9.13	1.36	1.05	0.84	0.73	0.10	0.31
Smooth Muscle Cells - Coronary Artery, donor1	11286-116I8	24.13	4.33	1.55	0.77	0.46	0.15	0.15	0.00
Smooth Muscle Cells - Coronary Artery, donor2	11363-117I4	17.25	4.31	2.16	1.08	0.00	0.00	0.00	1.08
Smooth Muscle Cells - Coronary Artery, donor3	11435-118H4	31.38	7.17	2.99	0.60	0.30	0.00	0.60	0.30
Smooth Muscle Cells - Esophageal, donor1	11508-119G5	28.68	3.41	0.68	0.00	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Esophageal, donor2	11588-120G4	134.05	5.10	2.83	0.63	1.02	0.31	0.08	0.39
Smooth Muscle Cells - Internal Thoracic Artery, donor1	11287-116I9	74.47	16.20	1.91	2.42	0.70	0.50	0.40	0.50
Smooth Muscle Cells - Internal Thoracic Artery, donor2	11364-117I5	28.67	7.28	1.59	1.37	1.14	0.23	0.23	0.23
Smooth Muscle Cells - Internal Thoracic Artery, donor3	11436-118H5	17.51	3.62	1.81	1.21	0.00	0.00	0.60	0.00
Smooth Muscle Cells - Intestinal, donor1	11509-119G6	373.02	22.52	3.18	5.30	2.38	0.79	0.26	1.06
Smooth Muscle Cells - Prostate, donor1	11257-116F6	88.55	11.72	3.73	1.33	0.40	0.40	0.40	0.27
Smooth Muscle Cells - Prostate, donor2	11335-117F3	49.09	9.27	0.38	0.38	0.63	0.25	0.38	0.00
Smooth Muscle Cells - Prostate, donor3	11465-119B7	24.86	6.09	1.27	0.00	0.51	0.25	0.00	0.00
Smooth Muscle Cells - Pulmonary Artery, donor1	11288-117A1	82.32	10.25	3.92	1.66	0.00	0.15	0.15	0.15
Smooth Muscle Cells - Pulmonary Artery, donor2	11365-117I6	19.50	6.75	0.75	2.25	0.75	0.00	0.75	0.00
Smooth Muscle Cells - Pulmonary Artery, donor3	11437-118H6	24.55	2.58	0.00	0.00	1.29	0.00	0.00	1.29
Smooth Muscle Cells - Subclavian Artery, donor1	11289-117A2	55.81	6.98	2.79	0.47	0.00	0.47	0.47	0.00
Smooth Muscle Cells - Subclavian Artery, donor2	11366-117I7	37.87	7.07	1.51	1.51	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Subclavian Artery, donor3	11438-118H7	18.49	6.58	1.57	0.31	0.31	0.00	0.31	0.00
Smooth Muscle Cells - Tracheal, donor1	11513-119H1	17.70	4.72	0.29	0.59	1.18	0.00	0.00	0.00
Smooth Muscle Cells - Tracheal, donor2	11593-120G9	173.03	17.24	3.42	3.08	2.50	0.17	0.17	1.42
Smooth Muscle Cells - Tracheal, donor3	11674-122G9	35.97	4.67	1.87	0.47	0.00	1.40	0.00	0.00
Smooth Muscle Cells - Umbilical Artery, donor1	11290-117A3	37.71	6.91	1.58	0.86	0.14	0.14	0.14	0.14
Smooth Muscle Cells - Umbilical Artery, donor2	11367-117I8	48.19	8.16	2.04	0.76	0.51	1.02	0.25	0.25
Smooth Muscle Cells - Umbilical Artery, donor3	11439-118H8	47.01	6.02	1.69	0.75	0.38	0.38	0.00	0.38
Smooth Muscle Cells - Umbilical Vein, donor1	11541-120B2	185.02	15.23	4.33	2.38	1.26	0.28	0.28	0.70
Smooth Muscle Cells - Umbilical Vein, donor2	11621-122B1	86.47	8.55	2.93	2.09	0.75	0.34	0.34	0.17
Smooth Muscle Cells - Umbilical Vein, donor3	11702-123B1	10.48	1.43	0.48	0.48	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Umbilical artery, donor0	11212-116A6	30.09	5.87	0.49	1.47	0.24	0.00	0.24	0.00
Smooth Muscle Cells - Uterine, donor1	11258-116F7	51.48	7.73	1.77	0.44	1.10	0.66	0.22	0.00
Smooth Muscle Cells - Uterine, donor3	11466-119B8	90.99	7.90	4.97	0.88	0.59	0.88	0.59	0.00
Smooth muscle cells - airway, asthmatic, donor1	11960-126C7	12.63	3.50	1.17	0.78	0.58	0.00	0.19	0.00
Smooth muscle cells - airway, asthmatic, donor2	11961-126C8	26.97	9.52	1.59	0.26	1.32	0.26	0.00	0.26
Smooth muscle cells - airway, asthmatic, donor3	11962-126C9	34.22	4.46	1.12	0.74	0.74	0.37	0.00	1.12
Smooth muscle cells - airway, asthmatic, donor4	11963-126D1	33.78	10.78	1.44	1.08	2.16	0.36	0.00	0.00
Smooth muscle cells - airway, asthmatic, donor5	11964-126D2	26.40	5.96	0.57	2.27	0.57	0.28	0.00	0.57
Smooth muscle cells - airway, asthmatic, donor6	11965-126D3	98.47	11.82	5.12	2.76	3.54	0.39	0.39	0.79
Smooth muscle cells - airway, control, donor1	11966-126D4	46.98	5.84	1.52	0.25	2.03	0.76	0.00	0.51
Smooth muscle cells - airway, control, donor2	11967-126D5	21.96	3.99	2.40	0.40	0.80	0.80	0.00	0.00
Smooth muscle cells - airway, control, donor3	11968-126D6	20.48	7.11	1.25	0.42	2.93	0.42	0.00	0.42
Smooth muscle cells - airway, control, donor4	11969-126D7	13.75	3.67	0.46	0.92	0.00	0.00	0.00	0.00
Synoviocyte, donor1	11291-117A4	39.56	11.45	2.19	1.18	0.34	0.34	0.00	0.00
Synoviocyte, donor2	11368-117I9	23.97	6.70	1.51	1.17	0.84	0.50	0.67	0.17
Synoviocyte, donor3	11440-118H9	19.44	7.60	1.12	0.45	0.22	0.22	0.22	0.00
Trabecular Meshwork Cells, donor1	11532-120A2	55.03	3.93	1.79	0.71	0.00	0.00	0.00	0.00
Trabecular Meshwork Cells, donor2	11612-122A1	25.77	3.96	0.00	0.00	1.98	0.00	0.00	0.00
Trabecular Meshwork Cells, donor3	11693-123A1	30.33	4.17	0.93	0.23	0.23	0.00	0.00	0.00
Tracheal Epithelial Cells, donor1	11292-117A5	70.47	7.53	1.15	1.29	0.57	0.22	0.22	0.22
Tracheal Epithelial Cells, donor2	11369-118A1	35.18	3.09	0.77	0.00	0.39	0.00	0.00	0.00
Tracheal Epithelial Cells, donor3	11441-118I1	22.91	3.44	0.57	1.72	0.57	0.00	0.57	0.00
Universal RNA - Human Normal Tissues Biochain, pool1	10007-101B4	64.10	18.45	3.20	2.21	2.09	0.12	0.00	0.86
Urethra, donor2	10319-105A4	10.79	12.59	0.00	3.60	0.00	0.00	0.00	1.80
Urothelial Cells, donor1	11520-119H8	13.81	1.59	0.53	0.53	0.00	0.00	0.00	0.53
Urothelial Cells, donor2	11600-120H7	12.42	2.00	0.40	0.00	0.40	0.00	0.40	0.00
Urothelial Cells, donor3	11681-122H7	11.46	1.60	0.46	0.23	0.23	0.00	0.00	0.00
Urothelial cells, donor0	11216-116B1	63.97	6.69	1.11	1.78	1.34	0.22	0.22	0.00
Whole blood (ribopure), donor090309, donation1	12179-129A1	9.79	4.45	0.89	0.00	0.00	0.00	0.00	0.00
Whole blood (ribopure), donor090309, donation2	12180-129A2	14.30	5.72	0.00	0.00	0.00	0.00	0.00	0.00
Whole blood (ribopure), donor090309, donation3	12181-129A3	6.16	3.42	0.00	0.00	0.00	0.00	0.00	0.00
Whole blood (ribopure), donor090325, donation1	12176-128I7	16.53	7.23	1.38	0.00	0.34	0.00	0.00	0.00
Whole blood (ribopure), donor090325, donation2	12177-128I8	10.46	6.97	0.58	1.16	0.00	0.00	0.00	0.00
Whole blood (ribopure), donor090612, donation1	12182-129A4	14.58	4.16	0.00	2.08	0.00	0.00	0.00	0.00
Whole blood (ribopure), donor090612, donation2	12183-129A5	21.11	3.67	0.00	1.84	0.00	0.00	0.00	0.00
Whole blood (ribopure), donor090612, donation3	12184-129A6	9.13	5.48	0.00	0.00	0.00	0.00	0.00	0.00
Wilms' tumor cell line:G-401	10809-111A8	169.13	5.55	8.88	0.62	1.85	2.34	0.00	1.11
Wilms' tumor cell line:HFWT	10597-108E3	23.76	5.28	0.00	1.76	0.00	0.00	0.00	0.00
acantholytic squamous carcinoma cell line:HCC1806	10717-109I6	142.45	13.69	3.35	1.68	1.12	0.00	0.28	0.84
achilles tendon, donor2	10292-104G4	22.73	6.20	2.07	0.00	4.13	2.07	4.13	0.00
acute lymphoblastic leukemia (B-ALL) cell line:BALL-1	10455-106G5	351.84	17.34	12.24	1.27	6.12	0.76	0.00	3.31
acute lymphoblastic leukemia (B-ALL) cell line:NALM-6	10534-107G3	430.45	20.20	17.88	3.71	5.80	1.86	0.23	1.63
acute lymphoblastic leukemia (T-ALL) cell line:HPB-ALL	10429-106D6	389.72	20.89	10.80	2.61	2.14	0.83	0.12	1.07
acute lymphoblastic leukemia (T-ALL) cell line:Jurkat	10464-106H5	518.65	21.50	19.86	2.18	4.63	2.45	0.27	2.18
acute myeloid leukemia (FAB M0) cell line:KG-1	10827-111C8	211.09	6.46	5.62	0.56	2.25	0.84	0.28	1.41
acute myeloid leukemia (FAB M0) cell line:Kasumi-3	10789-110H6	177.64	16.07	3.81	4.65	1.90	0.00	0.00	0.21
acute myeloid leukemia (FAB M1) cell line:HYT-1	10828-111C9	158.15	10.07	4.63	2.72	2.18	0.82	0.27	1.36
acute myeloid leukemia (FAB M2) cell line:Kasumi-1	10788-110H5	527.44	15.86	11.02	1.76	6.17	3.08	0.00	3.08
acute myeloid leukemia (FAB M2) cell line:Kasumi-6	10792-110H9	172.74	7.76	3.27	2.86	1.23	0.82	0.00	0.82
acute myeloid leukemia (FAB M2) cell line:NKM-1	10765-110E9	186.77	5.82	6.99	1.94	2.33	0.39	0.00	2.72
acute myeloid leukemia (FAB M3) cell line:HL60	10829-111D1	389.16	23.18	18.03	3.68	3.13	1.84	0.55	1.66
acute myeloid leukemia (FAB M4) cell line:FKH-1	10830-111D2	187.22	15.60	0.00	0.00	3.90	0.00	0.00	3.90
acute myeloid leukemia (FAB M4) cell line:HNT-34	10831-111D3	280.72	9.76	8.13	0.70	2.56	0.46	0.00	0.46
acute myeloid leukemia (FAB M4eo) cell line:EoL-1	10832-111D4	487.25	35.73	23.56	5.18	6.21	1.04	0.00	2.07
acute myeloid leukemia (FAB M4eo) cell line:EoL-3	10833-111D5	371.15	20.46	11.69	2.63	4.09	3.21	0.29	2.92
acute myeloid leukemia (FAB M5) cell line:NOMO-1	10764-110E8	66.46	18.59	1.86	1.39	2.79	0.00	0.00	0.46
acute myeloid leukemia (FAB M5) cell line:P31/FUJ	10770-110F5	142.29	9.46	4.11	3.29	1.65	0.82	0.00	1.65
acute myeloid leukemia (FAB M5) cell line:THP-1 (cytoplasmic fraction)	14298-155B5	32.84	12.28	2.15	0.92	4.30	1.84	0.61	4.91
acute myeloid leukemia (FAB M5) cell line:THP-1 (fresh)	10399-106A3	256.88	20.48	10.67	5.12	1.71	1.28	0.43	0.43
acute myeloid leukemia (FAB M5) cell line:THP-1 (revived)	10400-106A4	230.50	17.59	7.28	3.64	2.12	1.21	0.30	0.61
acute myeloid leukemia (FAB M5) cell line:THP-1 (thawed)	10405-106A9	278.01	17.57	9.39	2.89	2.65	1.44	0.00	0.24
acute myeloid leukemia (FAB M5) cell line:U-937 DE-4	10834-111D6	226.75	14.70	7.13	2.90	1.56	0.22	0.00	1.56
acute myeloid leukemia (FAB M6) cell line:EEB	10835-111D7	154.10	17.01	5.67	2.00	4.67	0.33	0.00	2.00
acute myeloid leukemia (FAB M6) cell line:F-36E	10836-111D8	66.90	18.58	7.43	0.00	5.57	0.00	0.00	0.00
acute myeloid leukemia (FAB M6) cell line:F-36P	10837-111D9	254.62	7.91	10.55	1.13	3.39	1.13	0.38	1.13
acute myeloid leukemia (FAB M7) cell line:M-MOK	10699-109G6	139.56	10.47	8.72	2.18	1.74	0.87	0.44	0.87
acute myeloid leukemia (FAB M7) cell line:MKPL-1	10802-111A1	37.49	9.37	1.87	0.00	0.00	0.00	0.00	0.00
adenocarcinoma cell line:IM95m	10796-110I4	107.39	20.49	1.88	5.18	0.94	0.47	0.24	0.47
adipose tissue, adult, pool1	10010-101C1	21.41	9.00	1.09	0.78	0.00	0.00	0.00	0.00
adipose, donor1	10184-103D4	413.42	18.18	12.31	2.35	9.97	5.28	1.17	6.45
adipose, donor2	10185-103D5	72.59	19.87	4.06	0.81	6.89	1.62	0.00	3.24
adipose, donor3	10186-103D6	122.80	13.61	5.45	1.63	7.35	1.36	0.54	2.45
adipose, donor4	10187-103D7	248.76	22.54	12.13	0.87	7.80	3.47	0.00	3.47
adrenal cortex adenocarcinoma cell line:SW-13	10810-111A9	137.78	11.05	1.74	1.42	1.74	0.47	0.79	1.10
adrenal gland, adult, pool1	10081-102A9	10.91	32.74	3.64	0.00	0.00	0.00	3.64	0.00
adult T-cell leukemia cell line:ATN-1	10421-106C7	92.05	28.02	5.34	3.07	1.07	0.53	0.13	0.27
alveolar cell carcinoma cell line:SW 1573	10708-109H6	86.82	4.29	4.64	1.07	1.43	0.00	0.00	0.71
amniotic membrane cells, donor1	12235-129G3	28.05	24.58	2.32	1.62	0.46	0.46	0.70	0.00
amniotic membrane cells, donor2	12236-129G4	53.08	16.57	11.50	3.04	0.00	0.34	0.68	0.34
amniotic membrane cells, donor3	12237-129G5	38.00	35.94	3.24	2.95	0.29	0.29	2.65	0.29
amygdala - adult, donor10196	10167-103B5	20.16	16.60	2.37	4.74	0.00	0.00	3.56	1.19
amygdala, adult, donor10252	10151-102I7	22.10	23.52	1.42	2.64	1.01	0.00	2.03	0.20
amygdala, newborn, donor10223	10360-105E9	15.17	15.82	0.65	1.29	0.65	0.65	0.97	0.97
anaplastic carcinoma cell line:8305C	10428-106D5	67.61	17.44	2.29	1.78	0.38	0.13	0.64	0.00
anaplastic large cell lymphoma cell line:Ki-JK	10795-110I3	148.70	16.99	6.40	3.31	3.31	1.10	0.22	1.99
anaplastic squamous cell carcinoma cell line:RPMI 2650	10805-111A4	170.02	17.04	1.34	1.00	3.01	1.34	0.67	1.34
aorta, adult, pool1	10052-101G7	9.02	9.22	0.98	0.78	0.98	0.20	0.59	0.20
appendix, adult	10189-103D9	37.65	14.36	2.33	1.16	1.16	0.00	0.39	0.39
argyrophil small cell carcinoma cell line:TC-YIK	10589-108D4	222.18	14.45	15.48	3.44	1.72	1.72	0.00	0.34
artery, adult	10190-103E1	4.08	12.23	1.36	1.36	0.00	0.00	1.36	0.00
astrocytoma cell line:TM-31	10425-106D2	226.86	37.38	5.07	4.35	3.19	0.43	0.58	0.87
b cell line:RPMI1788	10427-106D4	288.03	28.55	3.12	3.27	2.83	0.45	0.00	0.30
basal cell carcinoma cell line:TE 354.T	10702-109G9	58.82	10.82	3.05	1.66	0.55	0.28	0.00	0.55
bile duct carcinoma cell line:HuCCT1	10432-106D9	157.88	30.96	6.55	4.56	0.99	0.20	0.99	0.30
bile duct carcinoma cell line:TFK-1	10496-107C1	65.11	17.24	1.17	4.35	2.34	0.33	0.17	0.50
biphenotypic B myelomonocytic leukemia cell line:MV-4-11	10718-109I7	73.82	24.61	1.68	5.03	3.91	0.00	0.00	1.12
bladder, adult, pool1	10011-101C2	24.66	13.47	0.33	1.63	0.11	0.22	0.22	0.00
blood, adult, pool1	10053-101G8	4.43	2.21	0.00	0.00	0.00	0.00	0.00	0.00
bone marrow stromal cell line:StromaNKtert	10686-109F2	11.13	4.28	0.00	1.71	0.00	0.00	0.00	0.00
bone marrow, adult	10192-103E3	57.36	10.12	0.67	1.35	0.67	0.67	1.35	1.35
brain, adult, donor1	10084-102B3	12.30	14.35	1.03	0.00	0.00	1.03	1.03	0.00
brain, adult, pool1	10012-101C3	15.37	26.17	2.45	2.34	0.45	0.00	1.89	0.33
brain, fetal, pool1	10085-102B4	21.37	13.36	0.00	0.00	0.00	0.00	5.34	0.00
breast carcinoma cell line:MCF7	10482-107A5	63.10	24.78	0.66	3.63	2.31	0.99	0.33	2.31
breast carcinoma cell line:MDA-MB-453	10419-106C5	95.86	9.61	3.37	2.25	0.62	0.25	0.37	0.25
breast, adult, donor1	10080-102A8	11.36	6.31	0.63	1.26	0.00	0.00	0.00	0.63
bronchial squamous cell carcinoma cell line:KNS-62	10760-110E4	197.42	8.38	2.67	2.92	4.07	1.02	0.13	0.51
bronchioalveolar carcinoma cell line:NCI-H358	10709-109H7	159.87	21.95	4.02	3.71	5.88	1.86	0.93	3.09
bronchioalveolar carcinoma cell line:NCI-H650	10715-109I4	322.08	10.59	6.22	1.15	2.99	2.76	0.23	0.69
bronchogenic carcinoma cell line:ChaGo-K-1	10710-109H8	108.21	13.07	4.84	1.45	1.45	0.48	0.00	1.45
carcinoid cell line:NCI-H1770	10703-109H1	173.96	16.46	6.11	1.41	4.23	1.41	0.00	2.82
carcinoid cell line:NCI-H727	10735-110B6	43.42	10.94	0.98	1.42	0.33	0.00	0.55	0.11
carcinoid cell line:SK-PN-DW	10719-109I8	330.21	21.55	6.65	2.22	6.97	2.22	0.32	1.90
carcinosarcoma cell line:JHUCS-1	10642-109A3	212.94	12.78	7.19	2.66	2.66	1.06	0.00	1.60
caudate nucleus - adult, donor10196	10177-103C6	5.76	12.66	0.00	5.76	1.15	0.00	1.15	0.00
caudate nucleus, adult, donor10252	10164-103B2	15.39	14.72	1.00	1.51	0.67	0.17	1.17	0.17
caudate nucleus, adult, donor10258	10379-105H1	12.99	11.46	1.53	0.76	1.53	0.00	0.76	0.76
caudate nucleus, newborn, donor10223	10354-105E3	24.54	6.96	0.73	1.46	0.37	0.00	0.37	0.37
cerebellum - adult, donor10196	10173-103C2	26.22	17.48	2.91	2.91	0.00	0.00	2.91	0.00
cerebellum, adult, donor10252	10166-103B4	22.21	32.24	3.20	3.42	0.00	0.00	0.43	0.21
cerebellum, adult, pool1	10083-102B2	9.31	17.25	2.41	1.72	0.69	0.00	1.03	0.00
cerebellum, newborn, donor10223	10357-105E6	18.27	11.62	0.00	2.49	3.32	0.83	0.83	0.00
cerebral meninges, adult	10188-103D8	12.86	25.97	2.02	2.27	1.76	0.00	2.27	0.25
cerebrospinal fluid, donor2	10294-104G6	11.69	5.85	0.00	0.73	2.19	0.73	0.00	0.00
cervical cancer cell line:D98-AH2	10552-107I3	285.84	29.33	2.88	8.20	3.59	0.72	0.86	0.58
cervical cancer cell line:ME-180	10553-107I4	52.37	26.85	0.66	3.31	0.83	0.33	1.33	0.17
cervix, adult, pool1	10013-101C4	25.51	11.65	1.15	1.68	0.31	0.00	0.42	0.00
cholangiocellular carcinoma cell line:HuH-28	10536-107G5	39.15	8.22	2.23	0.84	0.14	0.28	0.42	0.14
chondrosarcoma cell line:SW 1353	10700-109G7	3.92	5.23	2.61	0.00	0.00	0.00	0.00	1.31
choriocarcinoma cell line:BeWo	10423-106C9	309.45	20.01	11.31	3.11	2.73	1.86	0.25	0.87
choriocarcinoma cell line:SCH	10785-110H2	144.04	3.57	3.70	1.36	3.20	1.36	0.25	0.37
choriocarcinoma cell line:T3M-3	10618-108G6	61.19	7.59	2.37	2.61	4.27	0.00	0.24	1.19
chorionic membrane cells, donor1	12238-129G6	23.65	9.97	2.28	1.14	0.85	0.28	0.57	0.00
chorionic membrane cells, donor2	12239-129G7	52.80	5.57	3.88	0.70	1.09	0.40	0.10	0.20
chorionic membrane cells, donor3	12240-129G8	41.76	6.59	1.10	2.20	0.00	0.55	0.00	0.00
chronic lymphocytic leukemia (T-CLL) cell line:SKW-3	10416-106C2	193.88	22.22	12.12	4.04	4.04	3.03	0.00	2.02
chronic myeloblastic leukemia (CML) cell line:KCL-22	10801-110I9	197.09	9.80	3.27	2.11	3.27	1.92	0.00	0.58
chronic myelogenous leukemia (CML) cell line:MEG-A2	10766-110F1	131.15	9.08	1.48	1.90	2.11	0.63	0.00	1.48
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep1	10824-111C5	269.64	18.23	14.38	5.14	5.91	0.51	0.00	2.05
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep2	10825-111C6	294.61	28.06	18.14	5.32	5.32	1.21	0.24	1.69
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep3	10826-111C7	272.02	24.43	17.10	5.50	2.65	2.04	0.00	1.02
chronic myelogenous leukemia cell line:K562	10454-106G4	500.57	32.98	24.15	7.07	9.13	3.83	0.59	4.71
chronic myelogenous leukemia cell line:KU812	10409-106B4	491.80	23.72	8.86	5.99	3.39	0.78	0.26	0.26
clear cell carcinoma cell line:JHOC-5	10638-108I8	120.69	13.49	1.83	1.37	0.91	2.29	1.37	1.14
clear cell carcinoma cell line:TEN	10636-108I6	154.59	12.32	6.77	1.91	1.39	0.17	0.17	0.87
colon carcinoma cell line:CACO-2	10513-107D9	249.49	14.64	17.57	2.56	2.56	0.92	0.00	1.46
colon carcinoma cell line:COLO-320	10420-106C6	870.77	38.39	19.76	5.70	1.52	2.28	0.76	0.38
colon, adult, donor1	10082-102B1	24.99	11.90	0.00	3.57	0.00	0.00	0.00	0.00
colon, adult, pool1	10014-101C5	21.74	10.69	0.94	0.59	0.47	0.12	0.35	0.00
colon, fetal, donor1	10070-101I7	24.10	14.21	0.62	1.24	0.62	0.00	0.62	0.00
common myeloid progenitor CMP, donor1	12130-128D6	13.75	0.00	0.00	0.00	4.58	0.00	0.00	0.00
common myeloid progenitor CMP, donor2	12134-128E1	150.22	0.00	0.00	25.04	0.00	0.00	0.00	0.00
cord blood derived cell line:COBL-a 24h infection(-C)	10452-106G2	191.64	18.70	6.37	5.10	1.27	0.85	0.42	0.42
cord blood derived cell line:COBL-a 24h infection	10453-106G3	305.33	13.28	12.68	3.62	1.81	0.75	0.00	1.21
cord blood derived cell line:COBL-a untreated	10449-106F8	367.05	13.26	12.97	3.24	1.83	0.85	0.14	0.85
corpus callosum, adult, pool1	10042-101F6	20.90	32.17	1.44	2.32	0.44	0.33	3.65	0.11
cruciate ligament, donor2	10295-104G7	18.64	8.92	0.81	0.00	0.00	0.00	0.00	0.81
diaphragm, fetal, donor1	10069-101I6	16.05	10.43	0.00	0.80	0.00	0.00	0.00	0.00
diencephalon, adult	10193-103E4	11.04	15.60	0.48	1.20	1.92	0.00	1.20	0.24
diffuse large B-cell lymphoma cell line:CTB-1	10631-108I1	327.66	21.12	8.27	2.76	6.20	1.84	0.23	2.07
ductal cell carcinoma cell line:KLM-1	10438-106E6	93.09	17.44	0.77	1.28	1.54	0.00	1.54	1.28
ductal cell carcinoma cell line:MIA Paca2	10488-107B2	107.60	11.07	1.69	1.20	1.69	0.72	0.48	0.24
ductus deferens, adult	10196-103E7	23.42	17.94	2.49	1.99	1.00	0.00	0.00	0.00
duodenum, fetal, donor1, tech_rep1	10071-101I8	27.36	11.52	0.00	2.88	1.44	0.00	0.00	1.44
duodenum, fetal, donor1, tech_rep2	10071-101I8	26.48	13.24	0.00	1.47	0.00	0.00	0.00	0.00
dura mater, adult, donor1	10041-101F5	33.37	14.78	1.16	0.74	0.17	0.00	0.33	0.17
embryonic kidney cell line: HEK293/SLAM infection, 24hr	10451-106G1	83.72	26.65	8.66	1.78	0.00	0.22	0.22	0.44
embryonic kidney cell line: HEK293/SLAM untreated	10450-106F9	212.36	23.07	19.77	2.72	2.15	0.86	0.14	0.57
embryonic pancreas cell line:1B2C6	10604-108F1	46.86	8.63	1.23	1.23	0.62	0.62	0.00	1.23
embryonic pancreas cell line:1C3D3	10605-108F2	84.76	9.38	3.03	0.91	2.12	0.00	0.30	0.00
embryonic pancreas cell line:1C3IKEI	10606-108F3	75.95	8.03	2.78	4.01	1.23	0.00	0.00	0.62
embryonic pancreas cell line:2C6	10603-108E9	36.78	9.19	1.31	2.63	1.31	0.00	0.00	0.00
endometrial carcinoma cell line:OMC-2	10497-107C2	76.09	5.70	3.35	0.67	2.68	0.34	0.00	1.34
endometrial stromal sarcoma cell line:OMC-9	10448-106F7	75.03	14.14	2.72	1.81	1.45	0.54	0.72	1.27
endometrioid adenocarcinoma cell line:JHUEM-1	10643-109A4	89.41	8.20	2.41	1.61	1.13	0.96	0.64	0.80
epidermoid carcinoma cell line:A431	10426-106D3	121.39	12.67	0.67	2.00	2.00	0.67	0.33	0.78
epidermoid carcinoma cell line:Ca Ski	10431-106D8	148.15	17.93	3.85	3.74	0.66	0.33	0.11	0.11
epididymis, adult	10197-103E8	11.93	12.14	1.88	2.09	0.21	0.00	0.63	0.00
epithelioid sarcoma cell line:HS-ES-1	10443-106F2	33.89	3.90	0.89	1.42	0.71	0.18	0.00	0.00
epithelioid sarcoma cell line:HS-ES-2R	10495-107B9	56.23	2.75	0.79	0.39	0.79	0.00	0.00	1.18
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep1	10815-111B5	214.40	15.07	14.28	4.06	6.42	1.57	0.26	1.18
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep2	10816-111B6	225.38	14.66	17.52	2.56	4.53	1.28	0.30	0.79
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep3	10817-111B7	214.98	14.79	15.35	3.47	7.28	1.46	0.45	0.90
esophagus, adult, pool1	10015-101C6	31.96	10.30	0.21	1.81	0.53	0.00	0.42	0.21
extraskeletal myxoid chondrosarcoma cell line:H-EMC-SS	10410-106B5	113.09	3.51	1.38	0.50	1.00	0.13	0.00	0.25
eye - muscle inferior rectus, donor1	10272-104E2	12.07	9.66	0.00	0.00	0.00	0.00	2.41	0.00
eye - muscle lateral, donor2	10298-104H1	4.21	10.52	0.00	0.00	0.00	0.00	0.00	0.00
eye - muscle medial, donor2	10299-104H2	1.49	11.91	0.00	1.49	0.00	0.00	0.00	0.00
eye - muscle superior, donor2	10297-104G9	16.05	9.17	0.00	0.00	2.29	0.00	0.00	1.15
eye - vitreous humor, donor1	10268-104D7	34.98	13.12	1.46	0.00	1.46	0.00	1.46	1.46
eye, fetal, donor1	10054-101G9	26.19	12.20	1.53	2.29	0.76	0.51	1.27	0.00
fibrosarcoma cell line:HT-1080	10758-110E2	159.51	10.51	8.33	1.28	2.31	0.90	0.00	1.03
fibrous histiocytoma cell line:GCT TIB-223	10711-109H9	110.64	11.40	4.75	1.19	1.90	0.24	0.47	0.95
frontal lobe, adult, pool1	10040-101F4	17.83	27.21	3.85	2.53	0.09	0.19	1.69	0.19
gall bladder carcinoma cell line:TGBC14TKB	10470-106I2	212.28	17.71	4.50	3.90	3.60	0.90	0.30	3.00
gall bladder carcinoma cell line:TGBC2TKB	10415-106C1	93.72	6.13	1.65	0.73	0.46	0.18	0.00	0.00
gall bladder, adult	10198-103E9	11.11	13.52	1.21	0.72	0.72	0.00	0.24	0.48
gamma delta positive T cells, donor1	11937-126A2	26.31	8.59	1.61	2.15	0.00	0.00	0.54	0.00
gamma delta positive T cells, donor2	11938-126A3	8.59	7.10	0.37	1.49	0.00	0.00	0.37	0.00
gastric adenocarcinoma cell line:MKN1	10614-108G2	38.86	5.49	1.48	1.06	1.90	0.21	0.21	0.00
gastric adenocarcinoma cell line:MKN45	10612-108F9	57.06	9.28	0.19	1.93	2.13	0.39	0.19	0.19
gastric cancer cell line:AZ521	10549-107H9	217.08	12.13	7.38	1.80	2.79	0.00	0.00	0.98
gastric cancer cell line:GSS	10560-108A2	151.93	10.98	4.58	0.00	3.66	0.00	0.00	0.92
gastrointestinal carcinoma cell line:ECC12	10615-108G3	140.96	9.82	0.46	0.69	2.28	0.46	0.46	0.91
giant cell carcinoma cell line:LU65	10487-107B1	174.41	54.27	13.77	11.02	3.56	1.26	0.23	1.49
giant cell carcinoma cell line:Lu99B	10433-106E1	132.96	10.78	0.84	2.24	0.70	0.14	0.42	0.14
glassy cell carcinoma cell line:HOKUG	10688-109F4	54.62	12.72	1.25	1.25	1.50	0.75	0.50	1.25
glioblastoma cell line:A172, tech_rep1	10444-106F3	47.50	9.08	4.96	1.06	1.37	0.32	0.32	0.63
glioblastoma cell line:A172, tech_rep2	10444-106F3	40.59	8.15	5.06	0.70	1.69	0.42	0.42	0.70
glioblastoma cell line:T98G	10485-107A8	150.22	9.49	5.30	1.55	3.42	0.77	0.22	1.21
glioma cell line:GI-1	10413-106B8	79.66	3.81	2.64	0.59	0.00	0.29	0.00	0.00
globus pallidus - adult, donor10196	10175-103C4	14.58	18.95	0.00	2.19	0.00	0.73	2.19	0.73
globus pallidus, adult, donor10252	10161-103A8	36.61	26.61	1.71	2.20	2.20	0.73	0.73	0.98
globus pallidus, adult, donor10258	10367-105F7	9.58	19.17	1.37	0.00	0.00	0.00	1.37	0.00
globus pallidus, newborn, donor10223	10364-105F4	24.51	10.13	0.53	1.60	1.60	0.00	1.07	0.00
granulocyte macrophage progenitor, donor1	12131-128D7	24.47	7.34	0.00	0.00	12.24	0.00	0.00	0.00
granulocyte macrophage progenitor, donor2	12135-128E2	76.50	0.00	0.00	0.00	0.00	10.93	0.00	0.00
granulocyte macrophage progenitor, donor3	12139-128E6	41.81	5.23	0.00	0.00	0.00	0.00	0.00	0.00
granulosa cell tumor cell line:KGN	10624-108H3	36.48	5.12	0.64	0.64	0.96	0.00	0.32	0.32
hIPS +CCl2, biol_rep1	14383-156B9	371.42	22.96	23.87	3.21	12.40	0.92	0.92	2.75
hIPS +CCl2, biol_rep2	14384-156C1	364.44	20.58	26.52	3.20	9.15	0.91	1.37	3.66
hIPS +CCl2, biol_rep3	14385-156C2	305.30	13.53	21.26	2.58	7.73	2.58	0.64	3.86
hIPS, biol_rep1	14380-156B6	333.45	7.19	25.87	4.31	17.25	2.87	0.00	2.87
hIPS, biol_rep2	14381-156B7	251.71	14.40	20.58	2.74	19.20	1.37	0.69	1.37
hIPS, biol_rep3	14382-156B8	36.41	16.55	5.52	3.31	2.21	0.00	4.41	1.10
hairy cell leukemia cell line:Mo	10712-109I1	183.04	22.41	7.47	4.02	2.30	2.01	0.00	0.86
heart - mitral valve, adult	10205-103F7	10.76	7.18	0.30	0.90	0.00	0.00	0.30	0.00
heart - pulmonic valve, adult	10206-103F8	5.23	9.94	0.26	1.83	0.00	0.52	0.52	0.00
heart - tricuspid valve, adult	10207-103F9	31.64	22.48	0.00	5.83	2.50	2.50	2.50	0.83
heart, adult, diseased post-infarction, donor1	10050-101G5	23.67	9.18	1.43	1.02	0.20	0.20	1.43	0.20
heart, adult, diseased, donor1	10051-101G6	7.24	16.61	0.00	1.28	0.00	0.00	0.43	0.00
heart, adult, pool1	10016-101C7	8.51	10.12	0.00	1.38	0.69	0.00	0.00	0.00
heart, fetal, pool1	10046-101G1	34.60	11.19	0.51	1.44	0.10	0.00	0.51	0.10
hepatic mesenchymal tumor cell line:LI90	10778-110G4	15.12	7.40	1.23	0.62	0.62	0.93	0.93	0.31
hepatoblastoma cell line:HuH-6	10633-108I3	41.62	13.08	0.00	2.38	1.19	0.00	0.00	1.19
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep1	10818-111B8	243.86	20.44	24.64	1.88	4.75	1.22	0.66	0.33
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep2	10819-111B9	280.86	24.52	25.49	2.55	5.95	1.21	0.61	2.31
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep3	10820-111C1	299.62	20.21	29.71	2.73	7.88	1.31	0.71	1.31
hepatoma cell line:Li-7	10484-107A7	68.95	6.78	0.89	1.56	1.22	0.33	0.11	0.22
hereditary spherocytic anemia cell line:WIL2-NS	10808-111A7	341.10	21.11	10.35	2.61	3.22	1.11	0.30	0.50
hippocampus - adult, donor10196	10169-103B7	12.30	19.87	2.84	1.89	0.95	0.95	3.79	2.84
hippocampus, adult, donor10252	10153-102I9	27.55	22.66	2.25	2.45	0.82	0.61	1.43	0.41
hippocampus, adult, donor10258	10374-105G5	9.96	8.96	4.98	3.49	2.49	1.00	3.98	0.00
hippocampus, newborn, donor10223	10363-105F3	13.75	10.57	0.70	1.06	1.41	0.00	0.00	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep1	13421-144D1	709.22	50.66	26.24	1.22	34.79	6.71	1.22	11.60
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep2	13425-144D5	301.80	24.94	17.28	3.14	7.85	3.14	0.59	2.16
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep3	13429-144D9	394.81	28.44	19.04	2.29	19.80	2.54	0.51	8.63
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep1	13422-144D2	170.85	13.53	8.46	0.56	10.71	4.51	0.56	3.95
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep2	13426-144D6	221.03	12.14	7.23	1.03	8.26	4.13	0.00	7.49
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep3	13430-144E1	228.53	21.26	13.29	1.14	14.05	2.28	0.00	4.18
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep1	13423-144D3	175.46	14.31	10.22	1.46	4.96	2.34	0.58	2.34
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep2	13427-144D7	165.66	17.67	8.62	1.08	2.80	1.72	0.65	4.09
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep3	13431-144E2	126.37	15.85	13.76	1.67	5.84	2.09	0.42	3.34
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep1	13424-144D4	240.82	19.42	13.97	3.08	7.10	1.42	0.95	2.13
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep2	13428-144D8	203.31	17.04	9.48	1.77	5.30	1.93	1.13	3.05
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep3	13432-144E3	210.07	14.14	13.47	4.71	1.35	2.69	1.35	0.67
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep1	13433-144E4	356.00	21.91	22.53	2.19	6.73	4.38	0.63	1.72
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep2	13437-144E8	444.13	21.62	22.60	1.97	16.21	5.40	0.49	5.90
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep3	13441-144F3	736.60	50.62	45.38	0.00	50.62	4.36	0.00	12.22
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep1	13434-144E5	159.22	11.45	6.87	0.76	3.44	1.53	0.19	4.39
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep2	13438-144E9	150.45	6.54	8.29	1.31	7.85	3.49	0.44	2.18
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep3	13442-144F4	200.40	16.99	10.49	0.50	15.49	3.00	0.00	7.00
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep1	13435-144E6	132.63	26.19	3.39	1.51	3.39	0.75	0.38	2.26
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep2	13439-144F1	129.14	24.55	5.00	2.27	5.00	0.91	0.45	4.09
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep3	13443-144F5	116.52	21.30	4.70	1.25	7.20	1.88	1.88	1.57
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep1	13436-144E7	123.29	11.59	5.39	1.47	3.10	1.96	0.33	3.10
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep2	13440-144F2	120.48	12.77	2.90	1.45	3.19	1.45	1.45	2.03
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep3	13444-144F6	104.62	12.26	2.39	1.49	6.28	1.20	1.20	0.90
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep1	13445-144F7	350.65	22.17	22.54	2.96	6.65	3.33	0.74	3.88
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep2	13449-144G2	325.79	18.54	19.68	1.14	11.41	2.00	0.00	4.28
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep3	13453-144G6	561.02	26.95	29.81	2.45	34.71	5.72	0.41	4.08
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep1	13446-144F8	208.08	13.03	7.04	0.70	4.22	4.58	0.00	3.52
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep2	13450-144G3	161.54	8.55	8.87	0.00	4.75	3.48	0.32	3.80
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep3	13454-144G7	169.47	16.34	9.38	1.21	8.78	2.42	0.00	3.93
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep1	13447-144F9	109.11	18.10	4.65	1.03	1.55	0.52	0.52	1.03
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep2	13451-144G4	130.18	19.26	9.30	1.33	3.98	3.32	1.99	1.99
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep3	13455-144G8	134.17	11.03	4.62	1.03	4.87	0.51	0.51	1.03
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep1	13448-144G1	144.70	12.53	4.35	0.51	4.09	1.53	0.77	1.79
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep2	13452-144G5	129.49	13.63	4.54	1.51	8.33	1.51	0.00	3.79
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep3	13456-144G9	133.41	8.74	4.03	1.34	6.39	2.69	0.67	1.34
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep1	13457-144H1	378.44	22.94	19.80	1.93	8.21	4.11	0.48	4.11
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep2	13461-144H5	444.77	30.75	23.17	3.12	33.42	3.12	0.00	8.02
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep3	13465-144H9	385.86	25.37	14.15	2.44	20.49	3.41	0.49	2.93
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep1	13458-144H2	169.01	11.00	8.25	0.92	5.20	2.44	0.31	1.53
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep2	13462-144H6	1877.12	74.82	35.79	9.76	39.04	19.52	0.00	9.76
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep3	13466-144I1	305.46	23.83	9.27	1.65	14.56	5.63	0.33	5.30
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep1	13459-144H3	155.98	18.06	6.57	2.19	3.83	0.00	0.00	0.55
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep2	13463-144H7	156.33	14.84	7.60	1.45	5.43	1.81	0.72	3.26
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep3	13467-144I2	155.52	16.73	9.61	0.71	9.25	0.71	0.36	2.85
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep1	13460-144H4	165.88	13.13	11.93	0.00	2.39	4.77	0.00	5.97
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep2	13464-144H8	280.20	19.50	9.89	2.98	3.39	1.76	0.27	1.76
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep3	13468-144I3	152.21	16.70	7.81	0.54	7.00	1.08	0.81	2.16
immature langerhans cells, donor1	11904-125F5	23.49	11.87	0.73	0.97	0.24	0.00	0.00	0.24
immature langerhans cells, donor2	11905-125F6	15.84	12.67	0.00	0.79	0.79	0.00	0.00	0.00
insula, adult, pool1	10039-101F3	18.93	28.39	4.07	3.22	0.47	0.19	2.65	0.38
keratoacanthoma cell line:HKA-1	10791-110H8	50.40	10.08	1.63	1.95	0.33	0.33	0.00	0.33
kidney, adult, pool1	10017-101C8	40.65	18.92	1.70	1.40	0.60	0.40	0.10	0.20
kidney, fetal, pool1	10045-101F9	42.58	12.87	1.13	0.99	0.28	0.14	0.57	0.14
large cell lung carcinoma cell line:IA-LM	10509-107D5	109.21	11.36	2.41	1.70	1.85	0.43	0.14	0.57
large cell lung carcinoma cell line:NCI-H460	10839-111E2	68.43	6.91	0.28	0.28	0.41	0.55	0.14	0.55
large cell non-keratinizing squamous carcinoma cell line:SKG-II-SF	10692-109F8	32.30	11.19	1.10	1.10	0.92	0.18	0.00	0.18
left atrium, adult, donor1	10079-102A7	8.72	3.27	1.09	0.54	0.54	0.00	1.63	0.00
left ventricle, adult, donor1	10078-102A6	7.08	7.58	0.00	0.51	0.00	0.51	0.51	0.00
leiomyoblastoma cell line:G-402	10721-110A1	112.18	3.28	1.09	0.82	3.01	1.09	0.27	1.09
leiomyoma cell line:10964C	10569-108B2	26.23	7.90	1.44	0.00	0.72	0.00	0.00	0.36
leiomyoma cell line:15242A	10570-108B3	24.46	3.80	2.17	2.72	1.09	0.00	0.54	0.54
leiomyoma cell line:15425	10571-108B4	44.92	8.01	3.16	2.67	0.49	0.24	0.49	0.73
leiomyosarcoma cell line:Hs 5.T	10722-110A2	25.40	6.35	0.00	0.00	6.35	0.00	0.00	0.00
lens epithelial cell line:SRA 01/04	10647-109A8	23.00	7.32	3.14	1.05	0.00	0.00	0.00	0.00
leukemia, chronic megakaryoblastic cell line:MEG-01	10752-110D5	172.13	8.26	1.89	2.01	2.83	1.18	0.00	0.71
liposarcoma cell line:KMLS-1	10782-110G8	66.08	11.72	3.28	2.34	1.25	0.31	0.16	0.47
liposarcoma cell line:SW 872	10726-110A6	69.57	5.36	5.00	0.97	1.46	0.37	0.24	0.61
liver, adult, pool1	10018-101C9	80.06	26.09	3.57	3.73	1.13	0.32	0.00	0.32
liver, fetal, pool1	10086-102B5	30.10	6.58	1.88	0.94	0.94	0.00	0.00	0.00
locus coeruleus - adult, donor10196	10182-103D2	16.62	32.81	2.62	3.79	1.46	0.44	2.04	1.02
locus coeruleus, adult, donor10252	10165-103B3	27.68	27.31	3.32	2.58	1.29	0.18	1.85	0.18
locus coeruleus, adult, donor10258	10375-105G6	21.72	21.72	1.69	1.41	1.69	1.41	3.95	1.41
locus coeruleus, newborn, donor10223	10362-105F2	57.62	18.51	0.84	0.42	0.84	0.00	1.26	2.52
lung adenocarcinoma cell line:A549	10499-107C4	61.72	10.10	1.80	1.25	1.80	0.28	0.00	0.42
lung adenocarcinoma cell line:PC-14	10408-106B3	24.82	6.20	1.38	0.00	0.00	0.00	0.00	0.00
lung adenocarcinoma, papillary cell line:NCI-H441	10742-110C4	85.42	8.17	1.32	1.05	2.90	1.05	0.40	0.53
lung, adult, pool1	10019-101D1	17.13	5.91	0.47	0.83	0.12	0.00	0.00	0.12
lung, fetal, donor1	10068-101I5	33.68	13.98	1.14	2.00	0.00	0.00	1.14	0.57
lung, right lower lobe, adult, donor1	10075-102A3	7.79	6.87	1.37	0.46	0.00	0.00	0.00	0.00
lymph node, adult, donor1	10077-102A5	32.19	10.41	0.47	0.47	0.95	0.00	0.00	0.47
lymphangiectasia cell line:DS-1	10727-110A7	131.29	24.77	5.70	2.63	4.16	1.10	0.00	0.66
lymphoma, malignant, hairy B-cell cell line:MLMA	10775-110G1	505.91	59.92	23.70	10.56	3.47	1.36	0.45	1.81
malignant trichilemmal cyst cell line:DJM-1	10412-106B7	73.06	8.49	0.00	3.40	2.55	0.00	0.00	2.55
mature adipocyte, donor1	12231-129F8	8.88	9.32	0.44	0.44	0.44	0.00	0.00	0.44
mature adipocyte, donor2	12232-129F9	7.47	8.92	0.21	1.45	0.21	0.00	0.00	0.00
mature adipocyte, donor3	12233-129G1	11.85	8.77	0.95	0.95	0.71	0.47	0.71	0.00
mature adipocyte, donor4	12234-129G2	16.32	10.53	0.53	1.05	0.26	0.00	0.00	0.00
maxillary sinus tumor cell line:HSQ-89	10414-106B9	106.26	29.78	4.29	4.53	2.86	0.24	1.19	0.71
medial frontal gyrus - adult, donor10196	10170-103B8	18.05	19.18	4.51	3.38	1.13	0.00	0.00	0.00
medial frontal gyrus, adult, donor10252	10150-102I6	17.29	22.25	2.39	2.39	0.37	0.55	1.66	0.55
medial frontal gyrus, adult, donor10258	10368-105F8	7.94	20.33	4.45	2.86	1.91	0.00	1.59	0.32
medial frontal gyrus, newborn, donor10223	10352-105E1	35.82	14.93	0.00	2.13	1.28	0.43	2.13	0.00
medial temporal gyrus - adult, donor10196	10183-103D3	18.56	22.11	2.53	2.87	2.03	1.01	2.70	0.51
medial temporal gyrus, adult, donor10252	10156-103A3	17.83	19.52	2.33	3.40	0.64	0.42	2.97	0.42
medial temporal gyrus, adult, donor10258, tech_rep1	10376-105G7	15.41	9.63	3.85	0.00	0.00	1.93	0.00	0.00
medial temporal gyrus, adult, donor10258, tech_rep2	10376-105G7	100.48	100.48	0.00	14.35	0.00	0.00	0.00	0.00
medial temporal gyrus, newborn, donor10223	10353-105E2	10.05	7.90	0.00	1.08	1.08	0.00	0.36	0.00
medulla oblongata - adult, donor10196	10174-103C3	23.36	18.17	5.19	5.84	3.89	0.65	1.95	1.30
medulla oblongata, adult, donor10252	10155-103A2	28.33	20.28	4.18	2.94	1.24	0.31	0.93	0.31
medulla oblongata, adult, pool1	10038-101F2	28.16	30.94	2.45	3.18	0.57	0.08	2.12	0.41
medulla oblongata, newborn, donor10223	10361-105F1	21.87	16.32	0.00	1.74	0.69	0.00	0.00	0.00
medulloblastoma cell line:D283 Med	10838-111E1	369.76	18.82	2.21	2.21	4.21	1.55	0.44	1.99
medulloblastoma cell line:ONS-76	10759-110E3	80.58	12.47	2.08	1.35	1.59	0.37	0.12	0.49
melanoma cell line:COLO 679	10514-107E1	55.92	9.77	1.29	3.31	1.87	0.14	0.29	0.72
melanoma cell line:G-361	10465-106H6	110.49	8.14	2.71	2.44	2.17	0.54	0.54	0.54
meningioma cell line:HKBMM	10691-109F7	56.98	9.95	0.72	1.09	1.27	0.00	0.18	0.36
merkel cell carcinoma cell line:MKL-1	10843-111E6	196.50	11.46	17.62	0.88	3.52	3.52	0.00	0.88
merkel cell carcinoma cell line:MS-1	10844-111E7	175.49	9.85	6.22	1.56	2.33	2.07	0.26	0.78
mesenchymal precursor cell - adipose, donor1	11747-123G1	142.08	9.97	3.84	1.69	0.77	0.61	0.46	0.31
mesenchymal precursor cell - adipose, donor2	11748-123G2	73.26	6.18	2.00	0.36	0.73	0.18	0.00	0.00
mesenchymal precursor cell - adipose, donor3	11749-123G3	76.61	5.80	5.38	1.24	0.00	0.41	0.00	0.41
mesenchymal precursor cell - bone marrow, donor1	11750-123G4	60.97	7.73	1.69	1.12	0.28	0.00	0.28	0.14
mesenchymal precursor cell - bone marrow, donor2	11751-123G5	52.96	6.74	1.16	0.96	1.16	0.19	0.39	0.00
mesenchymal precursor cell - bone marrow, donor3	11840-124H4	39.56	12.49	3.47	2.08	1.39	1.39	0.00	0.00
mesenchymal precursor cell - cardiac, donor1	11752-123G6	35.70	6.52	1.20	1.03	0.00	0.34	0.17	0.00
mesenchymal precursor cell - cardiac, donor2	11753-123G7	46.58	7.71	2.88	1.15	0.58	0.12	0.35	0.12
mesenchymal precursor cell - cardiac, donor3	11754-123G8	74.54	5.44	2.12	0.40	0.80	0.27	0.00	0.13
mesenchymal precursor cell - cardiac, donor4	11755-123G9	76.57	9.18	2.84	1.76	0.54	0.14	0.27	0.00
mesenchymal precursor cell - ovarian cancer left ovary, donor1	11756-123H1	74.55	9.53	2.56	0.43	0.14	0.43	0.43	0.14
mesenchymal precursor cell - ovarian cancer left ovary, donor2	11833-124G6	38.53	7.58	2.31	1.98	0.66	0.00	0.00	0.00
mesenchymal precursor cell - ovarian cancer left ovary, donor3	11760-123H5	71.26	5.12	2.21	0.14	0.14	0.42	0.14	0.14
mesenchymal precursor cell - ovarian cancer left ovary, donor4	11836-124G9	75.75	5.93	3.49	1.40	1.05	0.35	1.05	0.00
mesenchymal precursor cell - ovarian cancer metastasis, donor1	11758-123H3	45.73	7.15	2.04	1.02	0.00	0.00	0.61	0.20
mesenchymal precursor cell - ovarian cancer metastasis, donor2	11835-124G8	31.27	4.31	0.72	1.08	0.00	0.00	0.36	0.00
mesenchymal precursor cell - ovarian cancer metastasis, donor3	11762-123H7	38.38	3.21	1.66	0.41	0.21	0.21	0.21	0.00
mesenchymal precursor cell - ovarian cancer metastasis, donor4	11838-124H2	28.04	5.47	0.00	0.68	0.00	0.00	0.23	0.00
mesenchymal precursor cell - ovarian cancer right ovary, donor1	11757-123H2	161.95	21.40	4.62	3.78	0.00	1.68	0.42	0.84
mesenchymal precursor cell - ovarian cancer right ovary, donor2	11759-123H4	46.62	4.93	1.64	0.90	0.30	0.00	0.15	0.00
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02)	11761-123H6	55.67	5.08	2.19	0.61	0.26	0.09	0.09	0.09
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02-G)	11842-124H6	32.40	4.79	2.58	1.47	0.00	0.00	0.37	0.00
mesenchymal precursor cell - ovarian cancer right ovary, donor4	11837-124H1	34.05	5.44	0.86	0.29	0.00	0.57	0.00	0.00
mesenchymal stem cell line:Hu5/E18	10568-108B1	93.04	11.79	7.58	4.21	4.63	1.26	0.84	1.68
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep1	13229-141I7	31.97	9.59	0.91	1.37	1.37	0.46	0.46	0.91
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep2	13230-141I8	44.25	12.53	0.26	0.51	1.02	0.51	0.26	0.26
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep3	13231-141I9	32.72	8.90	1.05	0.52	0.52	0.26	1.05	0.26
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep1	13232-142A1	30.50	10.47	1.23	1.54	0.31	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep2	13233-142A2	46.13	8.47	1.65	0.94	0.71	0.24	0.24	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep3	13234-142A3	39.60	6.43	1.35	1.02	0.00	0.34	0.00	0.34
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep1	13235-142A4	36.15	5.89	1.57	0.39	0.00	0.00	0.00	0.39
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep2	13236-142A5	44.49	6.02	1.85	2.32	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep3	13237-142A6	0.00	0.00	48.30	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep1	13238-142A7	56.24	10.67	2.88	1.73	0.87	0.58	0.87	0.29
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep2	13239-142A8	42.84	9.37	1.56	1.78	0.67	0.22	0.00	0.22
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep3	13240-142A9	36.53	9.13	0.96	0.24	0.96	0.24	0.00	0.24
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep1	13241-142B1	30.80	8.07	0.73	1.47	0.73	0.00	0.73	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep2	13242-142B2	35.24	5.37	0.67	0.00	0.34	0.00	0.34	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep3	13243-142B3	35.62	5.32	1.23	3.28	0.41	0.41	0.82	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep1	13244-142B4	40.81	6.44	2.15	1.72	0.43	0.86	0.43	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep2	13245-142B5	32.81	0.00	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep3	13246-142B6	25.82	5.16	0.00	0.00	0.00	5.16	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep1	13247-142B7	31.83	9.42	0.65	0.65	0.65	0.00	0.32	0.65
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep2	13248-142B8	48.01	10.18	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep3	13249-142B9	32.52	13.33	0.53	0.00	0.53	0.00	0.53	0.53
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep1	13250-142C1	34.35	11.45	0.82	0.00	0.82	0.82	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep2	13251-142C2	39.26	12.44	1.17	1.55	0.39	0.39	0.78	1.55
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep3	13252-142C3	39.88	10.49	2.10	2.10	2.10	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep1	13253-142C4	35.76	12.92	1.99	0.99	0.00	0.99	0.99	1.99
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep2	13254-142C5	47.67	4.77	0.00	0.00	0.00	4.77	0.00	4.77
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep3	13255-142C6	34.39	13.64	2.37	1.78	2.37	0.59	0.00	0.59
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep1	13256-142C7	43.86	9.75	0.00	1.22	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep2	13257-142C8	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep3	13258-142C9	36.10	8.23	0.63	1.90	0.63	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep1	13259-142D1	35.18	11.38	0.69	0.34	0.69	0.00	0.00	1.72
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep2	13260-142D2	30.09	17.19	2.15	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep3	13261-142D3	43.91	7.98	3.99	0.00	0.00	0.00	0.00	3.99
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep1	13262-142D4	20.66	10.33	0.00	0.00	6.89	3.44	0.00	6.89
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep2	13263-142D5	31.38	4.89	0.81	1.63	0.41	0.41	0.00	0.81
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep3	13264-142D6	32.57	3.97	1.59	0.00	0.79	0.79	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep1	13265-142D7	21.22	3.54	0.59	2.36	1.18	0.00	0.00	0.59
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep2	13266-142D8	27.74	4.36	1.56	0.62	0.62	0.00	0.00	0.62
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep3	13267-142D9	24.06	5.35	1.34	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep1	13268-142E1	44.94	7.10	1.18	1.18	0.00	1.18	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep2	13269-142E2	46.22	2.57	0.00	2.57	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep3	13270-142E3	54.38	5.51	1.38	0.69	1.38	1.38	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep1	13271-142E4	41.07	5.94	0.99	0.49	3.46	0.49	0.00	0.49
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep2	13272-142E5	33.65	3.36	1.12	2.24	2.24	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep3	13273-142E6	36.26	6.36	1.91	0.64	1.91	2.54	0.64	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep1	13274-142E7	22.16	6.45	1.61	2.01	0.00	0.40	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep2	13275-142E8	37.07	4.36	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep3	13276-142E9	26.61	6.34	2.53	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep1	13277-142F1	12.14	3.03	0.61	1.82	0.00	0.00	1.21	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep2	13278-142F2	13.56	0.00	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep3	13279-142F3	14.00	3.29	0.82	0.00	1.65	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep1	13280-142F4	26.19	4.17	0.79	0.40	0.60	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep2	13281-142F5	21.74	2.92	0.97	0.32	1.30	0.00	0.32	0.00
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep3	13282-142F6	24.45	5.09	3.06	1.02	0.00	0.00	0.00	1.02
mesodermal tumor cell line:HIRS-BM	10696-109G3	14.70	6.96	0.00	0.00	0.00	0.00	0.00	0.00
mesothelioma cell line:ACC-MESO-1	10493-107B7	65.20	10.63	1.65	2.13	2.36	0.24	0.24	0.47
mesothelioma cell line:ACC-MESO-4	10494-107B8	91.05	4.87	5.33	0.93	3.01	0.46	0.23	0.93
mesothelioma cell line:Mero-14, tech_rep1	10849-111F3	89.75	0.00	4.27	0.00	0.00	0.00	0.00	0.00
mesothelioma cell line:Mero-14, tech_rep2	10849-111F3	64.84	4.83	1.34	0.62	2.67	0.51	0.10	0.51
mesothelioma cell line:Mero-25	10850-111F4	81.93	11.80	2.27	1.59	1.36	0.91	0.00	0.23
mesothelioma cell line:Mero-41	10851-111F5	81.17	9.53	3.42	2.44	0.00	0.00	0.49	0.24
mesothelioma cell line:Mero-48a	10852-111F6	40.96	5.54	1.11	1.11	0.44	0.89	0.22	0.22
mesothelioma cell line:Mero-82	10853-111F7	73.59	8.67	3.42	1.05	0.79	1.05	0.00	1.05
mesothelioma cell line:Mero-83	10854-111F8	110.13	9.19	5.28	1.87	1.36	0.34	0.17	1.02
mesothelioma cell line:Mero-84	10855-111F9	76.08	3.79	1.52	0.76	1.01	0.51	0.00	0.25
mesothelioma cell line:Mero-95	10856-111G1	88.41	5.38	4.97	2.07	0.62	1.04	0.62	0.62
mesothelioma cell line:NCI-H2052	10847-111F1	117.78	17.06	7.45	3.31	1.49	0.66	0.17	0.66
mesothelioma cell line:NCI-H226	10846-111E9	117.83	6.33	3.98	1.09	1.09	0.90	0.00	0.72
mesothelioma cell line:NCI-H2452	10848-111F2	108.47	7.86	5.98	1.20	0.85	0.85	0.00	0.68
mesothelioma cell line:NCI-H28	10845-111E8	147.34	18.83	6.36	3.31	2.29	2.04	0.51	0.76
mesothelioma cell line:No36	10857-111G2	102.43	6.52	6.85	0.98	1.30	0.98	0.33	0.00
mesothelioma cell line:ONE58	10858-111G3	51.75	5.69	2.71	0.81	0.54	0.54	0.27	0.00
migratory langerhans cells, donor1	11901-125F2	23.03	9.98	0.19	1.54	0.00	0.38	0.38	0.19
migratory langerhans cells, donor2	11902-125F3	12.09	5.74	0.49	0.24	0.12	0.00	0.37	0.12
migratory langerhans cells, donor3	11903-125F4	18.49	8.79	0.90	0.90	0.36	0.00	0.18	0.00
mixed mullerian tumor cell line:HTMMT	10689-109F5	38.85	3.26	1.63	0.65	1.63	1.31	0.00	0.65
mucinous adenocarcinoma cell line:JHOM-1	10648-109A9	96.22	5.72	2.12	0.21	4.66	1.27	0.21	1.06
mucinous cystadenocarcinoma cell line:MCAS	10784-110H1	54.83	20.96	0.92	3.23	0.92	0.00	0.46	0.69
mycosis fungoides, T cell lymphoma cell line:HuT 102 TIB-162	10744-110C6	119.88	7.23	5.52	0.95	1.90	0.76	0.00	0.95
myelodysplastic syndrome cell line:SKM-1	10772-110F7	323.02	21.25	7.39	4.07	3.70	0.18	0.00	1.29
myeloma cell line:PCM6	10474-106I6	73.14	16.80	1.38	2.37	1.58	0.00	0.00	0.40
myxofibrosarcoma cell line:MFH-ino	10600-108E6	42.11	7.10	0.00	0.51	1.01	0.00	0.00	1.01
myxofibrosarcoma cell line:NMFH-1	10684-109E9	24.32	8.43	1.96	2.35	0.00	0.00	0.00	0.00
nasal epithelial cells, donor1, tech_rep1	12226-129F3	58.28	18.16	0.78	3.23	0.56	0.11	0.45	0.00
nasal epithelial cells, donor1, tech_rep2	12226-129F3	66.41	15.22	0.74	3.02	0.81	0.00	0.22	0.22
nasal epithelial cells, donor2	12227-129F4	50.78	14.90	1.10	2.76	0.00	0.00	0.00	0.00
neuroblastoma cell line:CHP-134	10508-107D4	252.84	20.71	5.75	4.37	3.45	0.00	0.23	1.38
neuroblastoma cell line:NB-1	10539-107G8	304.76	32.55	7.11	7.86	3.93	1.12	0.37	0.94
neuroblastoma cell line:NBsusSR	10607-108F4	188.32	12.86	3.80	2.95	0.84	0.21	0.00	1.05
neuroblastoma cell line:NH-12	10555-107I6	291.45	13.23	5.03	3.91	5.03	1.49	0.19	1.49
neuroectodermal tumor cell line:FU-RPNT-1	10637-108I7	169.62	5.69	1.19	1.42	1.19	0.24	0.24	0.47
neuroectodermal tumor cell line:FU-RPNT-2	10663-109C6	135.26	7.13	1.90	1.27	3.33	1.27	0.00	0.48
neuroectodermal tumor cell line:TASK1	10774-110F9	193.61	8.25	2.62	0.81	2.82	0.81	0.00	1.21
neuroepithelioma cell line:SK-N-MC	10728-110A8	89.64	5.09	0.00	0.00	3.18	0.64	0.00	0.64
neurofibroma cell line:Hs 53.T	10729-110A9	50.31	7.72	2.40	0.53	1.86	0.27	0.00	0.53
neutrophil PMN, donor1	12133-128D9	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
neutrophil PMN, donor2	12137-128E4	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
neutrophil PMN, donor3	12141-128E8	0.00	9.47	0.00	0.00	0.00	0.00	0.00	0.00
non T non B acute lymphoblastic leukemia (ALL) cell line:P30/OHK	10430-106D7	564.02	19.96	8.29	2.88	2.88	1.52	0.17	2.03
non-small cell lung cancer cell line:NCI-H1385	10730-110B1	84.85	9.61	2.40	1.60	2.40	0.00	0.00	0.00
normal embryonic palatal mesenchymal cell line:HEPM	10813-111B3	41.68	4.49	1.28	0.32	1.92	0.96	0.00	0.00
normal intestinal epithelial cell line:FHs 74 Int	10812-111B2	31.27	6.31	1.05	0.79	0.79	0.26	0.26	0.00
nucleus accumbens, adult, pool1	10037-101F1	17.81	23.15	2.44	2.06	0.28	0.28	1.50	0.00
occipital cortex - adult, donor10196	10172-103C1	24.72	22.66	2.06	6.18	0.00	0.00	2.06	0.00
occipital cortex, adult, donor10252	10163-103B1	21.47	27.10	1.88	5.90	0.81	0.00	0.54	0.00
occipital cortex, newborn, donor10223	10355-105E4	12.74	8.37	0.36	0.73	0.36	0.36	0.36	0.36
occipital lobe, adult, donor1	10076-102A4	15.22	25.19	2.62	3.15	0.52	0.26	3.67	0.26
occipital lobe, fetal, donor1	10073-102A1	24.89	16.31	0.43	1.72	1.29	0.00	2.15	1.72
occipital pole, adult, pool1	10036-101E9	10.33	22.00	3.55	2.52	0.39	0.00	1.81	0.24
olfactory region, adult	10195-103E6	13.95	23.88	3.44	2.87	1.34	0.19	1.91	0.96
optic nerve, donor1	10277-104E7	0.00	46.02	4.00	2.00	0.00	0.00	4.00	0.00
oral squamous cell carcinoma cell line:Ca9-22	10434-106E2	43.51	6.26	2.85	1.71	0.34	0.11	0.00	0.00
oral squamous cell carcinoma cell line:HO-1-u-1	10550-107I1	262.68	11.54	8.52	1.24	1.51	0.55	0.00	0.82
oral squamous cell carcinoma cell line:HSC-3	10545-107H5	65.36	6.26	0.34	0.17	0.68	0.51	0.17	0.17
oral squamous cell carcinoma cell line:SAS	10544-107H4	97.95	11.44	1.62	1.85	2.31	0.58	0.12	0.35
osteoclastoma cell line:Hs 706.T	10704-109H2	24.40	15.29	2.35	1.47	0.29	0.00	1.18	0.88
osteosarcoma cell line:143B/TK^(-)neo^(R)	10510-107D6	76.62	9.34	0.93	1.87	0.93	0.93	0.00	0.00
osteosarcoma cell line:HS-Os-1	10558-107I9	111.12	4.24	2.76	0.85	1.06	0.21	0.00	0.21
ovary, adult, pool1	10020-101D2	31.36	17.21	0.61	2.45	0.17	0.26	0.61	0.09
pagetoid sarcoma cell line:Hs 925.T	10732-110B3	82.86	10.08	1.47	1.28	1.83	1.28	0.18	0.73
pancreas, adult, donor1	10049-101G4	38.57	17.87	0.00	1.88	0.94	0.00	0.00	0.00
pancreatic carcinoma cell line:NOR-P1	10698-109G5	120.48	7.83	9.50	1.68	3.35	1.12	0.28	2.24
papillary adenocarcinoma cell line:8505C	10437-106E5	107.66	13.12	4.60	2.21	0.85	0.51	0.17	0.68
papillotubular adenocarcinoma cell line:TGBC18TKB	10417-106C3	73.19	9.44	0.99	1.49	0.99	0.66	0.33	0.83
paracentral gyrus, adult, pool1	10035-101E8	18.76	26.18	4.21	3.66	0.27	0.37	1.83	0.09
parietal cortex, adult, donor10258	10373-105G4	16.88	11.01	2.94	1.47	1.47	0.00	2.20	0.73
parietal lobe - adult, donor10196	10171-103B9	15.99	21.63	0.94	4.70	0.00	0.94	3.76	0.94
parietal lobe, adult, donor10252	10157-103A4	19.95	23.09	4.28	3.99	0.86	0.00	1.14	0.29
parietal lobe, adult, pool1	10034-101E7	16.13	24.50	3.61	2.56	0.09	0.00	2.82	0.09
parietal lobe, fetal, donor1	10072-101I9	51.40	22.31	0.97	3.88	0.97	0.00	0.97	0.00
parietal lobe, newborn, donor10223	10356-105E5	17.57	11.22	0.37	0.75	2.24	0.00	1.87	0.00
parotid gland, adult	10199-103F1	16.03	25.28	1.23	1.23	0.00	0.00	0.62	0.00
penis, adult	10200-103F2	13.96	16.65	1.61	1.61	0.00	0.54	0.54	0.54
peripheral neuroectodermal tumor cell line:KU-SN	10697-109G4	67.49	5.58	0.19	0.19	0.56	0.19	0.37	0.37
pharyngeal carcinoma cell line:Detroit 562	10723-110A3	91.64	12.53	1.89	2.77	1.31	0.73	0.00	1.60
pineal gland - adult, donor10196	10179-103C8	5.81	52.89	5.16	7.74	0.65	0.00	5.81	3.23
pineal gland, adult, donor10252	10160-103A7	13.03	47.38	1.78	6.51	1.18	0.00	2.96	0.59
pineal gland, adult, donor10258	10377-105G8	10.66	53.30	5.02	6.27	3.14	0.00	7.52	0.00
pituitary gland - adult, donor10196	10180-103C9	30.35	21.25	6.07	4.05	0.00	0.00	0.00	0.00
pituitary gland, adult, donor10252	10162-103A9	39.09	33.88	7.30	1.04	0.00	0.52	2.61	0.00
pituitary gland, adult, donor10258	10378-105G9	21.28	34.05	10.21	1.70	3.40	0.85	4.26	0.85
placenta, adult, pool1	10021-101D3	35.26	8.71	2.90	0.65	0.32	0.22	0.43	0.11
plasma cell leukemia cell line:ARH-77	10840-111E3	204.47	29.13	2.91	3.05	1.46	1.06	0.40	0.79
pleomorphic hepatocellular carcinoma cell line:SNU-387	10706-109H4	25.06	4.98	0.93	0.93	0.00	0.16	0.16	0.31
pons, adult, pool1	10033-101E6	26.42	34.86	8.61	4.05	0.34	0.26	1.81	0.26
postcentral gyrus, adult, pool1	10032-101E5	15.60	27.20	3.14	3.05	0.26	0.00	1.83	0.09
promyelocytes/myelocytes PMC, donor1	12132-128D8	4.18	18.82	0.00	2.09	0.00	0.00	0.00	0.00
promyelocytes/myelocytes PMC, donor2	12136-128E3	49.57	5.51	0.00	0.00	5.51	0.00	0.00	0.00
promyelocytes/myelocytes PMC, donor3	12140-128E7	46.94	0.00	0.00	11.74	0.00	0.00	0.00	0.00
prostate cancer cell line:DU145	10490-107B4	145.81	9.32	5.97	0.73	3.35	0.73	0.58	1.31
prostate cancer cell line:PC-3	10439-106E7	257.19	19.60	9.26	2.90	8.71	0.54	0.18	2.18
prostate, adult, pool1	10022-101D4	19.14	14.15	1.36	1.36	0.91	0.27	0.36	0.00
putamen, adult, donor10196	10176-103C5	16.76	15.82	1.42	1.18	0.24	0.00	2.36	0.47
putamen, adult, donor10252	10152-102I8	17.65	13.73	3.92	3.92	3.92	0.00	5.88	0.00
putamen, adult, donor10258, tech_rep1	10372-105G3	139.88	3.28	10.93	0.00	4.37	0.00	1.09	0.00
putamen, adult, donor10258, tech_rep2	10372-105G3	9.91	11.11	3.14	0.48	0.72	0.72	1.21	0.24
putamen, newborn, donor10223	10365-105F5	33.73	10.50	0.75	0.00	0.75	0.75	0.75	2.25
rectal cancer cell line:TT1TKB	10469-106I1	61.10	10.76	0.87	0.87	2.33	0.00	0.29	0.29
rectum, fetal, donor1	10067-101I4	30.60	13.91	1.39	1.39	5.56	1.39	0.00	1.39
renal cell carcinoma cell line:OS-RC-2	10411-106B6	85.44	9.54	2.76	1.06	0.42	0.64	0.64	0.00
renal cell carcinoma cell line:TUHR10TKB	10471-106I3	108.94	14.91	3.31	1.24	1.24	1.24	0.00	1.24
retina, adult, pool1	10030-101E3	16.30	18.39	2.68	1.09	0.40	0.10	0.70	0.00
retinoblastoma cell line:Y79	10475-106I7	564.29	38.97	36.89	4.16	6.24	4.68	0.26	1.56
rhabdomyosarcoma cell line:KYM-1	10787-110H4	185.53	5.16	7.50	0.61	2.58	0.25	0.12	1.84
rhabdomyosarcoma cell line:RMS-YM	10477-106I9	150.16	8.15	3.66	1.41	6.47	0.28	0.00	1.97
sacrococcigeal teratoma cell line:HTST	10695-109G2	15.91	3.03	0.76	0.00	0.00	0.76	0.00	0.00
salivary acinar cells, donor1	11771-123I7	82.55	6.31	1.78	0.81	0.32	0.16	0.49	0.32
salivary acinar cells, donor2	11772-123I8	51.63	9.78	1.51	1.38	1.24	0.14	0.14	0.41
salivary acinar cells, donor3	11773-123I9	6.62	5.96	0.00	1.99	1.32	0.00	0.00	0.00
salivary gland, adult, pool1	10093-102C3	17.73	9.72	2.86	6.86	0.00	0.00	0.00	0.00
schwannoma cell line:HS-PSS, tech_rep1	10442-106F1	107.41	12.06	2.78	1.85	1.01	0.42	0.17	0.51
schwannoma cell line:HS-PSS, tech_rep2	10442-106F1	87.34	14.93	3.17	1.76	1.29	0.82	0.71	0.94
seminal vesicle, adult	10201-103F3	15.87	19.05	3.17	3.17	1.59	0.53	0.53	1.06
serous adenocarcinoma cell line:JHOS-2	10639-108I9	79.19	15.30	3.89	2.43	0.24	0.24	0.73	0.24
serous adenocarcinoma cell line:SK-OV-3-R after co-culture with SOC-57-02-G, biol_rep1	11843-124H7	33.47	9.31	2.26	1.51	0.50	0.00	0.50	0.00
serous adenocarcinoma cell line:SK-OV-3-R, biol_rep1	11841-124H5	84.30	16.06	2.01	2.01	2.01	1.00	0.00	1.00
serous cystadenocarcinoma cell line:HTOA	10693-109F9	55.88	13.16	3.49	1.75	0.81	0.40	0.13	0.00
signet ring carcinoma cell line:Kato III	10436-106E4	95.61	36.81	2.43	4.64	1.11	0.00	0.22	0.33
signet ring carcinoma cell line:NUGC-4	10483-107A6	130.96	19.48	3.35	3.35	3.10	0.65	0.00	1.42
skeletal muscle - soleus muscle, donor1	10282-104F3	10.64	24.12	0.00	5.67	0.00	0.71	2.13	0.71
skeletal muscle, adult, pool1	10023-101D5	12.35	20.03	0.36	2.04	0.12	0.12	0.48	0.00
skeletal muscle, fetal, donor1	10066-101I3	14.07	11.06	0.00	0.00	0.00	0.00	1.01	0.00
skin, adult, donor1	10074-102A2	20.36	0.00	0.00	0.00	0.00	0.00	0.00	0.00
skin, fetal, donor1	10065-101I2	31.56	14.52	1.89	2.52	0.00	1.26	1.26	0.63
small cell cervical cancer cell line:HCSC-1	10800-110I8	65.04	13.34	6.34	2.33	1.33	0.33	0.67	0.67
small cell gastrointestinal carcinoma cell line:ECC10	10610-108F7	125.14	8.83	5.04	1.58	0.95	0.32	0.00	0.32
small cell lung carcinoma cell line:DMS 144	10841-111E4	111.79	6.75	0.77	0.96	0.96	0.00	0.19	0.58
small cell lung carcinoma cell line:LK-2	10541-107H1	245.10	32.64	3.46	2.64	3.96	0.16	0.16	1.48
small cell lung carcinoma cell line:NCI-H82	10842-111E5	287.28	61.44	8.53	3.86	2.25	1.29	0.80	0.80
small cell lung carcinoma cell line:WA-hT	10562-108A4	133.15	22.23	6.32	2.62	3.27	0.00	0.87	0.87
small intestine, adult, pool1	10024-101D6	23.89	15.29	1.07	1.19	1.07	0.36	0.36	0.48
small intestine, fetal, donor1	10064-101I1	41.28	15.72	0.74	2.46	1.47	0.00	0.49	0.00
small-cell gastrointestinal carcinoma cell line:ECC4	10609-108F6	41.54	8.21	0.51	2.05	0.51	1.54	0.00	0.00
smooth muscle, adult, pool1	10048-101G3	10.86	13.96	0.52	0.78	0.26	0.00	0.78	0.00
somatostatinoma cell line:QGP-1	10781-110G7	34.57	12.06	1.07	4.82	2.68	0.00	0.27	0.27
spinal cord - adult, donor10196	10181-103D1	24.55	26.84	1.61	1.84	0.69	0.46	2.52	0.46
spinal cord, adult, donor10252	10159-103A6	39.82	20.11	2.37	2.76	1.18	0.79	1.58	0.00
spinal cord, adult, donor10258	10369-105F9	37.36	22.83	2.08	5.53	2.77	0.69	8.99	2.77
spinal cord, fetal, donor1	10056-101H2	20.73	19.51	1.22	4.27	0.00	0.00	1.83	0.61
spinal cord, newborn, donor10223	10359-105E8	35.82	20.21	1.84	1.84	0.46	0.46	2.30	0.46
spindle cell sarcoma cell line:Hs 132.T	10737-110B8	35.70	10.75	1.34	1.49	0.45	0.30	0.45	0.75
spleen, adult, pool1	10025-101D7	35.35	6.28	1.32	0.99	0.77	0.22	0.22	0.11
spleen, fetal, pool1	10044-101F8	38.14	5.64	1.35	1.11	0.16	0.16	0.08	0.08
splenic lymphoma with villous lymphocytes cell line:SLVL	10424-106D1	235.18	28.36	12.63	4.35	2.38	0.83	0.52	0.62
squamous cell carcinoma cell line:EC-GI-10	10463-106H4	44.43	5.70	0.38	0.95	1.14	0.38	0.00	0.38
squamous cell carcinoma cell line:JHUS-nk1	10646-109A7	51.72	10.13	1.75	2.45	0.35	1.05	0.35	0.00
squamous cell carcinoma cell line:T3M-5	10616-108G4	26.58	22.28	0.00	0.78	0.78	0.78	0.78	0.39
squamous cell lung carcinoma cell line:EBC-1	10486-107A9	67.09	62.92	5.97	12.27	2.59	1.46	1.01	0.79
squamous cell lung carcinoma cell line:LC-1F	10457-106G7	158.43	9.32	2.12	1.69	1.27	0.85	0.00	0.42
squamous cell lung carcinoma cell line:RERF-LC-AI	10501-107C6	44.42	2.54	3.81	0.00	1.27	0.42	0.00	0.00
stomach, fetal, donor1	10062-101H8	10.68	13.88	1.07	2.14	2.14	0.00	0.00	0.00
submaxillary gland, adult	10202-103F4	10.25	23.36	0.57	4.56	0.00	0.00	0.57	0.00
substantia nigra - adult, donor10196	10178-103C7	0.00	54.27	0.00	0.00	54.27	54.27	0.00	0.00
substantia nigra, adult, donor10252	10158-103A5	30.95	17.86	2.49	3.32	0.62	0.62	0.62	0.42
substantia nigra, adult, donor10258	10371-105G2	26.90	19.14	7.24	6.21	2.59	1.55	2.59	1.03
substantia nigra, newborn, donor10223	10358-105E7	19.78	11.31	2.12	1.41	1.41	0.00	2.12	2.83
synovial sarcoma cell line:HS-SY-II	10441-106E9	165.07	10.78	3.67	1.83	3.90	0.69	0.00	0.92
temporal lobe, adult, pool1	10031-101E4	13.48	20.94	2.97	2.12	0.76	0.08	1.61	0.08
temporal lobe, fetal, donor1, tech_rep1	10063-101H9	17.81	25.64	0.71	1.42	0.71	0.00	2.85	0.71
temporal lobe, fetal, donor1, tech_rep2	10063-101H9	24.61	16.26	0.00	3.08	0.44	0.00	2.64	0.44
tenocyte, donor1	11763-123H8	41.19	8.03	1.40	1.40	1.05	0.00	0.35	0.35
tenocyte, donor2	11765-123I1	16.79	6.10	0.76	0.76	0.00	0.00	0.00	0.38
tenocyte, donor3	11768-123I4	31.51	5.19	0.37	0.37	0.74	1.11	0.37	0.00
teratocarcinoma cell line:NCC-IT-A3	10790-110H7	395.33	22.09	21.42	3.06	10.88	1.19	0.68	3.40
teratocarcinoma cell line:NCR-G1	10798-110I6	180.35	12.49	12.49	1.54	5.86	1.85	0.46	1.08
teratocarcinoma cell line:PA-1	10807-111A6	387.44	30.22	15.50	2.94	4.03	1.55	0.62	2.94
testicular germ cell embryonal carcinoma cell line:ITO-II	10786-110H3	180.39	7.11	8.00	0.63	3.05	0.63	0.00	1.27
testicular germ cell embryonal carcinoma cell line:NEC14	10591-108D6	142.95	13.99	9.83	2.65	3.40	1.13	0.38	1.13
testicular germ cell embryonal carcinoma cell line:NEC15	10593-108D8	147.23	11.23	2.51	1.31	0.98	0.44	0.22	0.11
testicular germ cell embryonal carcinoma cell line:NEC8	10590-108D5	254.70	7.17	17.91	1.63	4.56	2.61	0.65	0.65
testis, adult, pool1	10026-101D8	21.69	15.68	3.65	1.93	0.43	0.11	3.44	0.43
testis, adult, pool2	10096-102C6	22.10	30.22	5.41	1.35	3.16	0.45	10.83	0.00
thalamus - adult, donor10196	10168-103B6	20.98	27.60	1.10	2.21	0.00	0.00	2.21	1.10
thalamus, adult, donor10252	10154-103A1	22.97	22.04	1.56	1.56	0.63	0.16	1.41	0.31
thalamus, adult, donor10258, tech_rep1	10370-105G1	20.02	13.86	1.54	7.70	3.08	0.00	0.00	0.00
thalamus, adult, donor10258, tech_rep2	10370-105G1	9.88	13.18	1.32	0.82	0.82	0.00	1.15	0.82
thalamus, newborn, donor10223	10366-105F6	20.14	6.33	1.73	1.73	1.15	0.00	1.15	0.58
throat, adult	10209-103G2	23.72	12.48	0.25	0.25	0.75	0.00	0.75	1.00
throat, fetal, donor1	10061-101H7	18.28	9.14	0.91	0.91	0.61	0.61	1.22	0.00
thymic carcinoma cell line:Ty-82	10803-111A2	366.46	13.12	5.96	1.39	1.99	1.39	0.60	1.59
thymus, adult, pool1	10027-101D9	99.02	7.75	2.68	1.29	0.60	0.30	0.30	0.30
thymus, fetal, pool1	10043-101F7	78.14	8.42	1.56	2.08	0.31	0.21	0.42	0.00
thyroid carcinoma cell line:KHM-5M	10776-110G2	97.33	8.11	4.12	0.53	1.06	0.53	0.27	0.13
thyroid carcinoma cell line:TCO-1	10783-110G9	97.78	10.90	2.10	1.12	2.51	0.56	0.14	0.56
thyroid, adult, pool1	10028-101E1	24.63	16.98	1.31	2.33	0.09	0.28	0.56	0.28
thyroid, fetal, donor1	10060-101H6	13.97	11.86	0.53	1.58	0.79	0.00	1.85	1.05
tongue epidermis (fungiform papillae), donor1	10288-104F9	6.16	21.56	3.08	3.08	6.16	0.00	0.00	0.00
tongue, adult	10203-103F5	35.35	16.28	1.40	0.70	0.00	0.00	0.93	0.00
tongue, fetal, donor1	10059-101H5	24.83	19.31	0.79	2.76	0.00	0.39	1.18	0.39
tonsil, adult, pool1	10047-101G2	51.69	15.73	2.10	2.70	0.30	0.20	0.20	0.20
trachea, adult, pool1	10029-101E2	43.60	11.78	1.31	1.64	0.74	0.16	0.49	0.33
trachea, fetal, donor1	10058-101H4	19.23	9.23	0.38	1.15	0.77	0.00	1.15	0.38
transitional cell carcinoma cell line:Hs 769.T	10707-109H5	66.60	12.05	2.13	0.71	0.71	0.71	0.71	1.42
transitional-cell carcinoma cell line:5637	10418-106C4	116.01	13.07	2.84	2.74	0.81	0.10	0.61	0.41
transitional-cell carcinoma cell line:JMSU1	10492-107B6	325.13	13.32	8.30	2.98	4.39	0.63	0.47	1.57
tridermal teratoma cell line:HGRT	10694-109G1	26.64	3.81	1.90	0.00	3.81	0.00	0.00	0.00
tubular adenocarcinoma cell line:SUIT-2	10797-110I5	72.12	12.27	2.79	2.12	1.19	0.34	0.42	0.42
umbilical cord, fetal, donor1	10057-101H3	27.12	10.43	2.09	0.00	0.00	0.00	0.00	0.00
uterus, adult, pool1	10100-102D1	27.98	14.33	1.19	2.39	0.17	0.00	0.68	0.34
uterus, fetal, donor1	10055-101H1	54.26	5.12	2.05	1.02	0.51	0.51	0.00	0.00
vagina, adult	10204-103F6	16.15	5.82	0.65	1.94	0.00	0.00	0.00	0.00
vein, adult	10191-103E2	14.25	9.86	0.66	0.88	0.00	0.00	0.44	0.00
xeroderma pigentosum b cell line:XPL 17	10563-108A5	106.55	13.08	4.01	2.14	1.87	0.00	0.27	1.07